200,000+ products from a single source!
sales@angenechem.com
Home > Other Building Blocks > 36791-04-5
36791-04-5 | 1-β-D-Ribofuranosyl-1H-1,2,4-triazole-3-carboxamide
CAS No: 36791-04-5 Catalog No: AG0039L3 MDL No:MFCD00058564
Product Description
Catalog Number:
AG0039L3
Chemical Name:
1-β-D-Ribofuranosyl-1H-1,2,4-triazole-3-carboxamide
CAS Number:
36791-04-5
Molecular Formula:
C8H12N4O5
Molecular Weight:
244.2047
MDL Number:
MFCD00058564
IUPAC Name:
1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,4-triazole-3-carboxamide
InChI:
InChI=1S/C8H12N4O5/c9-6(16)7-10-2-12(11-7)8-5(15)4(14)3(1-13)17-8/h2-5,8,13-15H,1H2,(H2,9,16)/t3-,4-,5-,8-/m1/s1
InChI Key:
IWUCXVSUMQZMFG-AFCXAGJDSA-N
SMILES:
OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc(n1)C(=O)N
UNII:
49717AWG6K
NSC Number:
758650
Properties
Complexity:
304
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1
Defined Atom Stereocenter Count:
4
Defined Bond Stereocenter Count:
0
Exact Mass:
244.081g/mol
Formal Charge:
0
Heavy Atom Count:
17
Hydrogen Bond Acceptor Count:
7
Hydrogen Bond Donor Count:
4
Isotope Atom Count:
0
Molecular Weight:
244.207g/mol
Monoisotopic Mass:
244.081g/mol
Rotatable Bond Count:
3
Topological Polar Surface Area:
144A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
-1.8
Literature
| Title | Journal |
|---|---|
| Profiling the immunotoxicity of chemicals based on in vitro evaluation by a combination of the Multi-ImmunoTox assay and the IL-8 Luc assay. | Archives of toxicology 20180601 |
| Dasabuvir (ABT333) for the treatment of chronic HCV genotype I: a new face of cure, an expert review. | Expert review of anti-infective therapy 20160101 |
| Interferon-free therapy for hepatitis C: The hurdles amid a golden era. | Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20150901 |
| Design and synthesis of imidazole N-H substituted amide prodrugs as inhibitors of hepatitis C virus replication. | Bioorganic & medicinal chemistry letters 20150815 |
| Hepatitis C virus: Virology, diagnosis and treatment. | World journal of hepatology 20150608 |
| Treatment with ledipasvir and sofosbuvir improves patient-reported outcomes: Results from the ION-1, -2, and -3 clinical trials. | Hepatology (Baltimore, Md.) 20150601 |
| Systems pharmacological analysis of drugs inducing stevens-johnson syndrome and toxic epidermal necrolysis. | Chemical research in toxicology 20150518 |
| Ombitasvir/paritaprevir/ritonavir and dasabuvir tablets for hepatitis C virus genotype 1 infection. | The Annals of pharmacotherapy 20150501 |
| Ledipasvir-sofosbuvir with or without ribavirin to treat patients with HCV genotype 1 infection and cirrhosis non-responsive to previous protease-inhibitor therapy: a randomised, double-blind, phase 2 trial (SIRIUS). | The Lancet. Infectious diseases 20150401 |
| Sofosbuvir plus ribavirin for treatment of hepatitis C virus in patients co-infected with HIV (PHOTON-2): a multicentre, open-label, non-randomised, phase 3 study. | Lancet (London, England) 20150321 |
| Cost-effectiveness of all-oral ledipasvir/sofosbuvir regimens in patients with chronic hepatitis C virus genotype 1 infection. | Alimentary pharmacology & therapeutics 20150301 |
| Dasabuvir : a new direct antiviral agent for the treatment of hepatitis C. | Expert opinion on pharmacotherapy 20150301 |
| Contribution of CNT1 and ENT1 to ribavirin uptake in human hepatocytes. | Archives of pharmacal research 20150101 |
| An update on the management of chronic hepatitis C: 2015 Consensus guidelines from the Canadian Association for the Study of the Liver. | Canadian journal of gastroenterology & hepatology 20150101 |
| Resveratrol inhibits enterovirus 71 replication and pro-inflammatory cytokine secretion in rhabdosarcoma cells through blocking IKKs/NF-κB signaling pathway. | PloS one 20150101 |
| Cost-effectiveness of sofosbuvir-based treatments for chronic hepatitis C in the US. | BMC gastroenterology 20150101 |
| In vitro activity and resistance profile of samatasvir, a novel NS5A replication inhibitor of hepatitis C virus. | Antimicrobial agents and chemotherapy 20140801 |
| Selective inhibition of hepatitis C virus infection by hydroxyzine and benztropine. | Antimicrobial agents and chemotherapy 20140601 |
| Preclinical characterization of BMS-791325, an allosteric inhibitor of hepatitis C Virus NS5B polymerase. | Antimicrobial agents and chemotherapy 20140601 |
| Synthesis and anti-BVDV activity of novel δ-sultones in vitro: implications for HCV therapies. | Bioorganic & medicinal chemistry letters 20140515 |
| Intracellular effects of the Hepatitis C virus nucleoside polymerase inhibitor RO5855 (Mericitabine Parent) and Ribavirin in combination. | Antimicrobial agents and chemotherapy 20140501 |
| 4'-Substituted pyrimidine nucleosides lacking 5'-hydroxyl function as potential anti-HCV agents. | Bioorganic & medicinal chemistry letters 20140301 |
| Dual inhibition of HCV and HIV by ring-expanded nucleosides containing the 5:7-fused imidazo[4,5-e][1,3]diazepine ring system. In vitro results and implications. | Bioorganic & medicinal chemistry letters 20140215 |
| Preclinical characterization of the novel hepatitis C virus NS3 protease inhibitor GS-9451. | Antimicrobial agents and chemotherapy 20140201 |
| Rhabdomyolysis in a hepatitis C virus infected patient treated with telaprevir and simvastatin. | Annals of hepatology 20140101 |
| Synthesis and antiviral activity of a novel class of (5-oxazolyl)phenyl amines. | European journal of medicinal chemistry 20131101 |
| Peroxisome proliferator-activated receptor delta antagonists inhibit hepatitis C virus RNA replication. | Bioorganic & medicinal chemistry letters 20130901 |
| Synthesis of 4-aminoquinoline-pyrimidine hybrids as potent antimalarials and their mode of action studies. | European journal of medicinal chemistry 20130801 |
| Synthesis and evaluation of a new phosphorylated ribavirin prodrug. | Antiviral research 20130701 |
| Oleanolic acid and ursolic acid: novel hepatitis C virus antivirals that inhibit NS5B activity. | Antiviral research 20130401 |
| Preclinical characterization of GS-9669, a thumb site II inhibitor of the hepatitis C virus NS5B polymerase. | Antimicrobial agents and chemotherapy 20130201 |
| Direct-acting antiviral agents for hepatitis C virus infection. | Annual review of pharmacology and toxicology 20130101 |
| New preclinical antimalarial drugs potently inhibit hepatitis C virus genotype 1b RNA replication. | PloS one 20130101 |
| Hepatitis C virus NS3 inhibitors: current and future perspectives. | BioMed research international 20130101 |
| Successful antiviral therapy for hepatitis C virus-induced cirrhosis after an increase in the platelet count with romiplostim: two case reports. | European journal of gastroenterology & hepatology 20121201 |
| Anti-viral activity of (-)- and (+)-usnic acids and their derivatives against influenza virus A(H1N1)2009. | Bioorganic & medicinal chemistry letters 20121201 |
| Synthesis of isoindole and benzoisoindole derivatives of teicoplanin pseudoaglycon with remarkable antibacterial and antiviral activities. | Bioorganic & medicinal chemistry letters 20121201 |
| Factors associated with HCV antiviral treatment uptake among participants of a community-based HCV programme for marginalized patients. | Journal of viral hepatitis 20121201 |
| Inhibition of norovirus replication by the nucleoside analogue 2'-C-methylcytidine. | Biochemical and biophysical research communications 20121102 |
| Vitamin D binding protein gene polymorphisms and baseline vitamin D levels as predictors of antiviral response in chronic hepatitis C. | Hepatology (Baltimore, Md.) 20121101 |
| The effect of increased oxidative stress and ferritin in reducing the effectiveness of therapy in chronic hepatitis C patients. | Clinical biochemistry 20121101 |
| Understanding the switchbacks: the impact of direct antivirals on the minimization of hepatitis C virus recurrence after transplantation. | Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20121101 |
| High serum palmitic acid is associated with low antiviral effects of interferon-based therapy for hepatitis C virus. | Lipids 20121101 |
| Synthesis and in vitro antitumour screening of 2-(β-D-xylofuranosyl)thiazole-4-carboxamide and two novel tiazofurin analogues with substituted tetrahydrofurodioxol moiety as a sugar mimic. | Bioorganic & medicinal chemistry letters 20121101 |
| (S)-N-(2,5-Dimethylphenyl)-1-(quinoline-8-ylsulfonyl)pyrrolidine-2-carboxamide as a small molecule inhibitor probe for the study of respiratory syncytial virus infection. | Journal of medicinal chemistry 20121025 |
| Ribavirin-induced externalization of phosphatidylserine in erythrocytes is predominantly caused by inhibition of aminophospholipid translocase activity. | European journal of pharmacology 20121015 |
| A new class of pyrimidine nucleosides: inhibitors of hepatitis B and C viruses. | Bioorganic & medicinal chemistry letters 20121015 |
| Insulin resistance and response to telaprevir plus peginterferon α and ribavirin in treatment-naive patients infected with HCV genotype 1. | Gut 20121001 |
| 25-Hydroxyvitamin D3 suppresses hepatitis C virus production. | Hepatology (Baltimore, Md.) 20121001 |
| The impact of lifetime alcohol use on hepatitis C treatment outcomes in privately insured members of an integrated health care plan. | Hepatology (Baltimore, Md.) 20121001 |
| Comparison of hepatitis C virus treatment between incarcerated and community patients. | Hepatology (Baltimore, Md.) 20121001 |
| Eukaryotic initiation factor 5B: a new player for the anti-hepatitis C virus effect of ribavirin? | Medical hypotheses 20121001 |
| Predicted effects of treatment for HCV infection vary among European countries. | Gastroenterology 20121001 |
| Synthesis and biological evaluation of novel homochiral carbocyclic nucleosides from 1-amino-2-indanols. | Bioorganic & medicinal chemistry 20121001 |
| Boceprevir: a protease inhibitor for the treatment of hepatitis C. | Clinical therapeutics 20121001 |
| Combination effect of ribavirin and erythropoietin treatment on hemoglobin A1c in a diabetic patient with chronic hepatitis C. | Journal of the Chinese Medical Association : JCMA 20121001 |
| Re-evaluation of 400 Crimean-Congo hemorrhagic fever cases in an endemic area: is ribavirin treatment suitable? | Vector borne and zoonotic diseases (Larchmont, N.Y.) 20120901 |
| Branch retinal artery occlusion and central retinal vein occlusion associated with pegylated interferon plus ribavirin combination therapy for chronic hepatitis C. | Cutaneous and ocular toxicology 20120901 |
| Impact of peginterferon alpha and ribavirin treatment on lipid profiles and insulin resistance in Hepatitis C virus/HIV-coinfected persons: the AIDS Clinical Trials Group A5178 Study. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20120901 |
| Treatment of recurrent HCV infection following liver transplantation: results of a multicenter, randomized, versus placebo, trial of ribavirin alone as maintenance therapy after one year of PegIFNα-2a plus ribavirin. | Journal of hepatology 20120901 |
| Factors that predict response of patients with hepatitis C virus infection to boceprevir. | Gastroenterology 20120901 |
| Protease inhibitors for the treatment of chronic hepatitis C genotype-1 infection: the new standard of care. | The Lancet. Infectious diseases 20120901 |
| Long-term follow-up of hepatitis B e antigen-negative patients treated with peginterferon α-2a: progressive decrease in hepatitis B surface antigen in responders. | European journal of gastroenterology & hepatology 20120901 |
| Combination of N-methylisatin-β-thiosemicarbazone derivative (SCH16) with ribavirin and mycophenolic acid potentiates the antiviral activity of SCH16 against Japanese encephalitis virus in vitro. | Letters in applied microbiology 20120901 |
| An open-label randomized controlled study of pegylated interferon/ribavirin combination therapy for chronic hepatitis C with versus without fluvastatin. | Journal of viral hepatitis 20120901 |
| Molecular diagnostics for lassa fever at Irrua specialist teaching hospital, Nigeria: lessons learnt from two years of laboratory operation. | PLoS neglected tropical diseases 20120901 |
| Pegylated interferon-associated retinopathy is frequent in hepatitis C virus patients with hypertension and justifies ophthalmologic screening. | Hepatology (Baltimore, Md.) 20120801 |
| Chronic hepatitis C genotype 1 patients with insulin resistance treated with pioglitazone and peginterferon alpha-2a plus ribavirin. | Hepatology (Baltimore, Md.) 20120801 |
| Prophylaxis for ribavirin-related anemia using eicosapentaenoic acid in chronic hepatitis C patients. | Pediatrics international : official journal of the Japan Pediatric Society 20120801 |
| Resveratrol Inhibits respiratory syncytial virus-induced IL-6 production, decreases viral replication, and downregulates TRIF expression in airway epithelial cells. | Inflammation 20120801 |
| Design, synthesis and antiviral activity of novel pyridazines. | European journal of medicinal chemistry 20120801 |
| Refinement of stopping rules during treatment of hepatitis C genotype 1 infection with boceprevir and peginterferon/ribavirin. | Hepatology (Baltimore, Md.) 20120801 |
| Randomised clinical trial: pre-dosing with taribavirin before starting pegylated interferon vs. standard combination regimen in treatment-naïve patients with chronic hepatitis C genotype 1. | Alimentary pharmacology & therapeutics 20120801 |
| Hepatitis C therapy in non-genotype 1 patients: the near future. | Journal of viral hepatitis 20120801 |
| High-dose silibinin rescue treatment for HCV-infected patients showing suboptimal virologic response to standard combination therapy. | Journal of viral hepatitis 20120801 |
| Telaprevir and boceprevir in African Americans with genotype 1 chronic hepatitis C: implications for patients and providers. | Southern medical journal 20120801 |
| The use of peginterferon in monotherapy or in combination with ribavirin for the treatment of acute hepatitis C. | European review for medical and pharmacological sciences 20120801 |
| Utility of high-resolution accurate MS to eliminate interferences in the bioanalysis of ribavirin and its phosphate metabolites. | Bioanalysis 20120801 |
| The adjuvant role of thyroxine in the treatment of chronic hepatitis C infection. | QJM : monthly journal of the Association of Physicians 20120701 |
| Hepatitis C virus selectively perturbs the distal cholesterol synthesis pathway in a genotype-specific manner. | Hepatology (Baltimore, Md.) 20120701 |
| IL28B polymorphism is associated with fatty change in the liver of chronic hepatitis C patients. | Journal of gastroenterology 20120701 |
| The outcomes of glucose abnormalities in pre-diabetic chronic hepatitis C patients receiving peginterferon plus ribavirin therapy. | Liver international : official journal of the International Association for the Study of the Liver 20120701 |
| Single centre experience with pegylated interferon and ribavirin for hepatitis C: looking back before moving forward. | Internal medicine journal 20120701 |
| Development and validation of a useful HPLC-UV method for quantification of total and phosphorylated-ribavirin in blood and erythrocytes of HCV+ patients. | Journal of pharmaceutical and biomedical analysis 20120701 |
| Methylenetetrahydrofolate reductase homozygosis and low-density lipoproteins in patients with genotype 1 chronic hepatitis C. | Journal of viral hepatitis 20120701 |
| Evolution of biomarkers of liver fibrosis and liver insufficiency in hepatitis C virus-infected patients treated with pegylated interferon plus ribavirin and rituximab. | Journal of viral hepatitis 20120701 |
| Structure-activity relationship of a cold-adapted purine nucleoside phosphorylase by site-directed mutagenesis. | Enzyme and microbial technology 20120610 |
| Hepatitis C treatment outcomes in Australian clinics. | The Medical journal of Australia 20120604 |
| Effect of mosapride citrate on gastric emptying in interferon-induced gastroparesis. | Digestive diseases and sciences 20120601 |
| Ranking predictors of a sustained viral response for patients with chronic hepatitis C treated with pegylated interferon and ribavirin in Scotland. | European journal of gastroenterology & hepatology 20120601 |
| 2-Aminopyrimidine based 4-aminoquinoline anti-plasmodial agents. Synthesis, biological activity, structure-activity relationship and mode of action studies. | European journal of medicinal chemistry 20120601 |
| Hepatitis C virus treatment and liver transplantation in the era of new antiviral therapies. | Current opinion in organ transplantation 20120601 |
| The effect of metformin on the efficacy of antiviral therapy in patients with genotype 1 chronic hepatitis C and insulin resistance. | International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 20120601 |
| Protein-tyrosine phosphatases are involved in interferon resistance associated with insulin resistance in HepG2 cells and obese mice. | The Journal of biological chemistry 20120601 |
| Implications of PNPLA3 polymorphism in chronic hepatitis C patients receiving peginterferon plus ribavirin. | Alimentary pharmacology & therapeutics 20120601 |
| Novel 1,2,4-triazole and imidazole derivatives of L-ascorbic and imino-ascorbic acid: synthesis, anti-HCV and antitumor activity evaluations. | Bioorganic & medicinal chemistry 20120601 |
| Severe transaminitis after interferon-ribavirin therapy in HIV/HCV-coinfected patients: influence of a sustained HCV response. | Journal of viral hepatitis 20120601 |
| Inhibition of influenza A virus replication by antagonism of a PI3K-AKT-mTOR pathway member identified by gene-trap insertional mutagenesis. | Antiviral chemistry & chemotherapy 20120514 |
| Crystal structures of murine norovirus-1 RNA-dependent RNA polymerase in complex with 2-thiouridine or ribavirin. | Virology 20120510 |
| New genetic discoveries and treatment for hepatitis C. | JAMA 20120509 |
| Interferon-alpha therapy in patients with hepatitis C virus infection increases plasma phenylalanine and the phenylalanine to tyrosine ratio. | Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 20120501 |
| Pretreatment serum microRNA-122 is not predictive for treatment response in chronic hepatitis C virus infection. | Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20120501 |
| Developing a modified directly observed therapy intervention for hepatitis C treatment in a methadone maintenance program: implications for program replication. | The American journal of drug and alcohol abuse 20120501 |
| Post-load insulin resistance does not predict virological response to treatment of chronic hepatitis C patients without the metabolic syndrome. | Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20120501 |
| Exploiting the anti-HIV-1 activity of acyclovir: suppression of primary and drug-resistant HIV isolates and potentiation of the activity by ribavirin. | Antimicrobial agents and chemotherapy 20120501 |
| [Use of boceprevir and telaprevir in patients with hepatitis C virus infection (practical considerations)]. | Gastroenterologia y hepatologia 20120501 |
| Neurobehavioral effects of interferon-α in patients with hepatitis-C: symptom dimensions and responsiveness to paroxetine. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20120501 |
| Impact of insulin resistance on HCV treatment response and impact of HCV treatment on insulin sensitivity using direct measurements of insulin action. | Diabetes care 20120501 |
| Synthesis and biological evaluation of a series of thieno-expanded tricyclic purine 2'-deoxy nucleoside analogues. | Bioorganic & medicinal chemistry 20120501 |
| Hepatitis C therapy update. | Current opinion in gastroenterology 20120501 |
| Interleukin 28B polymorphisms are the only common genetic variants associated with low-density lipoprotein cholesterol (LDL-C) in genotype-1 chronic hepatitis C and determine the association between LDL-C and treatment response. | Journal of viral hepatitis 20120501 |
| Update on the management and treatment of hepatitis C virus infection: recommendations from the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program Office. | The American journal of gastroenterology 20120501 |
| New virologic tools for management of chronic hepatitis B and C. | Gastroenterology 20120501 |
| Maximizing opportunities and avoiding mistakes in triple therapy for hepatitis C virus. | Gastroenterology 20120501 |
| Management of patients coinfected with HCV and HIV: a close look at the role for direct-acting antivirals. | Gastroenterology 20120501 |
| Genetic factors and hepatitis C virus infection. | Gastroenterology 20120501 |
| Changes in fasting plasma glucose levels with ribavirin and pegylated interferon treatment in normal and impaired glucose tolerant patients with chronic hepatitis C. | Hawai'i journal of medicine & public health : a journal of Asia Pacific Medicine & Public Health 20120501 |
| Quantitative liver function tests improve the prediction of clinical outcomes in chronic hepatitis C: results from the Hepatitis C Antiviral Long-term Treatment Against Cirrhosis Trial. | Hepatology (Baltimore, Md.) 20120401 |
| Hepatitis C virus reinfection and superinfection among treated and untreated participants with recent infection. | Hepatology (Baltimore, Md.) 20120401 |
| In vitro and in vivo evaluation of ribavirin and pleconaril antiviral activity against enterovirus 71 infection. | Archives of virology 20120401 |
| Hepatic Methionine-enkephalin may interfere with response to antiviral therapy in chronic hepatitis C. | European journal of gastroenterology & hepatology 20120401 |
| Should we treat HCV carriers with normal ALT levels? The '5Ws' dilemma. | Journal of viral hepatitis 20120401 |
| [Current indications for triple therapy in hepatitis C virus infection]. | Gastroenterologia y hepatologia 20120401 |
| Review of boceprevir and telaprevir for the treatment of chronic hepatitis C. | Canadian journal of gastroenterology = Journal canadien de gastroenterologie 20120401 |
| [Anti SSPE drugs]. | Nihon rinsho. Japanese journal of clinical medicine 20120401 |
| Chronic hepatitis C: treat or wait? Medical decision making in clinical practice. | World journal of gastroenterology 20120328 |
| Synthesis and anti-influenza activity of aminoalkyl rupestonates. | Bioorganic & medicinal chemistry letters 20120315 |
| [Hungarian consensus guideline for the diagnosis and treatment of B, C, and D viral hepatitis]. | Orvosi hetilap 20120311 |
| Comparison of ribavirin and oseltamivir in reducing mortality and lung injury in mice infected with mouse adapted A/California/04/2009 (H1N1). | Life sciences 20120310 |
| Retinal nerve fibre layer defects associated with cotton-wool spots in patients with interferon retinopathy. | Acta ophthalmologica 20120301 |
| Data mining model using simple and readily available factors could identify patients at high risk for hepatocellular carcinoma in chronic hepatitis C. | Journal of hepatology 20120301 |
| Effects of anti-viral therapy and HCV clearance on cerebral metabolism and cognition. | Journal of hepatology 20120301 |
| Evaluation of drugs with specific organ toxicities in organ-specific cell lines. | Toxicological sciences : an official journal of the Society of Toxicology 20120301 |
| UK consensus guidelines for the use of the protease inhibitors boceprevir and telaprevir in genotype 1 chronic hepatitis C infected patients. | Alimentary pharmacology & therapeutics 20120301 |
| Telaprevir for the treatment of hepatitis C. | Expert opinion on pharmacotherapy 20120301 |
| Low hemoglobin A(1c)--good diabetic control? | Clinical chemistry 20120301 |
| Boceprevir: an oral protease inhibitor for the treatment of chronic HCV infection. | Expert review of anti-infective therapy 20120301 |
| Does antiviral therapy reduce the risk of hepatocellular carcinoma in patients with chronic hepatitis C? | Minerva gastroenterologica e dietologica 20120301 |
| Recent trends in the treatment of chronic hepatitis C. | The Korean journal of hepatology 20120301 |
| The effect of alanine aminotransferase dynamics on predicting sustained virological response in chronic hepatitis C virus infection. | The Korean journal of hepatology 20120301 |
| Rapid normalization of alanine aminotransferase predicts viral response during combined peginterferon and ribavirin treatment in chronic hepatitis C patients. | The Korean journal of hepatology 20120301 |
| Evaluation of ITX 5061, a scavenger receptor B1 antagonist: resistance selection and activity in combination with other hepatitis C virus antivirals. | The Journal of infectious diseases 20120215 |
| Liver protein profiling in chronic hepatitis C: identification of potential predictive markers for interferon therapy outcome. | Journal of proteome research 20120203 |
| Predicting response to therapy in chronic hepatitis C: an approach combining interleukin-28B gene polymorphisms and clinical data. | Journal of gastroenterology and hepatology 20120201 |
| A multi-disciplinary approach to treating hepatitis C with interferon and ribavirin in alcohol-dependent patients with ongoing abuse. | Journal of hepatology 20120201 |
| [New treatments of chronic hepatitis C]. | Presse medicale (Paris, France : 1983) 20120201 |
| Interferon free hepatitis C treatment regimens: the beginning of another era. | Current gastroenterology reports 20120201 |
| Dynamic changes in HCV RNA levels and viral quasispecies in a patient with chronic hepatitis C after telaprevir-based treatment. | Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 20120201 |
| [Individualized treatment of hepatitis C virus infection]. | Presse medicale (Paris, France : 1983) 20120201 |
| Variants in the ITPA gene protect against ribavirin-induced hemolytic anemia in HIV/HCV-coinfected patients with all HCV genotypes. | The Journal of infectious diseases 20120201 |
| Neutrophil function and apoptosis in patients with chronic hepatitis C treated with pegylated interferon α and ribavirin. | Archivum immunologiae et therapiae experimentalis 20120201 |
| Telaprevir user's guide. | Liver international : official journal of the International Association for the Study of the Liver 20120201 |
| Phase III results of Boceprevir in treatment naïve patients with chronic hepatitis C genotype 1. | Liver international : official journal of the International Association for the Study of the Liver 20120201 |
| Boceprevir and telaprevir for the treatment of chronic hepatitis C: safety management in clinical practice. | Liver international : official journal of the International Association for the Study of the Liver 20120201 |
| Phase III results in Genotype 1 naïve patients: predictors of response with boceprevir and telaprevir combined with pegylated interferon and ribavirin. | Liver international : official journal of the International Association for the Study of the Liver 20120201 |
| Triple therapy with telaprevir: results in hepatitis C virus-genotype 1 infected relapsers and non-responders. | Liver international : official journal of the International Association for the Study of the Liver 20120201 |
| Triple therapy with boceprevir for HCV genotype 1 infection: phase III results in relapsers and nonresponders. | Liver international : official journal of the International Association for the Study of the Liver 20120201 |
| Triple therapy for HCV genotype 1 infection: telaprevir or boceprevir? | Liver international : official journal of the International Association for the Study of the Liver 20120201 |
| Triple combination treatment for chronic hepatitis C with protease inhibitors, pegylated interferon and ribavirin: 'lead-in or no lead-in'? | Liver international : official journal of the International Association for the Study of the Liver 20120201 |
| Response-guided and -unguided treatment of chronic hepatitis C. | Liver international : official journal of the International Association for the Study of the Liver 20120201 |
| Direct acting antivirals for the treatment of chronic hepatitis C: one pill a day for tomorrow. | Liver international : official journal of the International Association for the Study of the Liver 20120201 |
| The role of ribavirin in direct acting antiviral drug regimens for chronic hepatitis C. | Liver international : official journal of the International Association for the Study of the Liver 20120201 |
| Future treatment of patients with HCV cirrhosis. | Liver international : official journal of the International Association for the Study of the Liver 20120201 |
| Hepatitis C virus treatment pre- and post-liver transplantation. | Liver international : official journal of the International Association for the Study of the Liver 20120201 |
| Hepatitis C virus-human immunodeficiency virus coinfection. | Liver international : official journal of the International Association for the Study of the Liver 20120201 |
| What's new in HCV genotype 2 treatment. | Liver international : official journal of the International Association for the Study of the Liver 20120201 |
| Treatment of patients with genotype 3 chronic hepatitis C--current and future therapies. | Liver international : official journal of the International Association for the Study of the Liver 20120201 |
| The future for the treatment of genotype 4 chronic hepatitis C. | Liver international : official journal of the International Association for the Study of the Liver 20120201 |
| Barriers to hepatitis C treatment. | Liver international : official journal of the International Association for the Study of the Liver 20120201 |
| Efficacy and safety of telaprevir, a new protease inhibitor, for difficult-to-treat patients with genotype 1 chronic hepatitis C. | Journal of viral hepatitis 20120201 |
| Treatment failure with new hepatitis C drugs. | Expert opinion on pharmacotherapy 20120201 |
| Chemical compositions and anti-influenza activities of essential oils from Mosla dianthera. | Journal of ethnopharmacology 20120131 |
| Preliminary study of two antiviral agents for hepatitis C genotype 1. | The New England journal of medicine 20120119 |
| Toward the establishment of a prediction system for the personalized treatment of chronic hepatitis C. | The Journal of infectious diseases 20120115 |
| Efficacy and safety of treatment of hepatitis C virus infection in renal transplant recipients. | World journal of gastroenterology 20120107 |
| Pitavastatin enhances antiviral efficacy of standard pegylated interferon plus ribavirin in patients with chronic hepatitis C: a prospective randomized pilot study. | Journal of hepatology 20120101 |
| [Coinfection with HIV and HCV: abacavir and ribavirine, why not?]. | Revista clinica espanola 20120101 |
| AIDS-related Kaposi's sarcoma can occur during peginterferon-α and ribavirin therapy for chronic hepatitis C infection. | Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002) 20120101 |
| Rhabdomyolysis associated with the co-administration of daptomycin and pegylated interferon α-2b and ribavirin in a patient with hepatitis C. | The Journal of antimicrobial chemotherapy 20120101 |
| Combination PEG-IFN a-2b/ribavirin therapy following treatment of hepatitis C virus-associated hepatocellular carcinoma is capable of improving hepatic functional reserve and survival. | Hepato-gastroenterology 20120101 |
| The design, synthesis and biological evaluations of C-6 or C-7 substituted 2-hydroxyisoquinoline-1,3-diones as inhibitors of hepatitis C virus. | Bioorganic & medicinal chemistry 20120101 |
| Incidence and risk factors of retinopathy in Egyptian patients with chronic hepatitis C virus treated with pegylated interferon plus ribavirin. | International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 20120101 |
| Design, synthesis, antiviral and cytostatic evaluation of novel isoxazolidine nucleotide analogues with a 1,2,3-triazole linker. | European journal of medicinal chemistry 20120101 |
| Boceprevir and telaprevir in the management of hepatitis C virus-infected patients. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20120101 |
| Severe anaemia related to oseltamivir during treatment of chronic hepatitis C: a new drug interaction? | Journal of viral hepatitis 20120101 |
| Comparison of peginterferon pharmacokinetic and pharmacodynamic profiles. | Journal of viral hepatitis 20120101 |
| Influence of IL28B polymorphisms on response to a lower-than-standard dose peg-IFN-α 2a for genotype 3 chronic hepatitis C in HIV-coinfected patients. | PloS one 20120101 |
| Response rates of standard interferon therapy in chronic HCV patients of Khyber Pakhtunkhwa (KPK). | Virology journal 20120101 |
| Synthesis of novel aza-analogues of tiazofurin with 2-[5,5-bis(hydroxymethyl)pyrrolidin-2-yl] framework as sugar mimic. | Nucleosides, nucleotides & nucleic acids 20120101 |
| Factors linked to severe thrombocytopenia during antiviral therapy in patients with chronic hepatitis c and pretreatment low platelet counts. | BMC gastroenterology 20120101 |
| Efficacy of combined therapy with amantadine, oseltamivir, and ribavirin in vivo against susceptible and amantadine-resistant influenza A viruses. | PloS one 20120101 |
| Antiviral strategies in hepatitis C virus infection. | Journal of hepatology 20120101 |
| The vitamin D receptor gene bAt (CCA) haplotype impairs the response to pegylated-interferon/ribavirin-based therapy in chronic hepatitis C patients. | Antiviral therapy 20120101 |
| Hepatitis C: epidemiology, diagnosis, natural history and therapy. | Contributions to nephrology 20120101 |
| Sequence heterogeneity in NS5A of hepatitis C virus genotypes 2a and 2b and clinical outcome of pegylated-interferon/ribavirin therapy. | PloS one 20120101 |
| Deciphering the interleukin 28B variants that better predict response to pegylated interferon-α and ribavirin therapy in HCV/HIV-1 coinfected patients. | PloS one 20120101 |
| Pegylated interferon-alpha2b plus ribavirin for the treatment of chronic hepatitis C virus genotype 4 infection in patients with normal serum ALT. | Annals of hepatology 20120101 |
| Circulating sCD14 is associated with virological response to pegylated-interferon-alpha/ribavirin treatment in HIV/HCV co-infected patients. | PloS one 20120101 |
| Agranulocytosis during treatment of chronic hepatitis C complicated by hyperthyreosis. Case reports. | Endokrynologia Polska 20120101 |
| The effect of pegylated interferon-alpha2b and ribavirin combination therapy for chronic hepatitis C infection in elderly patients. | BMC research notes 20120101 |
| Engaging HIV-HCV co-infected patients in HCV treatment: the roles played by the prescribing physician and patients' beliefs (ANRS CO13 HEPAVIH cohort, France). | BMC health services research 20120101 |
| Suppression of ribosomal protein synthesis and protein translation factors by Peg-interferon alpha/ribavirin in HCV patients blood mononuclear cells (PBMC). | Journal of translational medicine 20120101 |
| Hepatitis C viral evolution in genotype 1 treatment-naïve and treatment-experienced patients receiving telaprevir-based therapy in clinical trials. | PloS one 20120101 |
| Altered thymic function during interferon therapy in HCV-infected patients. | PloS one 20120101 |
| Advances in the treatment of hepatitis C virus infection. | Topics in antiviral medicine 20120101 |
| Antioxidant supplementation attenuates oxidative stress in chronic hepatitis C patients. | Gastroenterologia y hepatologia 20120101 |
| An analogue of the antibiotic teicoplanin prevents flavivirus entry in vitro. | PloS one 20120101 |
| Impact of obesity on the bioavailability of peginterferon-α2a and ribavirin and treatment outcome for chronic hepatitis C genotype 2 or 3. | PloS one 20120101 |
| De novo Cryoglobulinaemic Mononeuritis Multiplex during Treatment of Chronic Hepatitis C Infection: A Viral Effect or Induced by Pegylated Interferon Alpha? | Case reports in gastroenterology 20120101 |
| Pegylated interferon, but not conventional interferon therapy induced severe skin lesions. | Annals of hepatology 20120101 |
| [Efficacy of triple therapy in patients with chronic hepatitis C not treated and patients previously treated ineffectively]. | Przeglad epidemiologiczny 20120101 |
| Therapeutic effectiveness of biosimilar standard interferon versus pegylated interferon for chronic hepatitis C genotypes 2 or 3. | The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases 20120101 |
| A genetic validation study reveals a role of vitamin D metabolism in the response to interferon-alfa-based therapy of chronic hepatitis C. | PloS one 20120101 |
| Interferon-α for patients with chronic hepatitis delta: a systematic review of randomized clinical trials. | Antiviral therapy 20120101 |
| [Efficacy of antiviral agents in the treatment of Crimean hemorrhagic fever]. | Klinicheskaia meditsina 20120101 |
| Antiviral activity of nucleoside analogues against norovirus. | Antiviral therapy 20120101 |
| Telaprevir: pharmacokinetics and drug interactions. | Antiviral therapy 20120101 |
| IL28B polymorphisms predict the response to chronic hepatitis C virus infection treatment in a Mexican population. | Annals of hepatology 20120101 |
| [Side-effects of pegylated interferon plus ribavirin therapy with or without protease inhibitor direct acting antiviral agents during treatment of chronic hepatitis C virus infection]. | Orvosi hetilap 20111211 |
| Does the antiviral therapy of patients with chronic hepatitis exert nephrotoxic effects? | Immunopharmacology and immunotoxicology 20111201 |
| The determination of GGT is the most reliable predictor of nonresponsiveness to interferon-alpha based therapy in HCV type-1 infection. | Journal of gastroenterology 20111201 |
| Efficacy of the protease inhibitor BI 201335, polymerase inhibitor BI 207127, and ribavirin in patients with chronic HCV infection. | Gastroenterology 20111201 |
| Effect of accompanying antiretroviral drugs on virological response to pegylated interferon and ribavirin in patients co-infected with HIV and hepatitis C virus. | The Journal of antimicrobial chemotherapy 20111201 |
| Randomised clinical trial: escitalopram for the prevention of psychiatric adverse events during treatment with peginterferon-alfa-2a and ribavirin for chronic hepatitis C. | Alimentary pharmacology & therapeutics 20111201 |
| Interferon-free treatment regimens for hepatitis C: are we there yet? | Gastroenterology 20111201 |
| Telaprevir for the treatment of chronic hepatitis C infection. | Expert review of anti-infective therapy 20111201 |
| Efficacy of pegylated interferon alfa-2a or alfa-2b in combination with ribavirin in the treatment of chronic hepatitis caused by hepatitis C virus genotype 1b. | Polskie Archiwum Medycyny Wewnetrznej 20111201 |
| Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps). | PLoS computational biology 20111201 |
| Thalidomide with peginterferon alfa-2b and ribavirin in the treatment of non-responders genotype 1 chronic hepatitis C patients: proof of concept. | Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva 20111201 |
| Challenges and opportunities for hepatitis C drug development in HIV-hepatitis C virus-co-infected patients. | AIDS (London, England) 20111128 |
| LC-MS/MS quantitation of ribavirin in serum and identification of endogenous isobaric interferences. | Clinica chimica acta; international journal of clinical chemistry 20111120 |
| Antiviral activity, safety, and pharmacokinetics of danoprevir/ritonavir plus PEG-IFN α-2a/RBV in hepatitis C patients. | Journal of hepatology 20111101 |
| Approach to a child with lower airway obstruction and bronchiolitis. | Indian journal of pediatrics 20111101 |
| Anemia is not predictive of sustained virological response in liver transplant recipients with hepatitis C virus who are treated with pegylated interferon and ribavirin. | Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20111101 |
| New treatments for chronic hepatitis C virus infection. | Medecine et maladies infectieuses 20111101 |
| Efficacy of pegylated interferon plus ribavirin combination therapy for hepatitis C patients with normal ALT levels: a matched case-control study. | Journal of gastroenterology 20111101 |
| Use of plethysmography in assessing the efficacy of antivirals in a mouse model of pandemic influenza A virus. | Antiviral research 20111101 |
| Female patients in fertile age with chronic hepatitis C, easy genotype, and persistently normal transaminases have a 100% chance to reach a sustained virological response. | European journal of gastroenterology & hepatology 20111101 |
| Ultra-rapid virological response, young age, low γ-GT/ALT-ratio, and absence of steatosis identify a subgroup of HCV Genotype 3 patients who achieve SVR with IFN-α(2a) monotherapy. | Digestive diseases and sciences 20111101 |
| [Subacute sclerosing panencephalitis (SSPE)]. | Rinsho shinkeigaku = Clinical neurology 20111101 |
| L-carnitine supplementation improves hematological pattern in patients affected by HCV treated with Peg interferon-α 2b plus ribavirin. | World journal of gastroenterology 20111021 |
| Lack of association of indoleamine 2,3-dioxygenase polymorphisms with interferon-alpha-related depression in hepatitis C. | Brain, behavior, and immunity 20111001 |
| [Gene expression profiling in the first twelve weeks of treatment in chronic hepatitis C patients]. | Enfermedades infecciosas y microbiologia clinica 20111001 |
| Natural leukocyte interferon alpha (Alfaferone) combined with ribavirin in the treatment of patients with HCV-related cirrhosis: our experience. | Infection 20111001 |
| Early changes in natural killer cell function indicate virologic response to interferon therapy for hepatitis C. | Gastroenterology 20111001 |
| Taribavirin in the treatment of hepatitis C. | Expert opinion on investigational drugs 20111001 |
| Synthesis, structure-activity relationship and in vitro biological evaluation of N-arylethyl isoquinoline derivatives as Coxsackievirus B3 inhibitors. | Bioorganic & medicinal chemistry letters 20111001 |
| Metabolic alterations and chronic hepatitis C: treatment strategies. | Expert opinion on pharmacotherapy 20111001 |
| Antiviral drugs for viruses other than human immunodeficiency virus. | Mayo Clinic proceedings 20111001 |
| Penile paraffinoma developing during treatment with pegylated interferon alfa-2a for chronic hepatitis C virus infection. | Archives of dermatology 20111001 |
| Thyroid hormonal disturbances related to treatment of hepatitis C with interferon-alpha and ribavirin. | Clinics (Sao Paulo, Brazil) 20111001 |
| [New triple therapy in chronic hepatitis C. Increased patient chances]. | MMW Fortschritte der Medizin 20110929 |
| Anti-influenza virus polyketides from the acid-tolerant fungus Penicillium purpurogenum JS03-21. | Journal of natural products 20110923 |
| Retinopathy associated with pegylated interferon and ribavirin causing permanent visual impairment in a patient with chronic hepatitis C. | Ophthalmic surgery, lasers & imaging : the official journal of the International Society for Imaging in the Eye 20110908 |
| Pegylated interferon alpha-2a for treatment of chronic HCV infection in hemodialysis patients: a single Saudi center experience. | International urology and nephrology 20110901 |
| Pretreatment prediction of anemia progression by pegylated interferon alpha-2b plus ribavirin combination therapy in chronic hepatitis C infection: decision-tree analysis. | Journal of gastroenterology 20110901 |
| Antiviral combination therapy with peginterferon and ribavirin does not induce a therapeutically resistant mutation in the HCV core region regardless of genetic polymorphism near the IL28B gene. | Journal of medical virology 20110901 |
| Pegylated interferon plus ribavirin therapy improves pancreatic β-cell function in chronic hepatitis C patients. | Liver international : official journal of the International Association for the Study of the Liver 20110901 |
| Treatment of severe acute hepatitis E by ribavirin. | Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 20110901 |
| Synergistic activity of baicalein with ribavirin against influenza A (H1N1) virus infections in cell culture and in mice. | Antiviral research 20110901 |
| Boceprevir: a protease inhibitor for the treatment of chronic hepatitis C. | The Annals of pharmacotherapy 20110901 |
| Will direct-acting antivirals make a difference in HIV-HCV coinfected patients? | Expert review of anti-infective therapy 20110901 |
| The supplementation of acetyl-L-carnitine decreases fatigue and increases quality of life in patients with hepatitis C treated with pegylated interferon-α 2b plus ribavirin. | Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 20110901 |
| [Effect of reducing injection on HFMD in children: a randomized controlled trial]. | Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine 20110901 |
| Durability of a sustained virological response in chronic hepatitis C patients treated with pegylated interferon alfa and ribavirin. | The Korean journal of hepatology 20110901 |
| Clinical features and treatment efficacy of peginterferon alfa plus ribavirin in chronic hepatitis C patients coinfected with hepatitis B virus. | The Korean journal of hepatology 20110901 |
| Peginterferon alpha and ribavirin combination therapy in patients with hepatitis C virus-related liver cirrhosis. | The Korean journal of hepatology 20110901 |
| Cyclosporine a-based immunosuppression reduces relapse rate after antiviral therapy in transplanted patients with hepatitis C virus infection: a large multicenter cohort study. | Transplantation 20110815 |
| Impact of donor and recipient IL28B rs12979860 genotypes on hepatitis C virus liver graft reinfection. | Journal of hepatology 20110801 |
| Early activation of p38 mitogen activated protein kinase is associated with interferon-alpha-induced depression and fatigue. | Brain, behavior, and immunity 20110801 |
| Depletion of GTP pool is not the predominant mechanism by which ribavirin exerts its antiviral effect on Lassa virus. | Antiviral research 20110801 |
| Acridine derivatives as anti-BVDV agents. | Antiviral research 20110801 |
| Mutations in the E2 and NS5A regions in patients infected with hepatitis C virus genotype 1a and their correlation with response to treatment. | Journal of medical virology 20110801 |
| Prediction of sustained virological response to combination therapy with pegylated interferon alfa and ribavirin in patients with genotype 3 chronic hepatitis C. | Digestive diseases and sciences 20110801 |
| Respiratory syncytial virus therapy and prophylaxis: have we finally turned the corner? | The European respiratory journal 20110801 |
| Definitive clearance of a chronic hepatitis E virus infection with ribavirin treatment. | The American journal of gastroenterology 20110801 |
| An overview of emerging therapies for the treatment of chronic hepatitis C. | Clinics in liver disease 20110801 |
| Boceprevir: a user's guide. | Clinics in liver disease 20110801 |
| Peginterferon alfa-2b and ribavirin therapy in Kuwaiti patients with chronic hepatitis C virus infection. | Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit 20110801 |
| Telaprevir (Incivek) and boceprevir (Victrelis) for chronic hepatitis C. | The Medical letter on drugs and therapeutics 20110725 |
| Boceprevir for chronic HCV genotype 1 infection. | The New England journal of medicine 20110714 |
| Boceprevir for chronic HCV genotype 1 infection. | The New England journal of medicine 20110714 |
| Decreased IFNγ production correlates with diminished production of cytokines by dendritic cells in patients infected with hepatitis C virus and receiving therapy. | Journal of viral hepatitis 20110701 |
| Hepatitis C virus genotype 4 with normal transaminases: histological changes, schistosomiasis and response to treatment. | Journal of viral hepatitis 20110701 |
| A comparison of the natural history and outcome of treatment for Asian and non-Asian hepatitis C-infected patients. | Journal of viral hepatitis 20110701 |
| Inhibition of eIF4E with ribavirin cooperates with common chemotherapies in primary acute myeloid leukemia specimens. | Leukemia 20110701 |
| Malnutrition impairs interferon signaling through mTOR and FoxO pathways in patients with chronic hepatitis C. | Gastroenterology 20110701 |
| Antiviral activity of the hepatitis C virus polymerase inhibitor filibuvir in genotype 1-infected patients. | Hepatology (Baltimore, Md.) 20110701 |
| Racial differences in hepatitis C treatment eligibility. | Hepatology (Baltimore, Md.) 20110701 |
| Sustained virologic response with ribavirin in chronic hepatitis E virus infection in heart transplantation. | The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 20110701 |
| TyG index, HOMA score and viral load in patients with chronic hepatitis C due to genotype 1. | Journal of viral hepatitis 20110701 |
| Long-term outcome of chronic hepatitis C in a population-based cohort and impact of antiviral therapy: a propensity-adjusted analysis. | Journal of viral hepatitis 20110701 |
| Telaprevir for retreatment of HCV infection. | The New England journal of medicine 20110623 |
| Therapeutics: new drugs hit the target. | Nature 20110608 |
| Rapid virological response as a predictor of sustained response in HCV-infected patients with persistently normal alanine aminotransferase levels: A multicenter study. | Journal of viral hepatitis 20110601 |
| Treatment of psoriasis in patients with hepatitis C virus infection. | Clinical and experimental dermatology 20110601 |
| Concurrent Crimean-Congo hemorrhagic fever and visceral leishmaniasis in a Turkish girl. | Vector borne and zoonotic diseases (Larchmont, N.Y.) 20110601 |
| Potency, safety, and pharmacokinetics of the NS3/4A protease inhibitor BI201335 in patients with chronic HCV genotype-1 infection. | Journal of hepatology 20110601 |
| Treatment of chronic hepatitis C patients with the NS3/4A protease inhibitor danoprevir (ITMN-191/RG7227) leads to robust reductions in viral RNA: a phase 1b multiple ascending dose study. | Journal of hepatology 20110601 |
| [Acute loss of vision during therapy of chronic hepatitis C]. | Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 20110601 |
| Low-molecular-mass purine nucleoside phosphorylase: characterization and application in enzymatic synthesis of nucleoside antiviral drugs. | Biotechnology letters 20110601 |
| IL28B genetic variations are associated with high sustained virological response (SVR) of interferon-α plus ribavirin therapy in Taiwanese chronic HCV infection. | Genes and immunity 20110601 |
| Coffee consumption is associated with response to peginterferon and ribavirin therapy in patients with chronic hepatitis C. | Gastroenterology 20110601 |
| Pharmacokinetic and safety profile of raltegravir and ribavirin, when dosed separately and together, in healthy volunteers. | The Journal of antimicrobial chemotherapy 20110601 |
| Chronic cough associated with interferon/ribavirin therapy for hepatitis C. | Journal of clinical pharmacy and therapeutics 20110601 |
| New prodrugs of Adefovir and Cidofovir. | Bioorganic & medicinal chemistry 20110601 |
| Reversal of hypolipidemia in chronic hepatitis C patients after successful antiviral therapy. | Journal of the Formosan Medical Association = Taiwan yi zhi 20110601 |
| [Pegylated interferon and ribavirin associated retinopathy in patients with hepatitis C]. | Archivos de la Sociedad Espanola de Oftalmologia 20110601 |
| [Results of treatment with peginterferon plus ribavirin in patients with chronic hepatitis C]. | Revista medica de Chile 20110601 |
| [New therapeutic options in chronic hepatitis C virus infection]. | Orvosi hetilap 20110529 |
| Cloning and characterization of purine nucleoside phosphorylase in Escherichia coli and subsequent ribavirin biosynthesis using immobilized recombinant cells. | Enzyme and microbial technology 20110506 |
| Role of nucleoside transporters SLC28A2/3 and SLC29A1/2 genetics in ribavirin therapy: protection against anemia in patients with chronic hepatitis C. | Pharmacogenetics and genomics 20110501 |
| Predictors of response to antiviral therapy in patients with chronic hepatitis C from Pakistani population. | Chinese medical journal 20110501 |
| [Improved virologic response in chronic hepatitis C treated with peginterferon, ribavirin and add-on drug]. | Nihon rinsho. Japanese journal of clinical medicine 20110501 |
| Pure red cell aplasia caused by pegylated interferon-α-2a plus ribavirin in the treatment of chronic hepatitis C. | World journal of gastroenterology 20110428 |
| Association of serum cytokine levels with treatment response to pegylated interferon and ribavirin therapy in genotype 1 chronic hepatitis C patients. | The Journal of infectious diseases 20110415 |
| Inhibitory properties of 2-substituent-1H-benzimidazole-4-carboxamide derivatives against enteroviruses. | Bioorganic & medicinal chemistry 20110415 |
| High ability to predict the treatment outcome of peginterferon and ribavirin combination therapy based on the reduction in HCV RNA levels at 4 weeks after starting therapy and amino acid substitutions in the hepatitis C virus in patients infected with HCV genotype 1b. | Journal of gastroenterology 20110401 |
| Prevalence and impact of hepatic steatosis on the response to antiviral therapy in Saudi patients with genotypes 1 and 4 chronic hepatitis C. | Digestive diseases and sciences 20110401 |
| The association of cryoglobulinaemia with sustained virological response in patients with chronic hepatitis C. | Journal of viral hepatitis 20110401 |
| Prophylactic treatment with escitalopram of pegylated interferon alfa-2a-induced depression in hepatitis C: a 12-week, randomized, double-blind, placebo-controlled trial. | The Journal of clinical psychiatry 20110401 |
| Hepatitis C recurrence: influence of serum cholesterol levels and liver steatosis on antiviral therapy. | Hepatology (Baltimore, Md.) 20110401 |
| Inosine triphosphate protects against ribavirin-induced adenosine triphosphate loss by adenylosuccinate synthase function. | Gastroenterology 20110401 |
| Factors predictive of sustained virological response following 72 weeks of combination therapy for genotype 1b hepatitis C. | Journal of gastroenterology 20110401 |
| Mechanism of action of ribavirin in a novel hepatitis C virus replication cell system. | Virus research 20110401 |
| Cryoglobulinemic membranoproliferative glomerulonephritis: beyond conventional therapy. | Clinical nephrology 20110401 |
| Complementary role of vitamin D deficiency and the interleukin-28B rs12979860 C/T polymorphism in predicting antiviral response in chronic hepatitis C. | Hepatology (Baltimore, Md.) 20110401 |
| Successful treatment of fibrosing cholestatic hepatitis after liver transplantation. | Transplantation proceedings 20110401 |
| Anterior ischemic optic neuropathy in a patient with hepatitis C treated with interferon-alpha and ribavirin. | The Israel Medical Association journal : IMAJ 20110401 |
| Efficacy and safety of pegylated interferon in children and adolescents infected with chronic hepatitis C: a preliminary study. | Journal of pharmacy practice 20110401 |
| The optimal dose of ribavirin for chronic hepatitis C: From literature evidence to clinical practice: The optimal dose of ribavirin for chronic hepatitis C. | Hepatitis monthly 20110401 |
| Boceprevir for untreated chronic HCV genotype 1 infection. | The New England journal of medicine 20110331 |
| Boceprevir for previously treated chronic HCV genotype 1 infection. | The New England journal of medicine 20110331 |
| A new era of hepatitis C therapy begins. | The New England journal of medicine 20110331 |
| Influence of mutagenesis and viral load on the sustained low-level replication of an RNA virus. | Journal of molecular biology 20110318 |
| Depressive symptoms following interferon-α therapy: mediated by immune-induced reductions in brain-derived neurotrophic factor? | The international journal of neuropsychopharmacology 20110301 |
| Seizures during pegylated interferon and ribavirin therapy for chronic Hepatitis C: observations from the WIN-R trial. | Journal of clinical gastroenterology 20110301 |
| Suicide risk in hepatitis C and during interferon-alpha therapy: a review and clinical update. | Journal of viral hepatitis 20110301 |
| Importance of IL28B gene polymorphisms in hepatitis C virus genotype 2 and 3 infected patients. | Journal of hepatology 20110301 |
| U.S. multicenter pilot study of daily consensus interferon (CIFN) plus ribavirin for 'difficult-to-treat' HCV genotype 1 patients. | Digestive diseases and sciences 20110301 |
| HIV/HCV co-infection: pathogenesis, clinical complications, treatment, and new therapeutic technologies. | Current HIV/AIDS reports 20110301 |
| The results of Phase III clinical trials with telaprevir and boceprevir presented at the Liver Meeting 2010: a new standard of care for hepatitis C virus genotype 1 infection, but with issues still pending. | Gastroenterology 20110301 |
| Efficacy of peg-interferon-α-2a plus ribavirin for patients aged 60 years and older with chronic hepatitis C in Korea. | Journal of gastroenterology and hepatology 20110301 |
| IL28B genetic variation and treatment response in patients with hepatitis C virus genotype 3 infection. | Hepatology (Baltimore, Md.) 20110301 |
| Factor VIII and IX deficiencies related to acquired inhibitors in a patient with chronic hepatitis C virus infection receiving treatment with pegylated interferon plus ribavirin. | Hematology (Amsterdam, Netherlands) 20110301 |
| Vogt-Koyanagi-Harada disease occurring during pegylated interferon-α2b and ribavirin combination therapy for chronic hepatitis C. | The Korean journal of hepatology 20110301 |
| Modulation in concentrative nucleoside transporters-mediated intestinal absorption of mizoribine, an immunosuppressive agent, in lipopolysaccharide-treated rats. | Die Pharmazie 20110301 |
| Diagnosing and treating hepatitis C virus infection. | The American journal of managed care 20110301 |
| A rapid chemokine response of macrophage inflammatory protein (MIP)-1α, MIP-1β and the regulated on activation, normal T expressed and secreted chemokine is associated with a sustained virological response in the treatment of chronic hepatitis C. | Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20110201 |
| FibroTest is an independent predictor of virologic response in chronic hepatitis C patients retreated with pegylated interferon alfa-2b and ribavirin in the EPIC³ program. | Journal of hepatology 20110201 |
| Big changes are coming in hepatitis C. | Current gastroenterology reports 20110201 |
| HCV substitutions and IL28B polymorphisms on outcome of peg-interferon plus ribavirin combination therapy. | Gut 20110201 |
| Changes in insulin sensitivity and body weight during and after peginterferon and ribavirin therapy for hepatitis C. | Gastroenterology 20110201 |
| Overview of the PROVE studies evaluating the use of telaprevir in chronic hepatitis C genotype 1 patients. | Expert review of anti-infective therapy 20110201 |
| Update on management of bronchiolitis. | Current opinion in pediatrics 20110201 |
| Synthesis of new C5-(1-substituted-1,2,3-triazol-4 or 5-yl)-2'-deoxyuridines and their antiviral evaluation. | European journal of medicinal chemistry 20110201 |
| Hepatitis in 2010: the dawn of a new era in HCV therapy. | Nature reviews. Gastroenterology & hepatology 20110201 |
| Ribavirin-induced anemia in hepatitis C virus patients undergoing combination therapy. | PLoS computational biology 20110201 |
| [A case with chronic hepatitis C who developed liver cirrhosis due to liver dysfunction caused by pegylated interferon plus ribavirin treatment despite negativity of serum HCV RNA, during therapy]. | Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20110201 |
| Treatment of chronic hepatitis C in Croatian war veterans: experiences from Croatian reference center for viral hepatitis. | Croatian medical journal 20110201 |
| Treatment of hepatitis C-virus-reinfection after liver transplant with silibinin in nonresponders to pegylated interferon-based therapy. | Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation 20110201 |
| Genetic polymorphism of low-density lipoprotein receptor did not affect treatment outcome of chronic hepatitis C genotype 3. | Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20110201 |
| Long-term outcome of chronic hepatitis C patients with sustained virological response to peginterferon plus ribavirin. | World journal of gastroenterology 20110128 |
| Comparative anti-infectious bronchitis virus (IBV) activity of (-)-pinene: effect on nucleocapsid (N) protein. | Molecules (Basel, Switzerland) 20110125 |
| Can Hepatitis C virus treatment be used as a prevention strategy? Additional model projections for Australia and elsewhere. | Drug and alcohol dependence 20110115 |
| Retinal vein thrombosis associated with peginterferon alpha 2b plus ribavirin in a chronic hepatitis C patient. | Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria 20110101 |
| Vitamin D supplementation improves response to antiviral treatment for recurrent hepatitis C. | Transplant international : official journal of the European Society for Organ Transplantation 20110101 |
| Statin therapy improves sustained virologic response among diabetic patients with chronic hepatitis C. | Gastroenterology 20110101 |
| Effects of PEG-interferon alpha plus ribavirin on tryptophan metabolism in patients with chronic hepatitis C. | Pharmacological research 20110101 |
| Hepatitis C testing and treatment among active drug users in Amsterdam: results from the DUTCH-C project. | European journal of gastroenterology & hepatology 20110101 |
| Lower liver stiffness in patients with sustained virological response 4 years after treatment for chronic hepatitis C. | European journal of gastroenterology & hepatology 20110101 |
| Assessment of liver fibrosis before and after antiviral therapy by different serum marker panels in patients with chronic hepatitis C. | Alimentary pharmacology & therapeutics 20110101 |
| Bitriazolyl acyclonucleosides synthesized via Huisgen reaction using internal alkynes show antiviral activity against tobacco mosaic virus. | Bioorganic & medicinal chemistry letters 20110101 |
| Effect of oral ribavirin treatment on the viral load and disease progression in Crimean-Congo hemorrhagic fever. | International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 20110101 |
| New Strategies for the Next Generation of Matrix-Metalloproteinase Inhibitors: Selectively Targeting Membrane-Anchored MMPs with Therapeutic Antibodies. | Biochemistry research international 20110101 |
| Respiratory syncytial virus disease: update on treatment and prevention. | Expert review of anti-infective therapy 20110101 |
| The role of triple therapy with protease inhibitors in hepatitis C virus genotype 1 naïve patients. | Liver international : official journal of the International Association for the Study of the Liver 20110101 |
| The role of triple therapy in HCV genotype 1-experienced patients. | Liver international : official journal of the International Association for the Study of the Liver 20110101 |
| New direct-acting antivirals' combination for the treatment of chronic hepatitis C. | Liver international : official journal of the International Association for the Study of the Liver 20110101 |
| Hepatitis C virus genotypes circulating in district Swat of Khyber Pakhtoonkhaw, Pakistan. | Virology journal 20110101 |
| Increased memory conversion of naïve CD8 T cells activated during late phases of acute virus infection due to decreased cumulative antigen exposure. | PloS one 20110101 |
| Role of interleukin-28B polymorphisms in the treatment of hepatitis C virus genotype 2 infection in Asian patients. | Hepatology (Baltimore, Md.) 20110101 |
| Ribavirin potentiates interferon action by augmenting interferon-stimulated gene induction in hepatitis C virus cell culture models. | Hepatology (Baltimore, Md.) 20110101 |
| Sarcoid-related dacryoadenitis following treatment with interferon alpha and ribavarin for hepatitis C. | Orbit (Amsterdam, Netherlands) 20110101 |
| Effect of interferon treatment on hearing of patients with chronic hepatitis C. | Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association 20110101 |
| Response prediction in chronic hepatitis C by assessment of IP-10 and IL28B-related single nucleotide polymorphisms. | PloS one 20110101 |
| Spectrofluorometric and HPLC determinations of ribavirin in capsules based on fluorescence derivatization of the sugar moiety. | Analytical sciences : the international journal of the Japan Society for Analytical Chemistry 20110101 |
| Acute pericarditis due to pegylated interferon alpha therapy for chronic HCV hepatitis - case report. | BMC gastroenterology 20110101 |
| IL28B SNP rs12979860 is a critical predictor for on-treatment and sustained virologic response in patients with hepatitis C virus genotype-1 infection. | PloS one 20110101 |
| Serpin induced antiviral activity of prostaglandin synthetase-2 against HIV-1 replication. | PloS one 20110101 |
| [Bronchiolitis. We know what is the reason and how to treat]. | Przeglad lekarski 20110101 |
| Core mutations, IL28B polymorphisms and response to peginterferon/ribavirin treatment in Swedish patients with hepatitis C virus genotype 1 infection. | BMC infectious diseases 20110101 |
| Inhibition of Hazara nairovirus replication by small interfering RNAs and their combination with ribavirin. | Virology journal 20110101 |
| Dysregulation of IFN system can lead to poor response to pegylated interferon and ribavirin therapy in chronic hepatitis C. | PloS one 20110101 |
| Characterization of hepatitis C Virus genotype 3a hypervariable region 1 in patients achieved rapid virological response to alpha interferon and ribavirin combination therapy. | Virology journal 20110101 |
| Response to combination therapy of HCV 3a infected Pakistani patients and the role of NS5A protein. | Virology journal 20110101 |
| A STAT-1 knockout mouse model for Machupo virus pathogenesis. | Virology journal 20110101 |
| A nosocomial transmission of crimean-congo hemorrhagic fever to an attending physician in North Kordufan, Sudan. | Virology journal 20110101 |
| Negative regulation of interferon-β gene expression during acute and persistent virus infections. | PloS one 20110101 |
| Effectiveness of treatment with pegylated interferon and ribavirin in an unselected population of patients with chronic hepatitis C: a Danish nationwide cohort study. | BMC infectious diseases 20110101 |
| Long-term effect of interferon plus ribavirin on hepatitis B surface antigen seroclearance in patients dually infected with hepatitis B and C viruses. | PloS one 20110101 |
| Outcome of combination antiviral therapy in chronic hepatitis C virus infection during therapy of acute lymphoblastic leukemia. | Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association 20110101 |
| [Therapy of hepatitis C: individualized approach to treatment]. | Przeglad epidemiologiczny 20110101 |
| Systemic analysis of heat shock response induced by heat shock and a proteasome inhibitor MG132. | PloS one 20110101 |
| An IL28B genotype-based clinical prediction model for treatment of chronic hepatitis C. | PloS one 20110101 |
| Serum fatty acids, antioxidants, and treatment response in hepatitis C infection: greater polyunsaturated fatty acid and antioxidant levels in hepatitis C responders. | Journal of clinical lipidology 20110101 |
| Relationship between circulating interleukin-10 and histological features in patients with chronic C hepatitis. | Annals of Saudi medicine 20110101 |
| Relationship between polymorphisms of the inosine triphosphatase gene and anaemia or outcome after treatment with pegylated interferon and ribavirin. | Antiviral therapy 20110101 |
| Impact of ribavirin on HCV replicon RNA decline during treatment with interferon-α and the protease inhibitors boceprevir or telaprevir. | Antiviral therapy 20110101 |
| [Evidence-based therapeutic drug monitoring for ribavirine]. | Therapie 20110101 |
| Extended interferon-alpha therapy accelerates telomere length loss in human peripheral blood T lymphocytes. | PloS one 20110101 |
| Early effect of peginterferon alpha-2b plus ribavirin treatment on blood pressure and insulin resistance in patients with chronic hepatitis C. | Hepato-gastroenterology 20110101 |
| Effectiveness and safety of everolimus in the treatment of autoimmune hepatitis related to anti-hepatitis C virus therapy after liver transplant: three case reports. | Transplantation proceedings 20110101 |
| Selection of hepatitis C virus resistant to ribavirin. | Virology journal 20110101 |
| Lassa hemorrhagic fever in a late term pregnancy from northern Sierra Leone with a positive maternal outcome: case report. | Virology journal 20110101 |
| In vitro and in vivo activity of ribavirin against Andes virus infection. | PloS one 20110101 |
| Zebrafish as a potential model organism for drug test against hepatitis C virus. | PloS one 20110101 |
| Thyroid disorders in patients with chronic hepatitis C using interferon-alpha and ribavirin therapy. | The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases 20110101 |
| X4 tropic multi-drug resistant quasi-species detected at the time of primary HIV-1 infection remain exclusive or at least dominant far from PHI. | PloS one 20110101 |
| Abacavir coadministration does not interfere with the suppressive activity of ribavirin in an HCV replicon system. | Antiviral therapy 20110101 |
| New therapies for hepatitis C virus infection. | Missouri medicine 20110101 |
| Danazol improves thrombocytopenia in HCV patients treated with peginterferon and ribavirin. | Annals of hepatology 20110101 |
| Concurrent autoimmune hepatitis and grave's disease in hepatitis C during pegylated interferon α-2a and ribavirin therapy. | Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association 20110101 |
| [Susceptibility of pandemic influenza virus A 2009 H1N1 and highly pathogenic avian influenza virus A H5N1 to antiinfluenza agents in cell culture]. | Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] 20110101 |
| [Minimization of endogenous intoxication syndrome by individual choice of drugs for therapy of chronic hepatitis]. | Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] 20110101 |
| A cost-effectiveness analysis of different therapies in patients with chronic hepatitis B in Italy. | ClinicoEconomics and outcomes research : CEOR 20110101 |
| Analysis of the complete open reading frame of genotype 2b hepatitis C virus in association with the response to peginterferon and ribavirin therapy. | PloS one 20110101 |
| Gamma-glutamyltranspeptidase in predicting sustained virological response in individuals with chronic hepatitis C. | Hepato-gastroenterology 20110101 |
| Treatment of chronic hepatitis C in a patient with Fanconi anaemia. | Advances in medical sciences 20110101 |
| Genetic heterogeneity of hepatitis C virus in association with antiviral therapy determined by ultra-deep sequencing. | PloS one 20110101 |
| Impact of pentoxifylline and vitamin e on ribavirin-induced haemolytic anaemia in chronic hepatitis C patients: an egyptian survey. | International journal of hepatology 20110101 |
| Determination of ADAMTS13 and Its Clinical Significance for ADAMTS13 Supplementation Therapy to Improve the Survival of Patients with Decompensated Liver Cirrhosis. | International journal of hepatology 20110101 |
| IL28B alleles exert an additive dose effect when applied to HCV-HIV coinfected persons undergoing peginterferon and ribavirin therapy. | PloS one 20110101 |
| Rapid viral response of once-daily TMC435 plus pegylated interferon/ribavirin in hepatitis C genotype-1 patients: a randomized trial. | Antiviral therapy 20110101 |
| Ramsay Hunt syndrome with unilateral polyneuropathy involving cranial nerves V, VII, VIII, and XII in a diabetic patient. | Quintessence international (Berlin, Germany : 1985) 20110101 |
| Genetic variation of the IL-28B promoter affecting gene expression. | PloS one 20110101 |
| Rationale and design of a randomized controlled trial of directly observed hepatitis C treatment delivered in methadone clinics. | BMC infectious diseases 20110101 |
| Successful treatment of activated occult hepatitis B in a non-responder chronic hepatitis C patient. | Virology journal 20110101 |
| Ribavirin enhances IFN-α signalling and MxA expression: a novel immune modulation mechanism during treatment of HCV. | PloS one 20110101 |
| Impact of HCV protease-inhibitor-based triple therapy for chronic HCV genotype 1 infection. | Antiviral therapy 20110101 |
| Ribavirin and interferon alter MMP-9 abundance in vitro and in HIV-HCV-coinfected patients. | Antiviral therapy 20110101 |
| Intravenous silibinin as 'rescue treatment' for on-treatment non-responders to pegylated interferon/ribavirin combination therapy. | Antiviral therapy 20110101 |
| Open-label phase 1b pilot study to assess the antiviral efficacy of simvastatin combined with sertraline in chronic hepatitis C patients. | Antiviral therapy 20110101 |
| Association of interleukin-28B and hepatitis C genotype 1 with a high viral load and response to pegylated interferon plus ribavirin therapy. | Digestion 20110101 |
| Prediction of effect of pegylated interferon alpha-2b plus ribavirin combination therapy in patients with chronic hepatitis C infection. | PloS one 20110101 |
| The impact of antiviral therapy and the influence of metabolic cofactors on the outcome of chronic HCV infection. | International journal of hepatology 20110101 |
| Hepatic STAT1-nuclear translocation and interleukin 28B polymorphisms predict treatment outcomes in hepatitis C virus genotype 1-infected patients. | PloS one 20110101 |
| Inhibitors of alphavirus entry and replication identified with a stable Chikungunya replicon cell line and virus-based assays. | PloS one 20110101 |
| Adjuvant therapy after curative treatment for hepatocellular carcinoma. | Oncology 20110101 |
| Triple combination antiviral drug (TCAD) composed of amantadine, oseltamivir, and ribavirin impedes the selection of drug-resistant influenza A virus. | PloS one 20110101 |
| IL28B polymorphism -- predictive factor of HCV infected genotype 1 individuals to treatment response and management of therapy. | Romanian journal of internal medicine = Revue roumaine de medecine interne 20110101 |
| [Investigation of luromarin efficacy on mice with experimental tick-borne encephalitis]. | Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] 20110101 |
| [Experience with empirical treatment of severe acute respiratory syndrome due to coronavirus, genotype IV]. | Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] 20110101 |
| Structure-based and ligand-based virtual screening of novel methyltransferase inhibitors of the dengue virus. | BMC bioinformatics 20110101 |
| [Present state of in vitro and in vivo studies on efficacy of medical nonspecific protective agents with respect to genotype IV coronavirus causing severe acute respiratory syndrome]. | Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] 20110101 |
| [Influence of rimantadine, ribavirine and triazavirine on influenza A virus replication in human monolayer and lymphoblastoid cell lines]. | Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] 20110101 |
| Discovery of novel GSK-3β inhibitors with potent in vitro and in vivo activities and excellent brain permeability using combined ligand- and structure-based virtual screening. | Journal of medicinal chemistry 20101223 |
| Chemoenzymatic syntheses and anti-HIV-1 activity of glucose-nucleoside conjugates as prodrugs. | Bioconjugate chemistry 20101215 |
| Association between phospholipids and free cholesterol in high-density lipoprotein and the response to hepatitis C treatment in Japanese with genotype 1b. | Journal of viral hepatitis 20101201 |
| Differences in liver fibrosis and response to pegylated interferon plus ribavirin in HIV/HCV-coinfected patients with normal vs elevated liver enzymes. | Journal of viral hepatitis 20101201 |
| Hepatitis C virus quasispecies in chronically infected children subjected to interferon-ribavirin therapy. | Archives of virology 20101201 |
| A predictive ligand-based Bayesian model for human drug-induced liver injury. | Drug metabolism and disposition: the biological fate of chemicals 20101201 |
| 4-[1-(Substituted aryl/alkyl carbonyl)-benzoimidazol-2-yl]-benzenesulfonic acids: synthesis, antimicrobial activity, QSAR studies, and antiviral evaluation. | European journal of medicinal chemistry 20101201 |
| Association of host pharmacodynamic effects with virologic response to pegylated interferon alfa-2a/ribavirin in chronic hepatitis C. | Hepatology (Baltimore, Md.) 20101201 |
| Virologic response to treatment with Pegylated Interferon alfa-2b and Ribavirin for chronic hepatitis C in children. | Medical science monitor : international medical journal of experimental and clinical research 20101201 |
| Ribavirin for Lassa fever postexposure prophylaxis. | Emerging infectious diseases 20101201 |
| Synthesis of a 6-methyl-7-deaza analogue of adenosine that potently inhibits replication of polio and dengue viruses. | Journal of medicinal chemistry 20101125 |
| RG7128 alone or in combination with pegylated interferon-α2a and ribavirin prevents hepatitis C virus (HCV) Replication and selection of resistant variants in HCV-infected patients. | The Journal of infectious diseases 20101115 |
| Flexible and individualized treatment to achieve sustained viral response for recurrent hepatitis C in liver transplant recipients. | Journal of viral hepatitis 20101101 |
| Current practice of hepatitis C treatment in Southern Italy. | Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20101101 |
| [Thrombotic thrombocytopenic purpura mediated by an ADAMTS13-inhibitor related to a treatment with pegylated-interferon alpha-2a and ribavirine in a patient with chronic hepatitis C]. | Presse medicale (Paris, France : 1983) 20101101 |
| A sustained virologic response is durable in patients with chronic hepatitis C treated with peginterferon alfa-2a and ribavirin. | Gastroenterology 20101101 |
| Retinopathy associated with pegylated interferon and ribavirin treatment for chronic hepatitis C. | Optometry (St. Louis, Mo.) 20101101 |
| Predictors of early treatment discontinuation among patients with genotype 1 hepatitis C and implications for viral eradication. | Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20101101 |
| Ribavirin therapy inhibits viral replication on patients with chronic hepatitis e virus infection. | Gastroenterology 20101101 |
| Suboptimal endogenous erythropoietin response in chronic hepatitis C patients during ribavirin and PEG interferon treatment. | European journal of gastroenterology & hepatology 20101101 |
| Serum lipids in European chronic HCV genotype 1 patients during and after treatment with pegylated interferon-α-2a and ribavirin. | European journal of gastroenterology & hepatology 20101101 |
| Design and synthesis of bioactive adamantanaminoalcohols and adamantanamines. | European journal of medicinal chemistry 20101101 |
| Synthesis and in vitro antiviral activities of 3'-fluoro (or chloro) and 2',3'-difluoro 2',3'-dideoxynucleoside analogs against hepatitis B and C viruses. | Bioorganic & medicinal chemistry 20101101 |
| Fluoxetine disposition in patients with chronic hepatitis C treated with interferon-α. | Clinical pharmacokinetics 20101101 |
| Management of untreated and nonresponder patients with chronic hepatitis C. | Seminars in liver disease 20101101 |
| Fatal avian influenza (H5N1) infection in Human, China. | Emerging infectious diseases 20101101 |
| The persistence of influenza infection. | Emerging infectious diseases 20101101 |
| Synthesis and antiviral activities of synthetic glutarimide derivatives. | Chemical & pharmaceutical bulletin 20101101 |
| Vogt-Koyanagi-Harada disease occurring during interferon-alpha and ribavirin therapy for chronic hepatitis C virus infection. | International ophthalmology 20101001 |
| Peginterferon α-2a plus ribavirin in Latino and Non-Latino Whites with HCV genotype 1: Histologic outcomes and tolerability from the LATINO Study. | The American journal of gastroenterology 20101001 |
| Variants in the ITPA gene protect against ribavirin-induced hemolytic anemia and decrease the need for ribavirin dose reduction. | Gastroenterology 20101001 |
| Subacute sclerosing panencephalitis: an update. | Developmental medicine and child neurology 20101001 |
| Albinterferon Alfa-2b was not inferior to pegylated interferon-α in a randomized trial of patients with chronic hepatitis C virus genotype 2 or 3. | Gastroenterology 20101001 |
| Amino acid substitutions of hepatitis C virus core protein are not associated with intracellular antiviral response to interferon-α in vitro. | Liver international : official journal of the International Association for the Study of the Liver 20101001 |
| Ribavirin as an anti-cancer therapy: acute myeloid leukemia and beyond? | Leukemia & lymphoma 20101001 |
| Hepatitis C: viral and host factors associated with non-response to pegylated interferon plus ribavirin. | Liver international : official journal of the International Association for the Study of the Liver 20101001 |
| ITPA polymorphism affects ribavirin-induced anemia and outcomes of therapy--a genome-wide study of Japanese HCV virus patients. | Gastroenterology 20101001 |
| Changes in liver stiffness in patients with chronic hepatitis C with and without HIV co-infection treated with pegylated interferon plus ribavirin. | The Journal of antimicrobial chemotherapy 20101001 |
| Hepatitis C virus directly acting antivirals: current developments with NS3/4A HCV serine protease inhibitors. | The Journal of antimicrobial chemotherapy 20101001 |
| Successful HCV eradication and inhibition of HIV replication by intravenous silibinin in an HIV-HCV coinfected patient. | Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 20101001 |
| Virologic response rates of weight-based taribavirin versus ribavirin in treatment-naive patients with genotype 1 chronic hepatitis C. | Hepatology (Baltimore, Md.) 20101001 |
| Prediction of response to pegylated interferon plus ribavirin by IL28B gene variation in patients coinfected with HIV and hepatitis C virus. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20101001 |
| A multidisciplinary therapeutic approach for reducing the risk of psychiatric side effects in patients with chronic hepatitis C treated with pegylated interferon α and ribavirin. | Journal of clinical gastroenterology 20101001 |
| Early diagnosis and treatment resolved cholestatic hepatitis C without fibrosis after living donor liver transplantation: report of a case. | Surgery today 20101001 |
| The next step for taribavirin. | Hepatology (Baltimore, Md.) 20101001 |
| Inflammatory bowel disease and hepatitis B and C in Western Balkans: a referral centre study and review of the literature. | Journal of Crohn's & colitis 20101001 |
| T-cell responses at baseline and during therapy with peginterferon-alpha and ribavirin are not associated with outcome in chronic hepatitis C infected patients. | Antiviral research 20100901 |
| Serum cholesterol and statin use predict virological response to peginterferon and ribavirin therapy. | Hepatology (Baltimore, Md.) 20100901 |
| Pegylated interferons alpha2a and alpha2b in the treatment of chronic hepatitis C. | Nature reviews. Gastroenterology & hepatology 20100901 |
| Associations between serum lipids and hepatitis C antiviral treatment efficacy. | Hepatology (Baltimore, Md.) 20100901 |
| Macrophage-dominant sialadenitis in human T-cell leukemia virus type I-associated myelopathy after living-donor liver transplantation. | Transplantation proceedings 20100901 |
| Telaprevir. | Drugs in R&D 20100901 |
| Boceprevir. | Drugs in R&D 20100901 |
| Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial. | Lancet (London, England) 20100828 |
| Procyanidin B1 purified from Cinnamomi cortex suppresses hepatitis C virus replication. | Antiviral chemistry & chemotherapy 20100811 |
| Treatment of chronic hepatitis C using a 4-week lead-in with nitazoxanide before peginterferon plus nitazoxanide. | Journal of clinical gastroenterology 20100801 |
| Thyroid dysfunction in a UK hepatitis C population treated with interferon-alpha and ribavirin combination therapy. | Clinical endocrinology 20100801 |
| Hashimoto's encephalopathy after interferon therapy for hepatitis C virus in adult liver transplant recipient accompanied by post-transplant lymphoproliferative disorder related to Epstein-Barr virus infection. | Transplant infectious disease : an official journal of the Transplantation Society 20100801 |
| A randomized trial of peginterferon alpha-2a with or without ribavirin for HBeAg-negative chronic hepatitis B. | The American journal of gastroenterology 20100801 |
| The mitochondria-targeted anti-oxidant mitoquinone decreases liver damage in a phase II study of hepatitis C patients. | Liver international : official journal of the International Association for the Study of the Liver 20100801 |
| Telaprevir: a new hope in the treatment of chronic hepatitis C? | Advances in therapy 20100801 |
| Crimean-Congo hemorrhagic fever in man, Republic of Georgia, 2009. | Emerging infectious diseases 20100801 |
| Danoprevir, a small-molecule NS3/4A protease inhibitor for the potential oral treatment of HCV infection. | Current opinion in investigational drugs (London, England : 2000) 20100801 |
| A multi-step process of viral adaptation to a mutagenic nucleoside analogue by modulation of transition types leads to extinction-escape. | PLoS pathogens 20100801 |
| Combination chemotherapy for influenza. | Viruses 20100801 |
| [Combined interferon, ribavirin treatment and the occurrence of hepatocellular carcinoma]. | Orvosi hetilap 20100718 |
| An updated follow-up of chronic hepatitis C after three decades of observation in pediatric patients cured of malignancy. | Pediatric blood & cancer 20100715 |
| Hepatitis C: not so indolent in survivors of pediatric cancer? | Pediatric blood & cancer 20100715 |
| Studies on the anti-hepatitis C virus activity of newly synthesized tropolone derivatives: identification of NS3 helicase inhibitors that specifically inhibit subgenomic HCV replication. | Bioorganic & medicinal chemistry 20100715 |
| Antiviral flavonoids from Mosla scabra. | Fitoterapia 20100701 |
| Treatment outcome in relation to alcohol consumption during hepatitis C therapy: an analysis of the Swiss Hepatitis C Cohort Study. | Drug and alcohol dependence 20100701 |
| Benzylidene/2-chlorobenzylidene hydrazides: synthesis, antimicrobial activity, QSAR studies and antiviral evaluation. | European journal of medicinal chemistry 20100701 |
| Preparation and characterization of niosomes containing ribavirin for liver targeting. | Drug delivery 20100701 |
| A novel nucleoside analog, 1-beta-d-ribofuranosyl-3-ethynyl-[1,2,4]triazole (ETAR), exhibits efficacy against a broad range of flaviviruses in vitro. | Antiviral research 20100701 |
| The hepatitis C virus (HCV) NS4B RNA binding inhibitor clemizole is highly synergistic with HCV protease inhibitors. | The Journal of infectious diseases 20100701 |
| Mitochondrial toxicity is associated with virological response in patients with HIV and hepatitis C virus coinfection treated with ribavirin and highly active antiretroviral therapy. | The Journal of infectious diseases 20100701 |
| Inhibitory effects of orobol 7-O-D-glucoside from banaba (Lagerstroemia speciosa L.) on human rhinoviruses replication. | Letters in applied microbiology 20100701 |
| The Ribavirin Pregnancy Registry: Findings after 5 years of enrollment, 2003-2009. | Birth defects research. Part A, Clinical and molecular teratology 20100701 |
| Expectoration of large bronchial casts secondary to the treatment of chronic hepatitis C with pegylated interferon and ribavirin. | Clinics (Sao Paulo, Brazil) 20100701 |
| [The mechanism of signal extension in Haoqin Qingdan decoction immunity activity in Damp-heat syndrome of pneumonia disease infected by influenza virus]. | Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine] 20100701 |
| New trends in nucleoside biotechnology. | Acta naturae 20100701 |
| Etanercept as prophylactic psoriatic therapy before interferon-alpha and ribavirin treatment for active hepatitis C infection. | Clinical and experimental dermatology 20100601 |
| Effect of liver steatosis on therapeutic response in chronic hepatitis C virus genotype 1 infected patients in hungary. | Pathology oncology research : POR 20100601 |
| Successful treatment of chronic hepatitis C virus infection in severely opioid-dependent patients under heroin maintenance. | Drug and alcohol dependence 20100601 |
| Evaluating treatment of hepatitis C for hemolytic anemia management. | Mathematical biosciences 20100601 |
| High rates of sustained virological response in hepatitis C virus-infected injection drug users receiving directly observed therapy with peginterferon alpha-2a (40KD) (PEGASYS) and once-daily ribavirin. | Journal of substance abuse treatment 20100601 |
| Outcome of a hepatitis C outbreak among patients in a pain management clinic. | Digestive diseases and sciences 20100601 |
| Positive selection of core 70Q variant genotype 1b hepatitis C virus strains induced by pegylated interferon and ribavirin. | The Journal of infectious diseases 20100601 |
| Viral hepatitis and inflammatory bowel disease. | Inflammatory bowel diseases 20100601 |
| Hepatitis C: diagnosis and treatment. | American family physician 20100601 |
| Association between HCV amino acid substitutions and outcome of peginterferon and ribavirin combination therapy in HCV genotype 1b and high viral load. | Journal of gastroenterology and hepatology 20100601 |
| [Occurrence of diabetic ketoacidosis and autoimmune thyroiditis in a patient treated with pegylated interferon-alpha 2b and ribavirin for chronic hepatitis C]. | The Korean journal of hepatology 20100601 |
| Does abacavir use influence HCV treatment response? | Journal watch. AIDS clinical care 20100601 |
| Interferon alpha-induced hashimoto thyroiditis followed by transient graves disease in a patient with chronic HCV infection. | Southern medical journal 20100601 |
| Safe co-administration of raltegravir, pegylated-interferon and, ribavirin in HIV individuals with hepatitis C virus-related liver damage. | AIDS (London, England) 20100515 |
| 'Viologen' dendrimers as antiviral agents: the effect of charge number and distance. | Journal of medicinal chemistry 20100513 |
| Chemical and enzymatic stability of amino acid derived phosphoramidates of antiviral nucleoside 5'-monophosphates bearing a biodegradable protecting group. | Organic & biomolecular chemistry 20100507 |
| Interferon-alpha effects on diurnal hypothalamic-pituitary-adrenal axis activity: relationship with proinflammatory cytokines and behavior. | Molecular psychiatry 20100501 |
| Similar treatment response to peginterferon and ribavirin in Asian and Caucasian patients with chronic hepatitis C. | The American journal of gastroenterology 20100501 |
| Review article: optimizing SVR and management of the haematological side effects of peginterferon/ribavirin antiviral therapy for HCV - the role of epoetin, G-CSF and novel agents. | Alimentary pharmacology & therapeutics 20100501 |
| Personalized molecular targeted therapy in advanced, recurrent hepatocellular carcinoma after liver transplantation: a proof of principle. | Journal of hepatology 20100501 |
| Click reaction synthesis of carbohydrate derivatives from ristocetin aglycon with antibacterial and antiviral activity. | Bioorganic & medicinal chemistry letters 20100501 |
| Risk factors for relapse in chronic hepatitis C patients who have achieved end of treatment response. | Journal of gastroenterology and hepatology 20100501 |
| Synthesis of new acridone derivatives, inhibitors of NS3 helicase, which efficiently and specifically inhibit subgenomic HCV replication. | Journal of medicinal chemistry 20100422 |
| (-)-Carbodine: enantiomeric synthesis and in vitro antiviral activity against various strains of influenza virus including H5N1 (avian influenza) and novel 2009 H1N1 (swine flu). | Bioorganic & medicinal chemistry letters 20100415 |
| Antiviral activity of benzimidazole derivatives. II. Antiviral activity of 2-phenylbenzimidazole derivatives. | Bioorganic & medicinal chemistry 20100415 |
| Telaprevir for previously treated chronic HCV infection. | The New England journal of medicine 20100408 |
| Association between lipoprotein subfraction profile and the response to hepatitis C treatment in Japanese patients with genotype 1b. | Journal of viral hepatitis 20100401 |
| Antiviral efficacy of EICAR against canine distemper virus (CDV) in vitro. | Research in veterinary science 20100401 |
| CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depression. | Molecular psychiatry 20100401 |
| The use of antiviral agents for the management of severe influenza. | Critical care medicine 20100401 |
| Fluvastatin as an adjuvant to pegylated interferon and ribavirin in HIV/hepatitis C virus genotype 1 co-infected patients: an open-label randomized controlled study. | The Journal of antimicrobial chemotherapy 20100401 |
| Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis C. | Hepatology (Baltimore, Md.) 20100401 |
| Characterization of ribavirin uptake systems in human hepatocytes. | Journal of hepatology 20100401 |
| Application of the phosphoramidate ProTide approach to the antiviral drug ribavirin. | Bioorganic & medicinal chemistry 20100401 |
| Stability of ribavirin concentrations depending on the type of blood collection tube and preanalytical conditions. | Therapeutic drug monitoring 20100401 |
| [Consensus conference on acute bronchiolitis (IV): Treatment of acute bronchiolitis. Review of scientific evidence]. | Anales de pediatria (Barcelona, Spain : 2003) 20100401 |
| Preemptive erythropoietin plus high ribavirin doses to increase rapid virological responses in HIV patients treated for chronic hepatitis C. | AIDS research and human retroviruses 20100401 |
| Anti-human rhinovirus activity of raoulic acid from Raoulia australis. | Journal of medicinal food 20100401 |
| Natural killer cell receptor and HLA-C gene polymorphisms among patients with hepatitis C: a comparison between sustained virological responders and non-responders. | Liver international : official journal of the International Association for the Study of the Liver 20100401 |
| [Use of immunomodulators in the therapy of chronic hepatitis C: improving standard approach]. | Eksperimental'naia i klinicheskaia farmakologiia 20100401 |
| Thymosin alpha 1 for treatment of hepatitis C virus: promise and proof. | Annals of the New York Academy of Sciences 20100401 |
| Thymalfasin in the treatment of hepatitis B and C. | Annals of the New York Academy of Sciences 20100401 |
| Immunological modifications during treatment with thymosin alpha1 plus antiviral therapy in chronic hepatitis C. | Annals of the New York Academy of Sciences 20100401 |
| Microalbuminuria in hepatitis C-genotype 4: effect of pegylated interferon and ribavirin. | World journal of gastroenterology 20100314 |
| Synthesis of 4-methyl-1,2,3-thiadiazole derivatives via Ugi reaction and their biological activities. | Journal of agricultural and food chemistry 20100310 |
| Synthesis, crystal structure, and biological activity of 4-methyl-1,2,3-thiadiazole-containing 1,2,4-triazolo[3,4-b][1,3,4]thiadiazoles. | Journal of agricultural and food chemistry 20100310 |
| Pneumonitis as a consequence of (peg)interferon-ribavirin combination therapy for hepatitis C: a review of the literature. | Digestive diseases and sciences 20100301 |
| Effect of ribavirin on the frequency of RNase L cleavage sites within the hepatitis C viral genome. | Journal of viral hepatitis 20100301 |
| Pioglitazone improves virological response to peginterferon alpha-2b/ribavirin combination therapy in hepatitis C genotype 4 patients with insulin resistance. | Liver international : official journal of the International Association for the Study of the Liver 20100301 |
| Synthesis, antibacterial and antiviral properties of curcumin bioconjugates bearing dipeptide, fatty acids and folic acid. | European journal of medicinal chemistry 20100301 |
| Kinetic study of anti-viral ribavirin uptake mediated by hCNT3 and hENT1 in Xenopus laevis oocytes. | Biophysical chemistry 20100301 |
| Transient reappearance of serum hepatitis C virus RNA observed by real-time PCR during antiviral therapy with peginterferon and ribavirin in patients with HCV genotype 1b. | Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 20100301 |
| [Vogt-Koyanagi-Harada disease associated with interferon-alpha and ribavirin therapy for chronic hepatitis C infection]. | Journal francais d'ophtalmologie 20100301 |
| Metformin improves sustained virologic response in difficult-to-cure hepatitis C: more questions than answers. | Hepatology (Baltimore, Md.) 20100301 |
| Hepatitis C virus recurrence after liver transplantation: analysis of factors related to sustained viral response. | Transplantation proceedings 20100301 |
| Study on intestinal absorption sites of mizoribine and ribavirin, substrates for concentrative nucleoside transporter(s), in rats. | European journal of pharmacology 20100225 |
| Outcome of retinopathy in chronic hepatitis C patients treated with peginterferon and ribavirin. | Digestive diseases and sciences 20100201 |
| Predictors of hematological abnormalities in patients with chronic hepatitis C treated with interferon and ribavirin. | Annals of hematology 20100201 |
| Factors associated with rapid and early virologic response to peginterferon alfa-2a/ribavirin treatment in HCV genotype 1 patients representative of the general chronic hepatitis C population. | Journal of viral hepatitis 20100201 |
| A multi-drug regimen for respiratory syncytial virus and parainfluenza virus infections in adult lung and heart-lung transplant recipients. | Transplant infectious disease : an official journal of the Transplantation Society 20100201 |
| Therapeutic effects of pegylated interferon plus ribavirin in chronic hepatitis C patients with occult hepatitis B virus dual infection. | Journal of gastroenterology and hepatology 20100201 |
| Synthesis, anti-HCV, antioxidant, and peroxynitrite inhibitory activity of fused benzosuberone derivatives. | European journal of medicinal chemistry 20100201 |
| [Antiviral therapy for chronic hepatitis C: current status and perspectives]. | Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20100201 |
| Occult hepatitis B virus infection in patients with chronic hepatitis C: An actor behind the scene or just a bystander? | Journal of gastroenterology and hepatology 20100201 |
| An antioxidant resveratrol significantly enhanced replication of hepatitis C virus. | World journal of gastroenterology 20100114 |
| Whole-body insulin sensitivity index is a highly specific predictive marker for virological response to peginterferon plus ribavirin therapy in chronic hepatitis C patients with genotype 1b and high viral load. | Digestive diseases and sciences 20100101 |
| Long-term effectiveness and cost-effectiveness of antiviral treatment in hepatitis C. | Journal of viral hepatitis 20100101 |
| The use of cyclosporine for recurrent hepatitis C after liver transplant: a randomized pilot study. | Digestive diseases and sciences 20100101 |
| Partial splenic embolization and peg-IFN plus RBV in liver transplanted patients with hepatitis C recurrence: safety, efficacy and long-term outcome. | Clinical transplantation 20100101 |
| Platelet serotonin (5-HT) levels in interferon-treated patients with hepatitis C and its possible association with interferon-induced depression. | Journal of hepatology 20100101 |
| Use of epoetin beta during combination therapy of infection with hepatitis c virus with ribavirin improves a sustained viral response. | Journal of medical virology 20100101 |
| PEG-IFNalpha/RBV combination therapy for chronic hepatitis C patients increases serum ferritin level while it improves sustained viral response rate. | Intervirology 20100101 |
| Weight loss, leukopenia and thrombocytopenia associated with sustained virologic response to Hepatitis C treatment. | International journal of medical sciences 20100101 |
| Pegylated interferons for the treatment of chronic hepatitis C: pharmacological and clinical differences between peginterferon-alpha-2a and peginterferon-alpha-2b. | Drugs 20100101 |
| Contribution of genome-wide HCV genetic differences to outcome of interferon-based therapy in Caucasian American and African American patients. | PloS one 20100101 |
| The influence of abacavir and other antiretroviral agents on virological response to HCV therapy among antiretroviral-treated HIV-infected patients. | Antiviral therapy 20100101 |
| Short versus standard treatment with pegylated interferon alfa-2A plus ribavirin in patients with hepatitis C virus genotype 2 or 3: the cleo trial. | BMC gastroenterology 20100101 |
| Triple combination of amantadine, ribavirin, and oseltamivir is highly active and synergistic against drug resistant influenza virus strains in vitro. | PloS one 20100101 |
| Hepatic steatosis in genotype 4 chronic hepatitis C patients: implication for therapy. | Journal of clinical gastroenterology 20100101 |
| Quasispecies of genotype 4 of hepatitis C virus genomes in Saudi patients managed with interferon alfa and ribavirin therapy. | Annals of Saudi medicine 20100101 |
| Treatment of acute HCV infection in HIV-positive patients: experience from a multicentre European cohort. | Antiviral therapy 20100101 |
| Excellent superiority and specificity of COBAS TaqMan HCV assay in an early viral kinetic change during pegylated interferon alpha-2b plus ribavirin treatment. | BMC gastroenterology 20100101 |
| Infection with hepatitis C virus genotype 3--experience of a tertiary health care centre in south India. | Indian journal of medical microbiology 20100101 |
| [Efficacy of combined antiviral therapy with pegylated interferon alpha-2a and ribavirin for chronic hepatitis C infection in intravenous drug users]. | Srpski arhiv za celokupno lekarstvo 20100101 |
| Thyroid function outcomes after pegylated interferon-α and ribavirin therapy for chronic hepatitis C. | Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 20100101 |
| Raltegravir, tenofovir, and emtricitabine in an HIV-infected patient with HCV chronic hepatitis, NNRTI intolerance and protease inhibitors-induced severe liver toxicity. | European journal of medical research 20100101 |
| The influence of HAART on the efficacy and safety of pegylated interferon and ribavirin therapy for the treatment of chronic HCV infection in HIV-positive Individuals. | European journal of medical research 20100101 |
| Toll-like receptor (TLR) expression on CD4+ and CD8+ T-cells in patients chronically infected with hepatitis C virus. | Cellular immunology 20100101 |
| Cell type mediated resistance of vesicular stomatitis virus and Sendai virus to ribavirin. | PloS one 20100101 |
| Prevalence and clinical relevance of serum autoantibodies in patients with chronic hepatitis C. | Chang Gung medical journal 20100101 |
| Pegylated interferon-alpha2b plus ribavirin therapy in patients with hepatitis C and psychiatric disorders: results of a cohort study. | Antiviral therapy 20100101 |
| [Study of the antiviral activity of Russian anti-influenza agents in cell culture and animal models]. | Voprosy virusologii 20100101 |
| Ribavirin for Crimean-Congo hemorrhagic fever: systematic review and meta-analysis. | BMC infectious diseases 20100101 |
| Retreatment of hepatitis C patients with pegylated interferon combined with ribavirin in non-responders to interferon plus ribavirin. Is it different in real life? | BMC infectious diseases 20100101 |
| Treatment of hepatitis C in HCV mono-infected and in HIV-HCV co-infected patients: an open-labelled comparison study. | Swiss medical weekly 20100101 |
| Fibrosis progression and the pros and cons of antiviral therapy for hepatitis C virus recurrence after liver transplantation: a review. | Transplantation proceedings 20100101 |
| [Pathogenetically substantiated therapy of patients with virus hepatitis C, quality of life, and the disease outcome risk (clinical survey)]. | Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] 20100101 |
| Can angiogenesis be a target of treatment for ribavirin associated hemolytic anemia? | Hepato-gastroenterology 20100101 |
| Ribavirin monitoring in chronic hepatitis C therapy: anaemia versus efficacy. | Antiviral therapy 20100101 |
| Response to anti-HCV therapy in HIV-HCV-coinfected patients: does the lipid profile really have an effect? | Antiviral therapy 20100101 |
| Clinical approach to the patient with chronic hepatitis C infection and normal aminotransferases. | Annals of hepatology 20100101 |
| A case of severe thrombocytopenia in a patient with chronic hepatitis C caused by a single administration of pegylated interferon α 2a subsequent to 48 weeks of pegylated interferon α 2b plus ribavirin therapy. | Internal medicine (Tokyo, Japan) 20100101 |
| Drug rash with eosinophilia and systemic symptoms due to telaprevir. | Dermatology (Basel, Switzerland) 20100101 |
| Human erythrocyte nucleoside transporter ENT1 functions at ice-cold temperatures. | Drug metabolism and pharmacokinetics 20100101 |
| A case of type 1 diabetes onset and recurrence of Graves' disease during pegylated interferon-α plus ribavirin treatment for chronic hepatitis C. | Internal medicine (Tokyo, Japan) 20100101 |
| Quantitative analysis of interferon alpha receptor subunit 1 and suppressor of cytokine signaling 1 gene transcription in blood cells of patients with chronic hepatitis C. | Virology journal 20100101 |
| Use of a highly sensitive strand-specific quantitative PCR to identify abortive replication in the mouse model of respiratory syncytial virus disease. | Virology journal 20100101 |
| Development of mathematical models for the analysis of hepatitis delta virus viral dynamics. | PloS one 20100101 |
| Etanercept therapy in patients with psoriasis and concomitant HCV infection. | International journal of immunopathology and pharmacology 20100101 |
| Hepatitis C treatment: current and future perspectives. | Virology journal 20100101 |
| IL28B SNP rs8099917 is strongly associated with pegylated interferon-α and ribavirin therapy treatment failure in HCV/HIV-1 coinfected patients. | PloS one 20100101 |
| S-adenosyl-methionine and betaine improve early virological response in chronic hepatitis C patients with previous nonresponse. | PloS one 20100101 |
| Occult hepatitis B infection in egyptian chronic hepatitis C patients: prevalence, impact on pegylated interferon/ribavirin therapy. | Virology journal 20100101 |
| Influence of pre-analytical conditions on plasma ribavirin concentrations. | Arzneimittel-Forschung 20100101 |
| Should active injecting drug users receive treatment for chronic hepatitis C? | Arquivos de gastroenterologia 20100101 |
| Baseline prediction of combination therapy outcome in hepatitis C virus 1b infected patients by discriminant analysis using viral and host factors. | PloS one 20100101 |
| An adult case with onset of celiac disease during chronic hepatitis C antiviral treatment. | Romanian journal of internal medicine = Revue roumaine de medecine interne 20100101 |
| Mutations in the E2-PePHD region of hepatitis C virus genotype-3a and correlation with response to interferon and ribavirin combination therapy in Pakistani patients. | Virology journal 20100101 |
| Prompt arrival of antivirals against hepatitis C for HIV patients. | AIDS reviews 20100101 |
| [Evaluation of selected laboratory markers of liver fibrosis in patients with chronic hepatitis type C]. | Przeglad lekarski 20100101 |
| European vs. Egyptian HCV-4 patients with elevated baseline HCV RNA, treated with PEG-IFN-α2a and ribavirin: the role of rapid and early virologic response. | Hepatitis monthly 20100101 |
| Treatment of hepatitis C in 2011. | Journal of Ayub Medical College, Abbottabad : JAMC 20100101 |
| Ketoprofen, peginterferon 2a and ribavirin for genotype 1 chronic hepatitis C: a phase II study. | World journal of gastroenterology 20091221 |
| Functional polymorphisms in the interleukin-6 and serotonin transporter genes, and depression and fatigue induced by interferon-alpha and ribavirin treatment. | Molecular psychiatry 20091201 |
| Insulin resistance and geographical origin: major predictors of liver fibrosis and response to peginterferon and ribavirin in HCV-4. | Gut 20091201 |
| Prospective analysis of depression during peginterferon and ribavirin therapy of chronic hepatitis C: results of the Virahep-C study. | The American journal of gastroenterology 20091201 |
| Repeated episodes of fixed eruption 3 months after discontinuing pegylated interferon-alpha-2b plus ribavirin combination therapy in a patient with chronic hepatitis C virus infection. | Clinical and experimental dermatology 20091201 |
| Treatment of insulin resistance with metformin in naïve genotype 1 chronic hepatitis C patients receiving peginterferon alfa-2a plus ribavirin. | Hepatology (Baltimore, Md.) 20091201 |
| Merimepodib, pegylated interferon, and ribavirin in genotype 1 chronic hepatitis C pegylated interferon and ribavirin nonresponders. | Hepatology (Baltimore, Md.) 20091201 |
| NS5A(ISDR-V3) region genetic variability of Tunisian HCV-1b strains: Correlation with the response to the combined interferon/ribavirin therapy. | Journal of medical virology 20091201 |
| Synthesis, tautomerism, and antimicrobial, anti-HCV, anti-SSPE, antioxidant, and antitumor activities of arylazobenzosuberones. | Bioorganic & medicinal chemistry 20091201 |
| Metformin, hepatitis C, and insulin resistance: sufficient evidence? | Hepatology (Baltimore, Md.) 20091201 |
| Effectiveness of ribavirin and corticosteroids for severe acute respiratory syndrome. | The American journal of medicine 20091201 |
| The benefits of interferon treatment in patients without sustained viral response after living donor liver transplantation for hepatitis C. | Transplantation proceedings 20091201 |
| Treatment of chronic hepatitis C. | Minerva medica 20091201 |
| Low-dose IL-2 therapy reduces HCV RNA and HBV DNA: case report. | Anticancer research 20091201 |
| Necrolytic acral erythema: an expanding spectrum. | Cutis 20091201 |
| [Retreatment options for patients with chronic hepatitis C]. | Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti 20091201 |
| [Treatment of chronic hepatitis C in human immunodeficiency virus infected patients]. | Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti 20091201 |
| [Treatment of viral hepatitis in children]. | Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti 20091201 |
| [Management of side effects during antiviral therapy]. | Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti 20091201 |
| Antiviral treatment of recurrent hepatitis C after liver transplantation: predictors of response and long-term outcome. | Transplantation 20091127 |
| Factors influencing long-term changes in mental health after interferon-alpha treatment of chronic hepatitis C. | Alimentary pharmacology & therapeutics 20091115 |
| Inhibition of bovine viral diarrhea virus in vitro by xanthohumol: comparisons with ribavirin and interferon-alpha and implications for the development of anti-hepatitis C virus agents. | European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20091105 |
| Treatment of hepatitis C virus carriers with persistently normal alanine aminotransferase levels with peginterferon alpha-2a and ribavirin: a multicentric study. | Liver international : official journal of the International Association for the Study of the Liver 20091101 |
| Infection of human retinal pigment epithelial cells with influenza A viruses. | Investigative ophthalmology & visual science 20091101 |
| Impact of pegylated interferon and ribavirin on morbidity and mortality in patients with chronic hepatitis C and normal aminotransferases in France. | Hepatology (Baltimore, Md.) 20091101 |
| Betulin-derived compounds as inhibitors of alphavirus replication. | Journal of natural products 20091101 |
| Morphological transformation and phosphatidylserine exposure in erythrocytes treated with ribavirin. | Biological & pharmaceutical bulletin 20091101 |
| Potential benefits of sequential inhibitor-mutagen treatments of RNA virus infections. | PLoS pathogens 20091101 |
| Retinopathy in hepatitis C patients due to combination therapy with pegylated interferon and ribavirin. | Japanese journal of ophthalmology 20091101 |
| Hepatitis C comorbidities affecting the course and response to therapy. | World journal of gastroenterology 20091028 |
| Diazo transfer-click reaction route to new, lipophilic teicoplanin and ristocetin aglycon derivatives with high antibacterial and anti-influenza virus activity: an aggregation and receptor binding study. | Journal of medicinal chemistry 20091008 |
| Use of agents stimulating erythropoiesis in digestive diseases. | World journal of gastroenterology 20091007 |
| Ribavirin monotherapy for chronic hepatitis C. | The Cochrane database of systematic reviews 20091007 |
| Patients achieving clearance of HCV with interferon therapy recover from decreased retinol-binding protein 4 levels. | Journal of viral hepatitis 20091001 |
| [Eradication of hepatitis C virus after a 5-week treatment]. | La Revue de medecine interne 20091001 |
| Mevalonate pathway modulation is associated with hepatitis C virus RNA presence in peripheral blood mononuclear cells. | Virus research 20091001 |
| The role of nucleoside transporters in the erythrocyte disposition and oral absorption of ribavirin in the wild-type and equilibrative nucleoside transporter 1-/- mice. | The Journal of pharmacology and experimental therapeutics 20091001 |
| A novel combined vaccine candidate containing epitopes of HCV NS3, core and E1 proteins induces multi-specific immune responses in BALB/c mice. | Antiviral research 20091001 |
| Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum. | Nature chemical biology 20091001 |
| Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C. | Nature genetics 20091001 |
| IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy. | Nature genetics 20091001 |
| Antiviral treatments reduce severity of diabetes in Ljungan virus-infected CD-1 mice and delay onset in diabetes-prone BB rats. | Microbiology and immunology 20091001 |
| Impact of hyperglycaemia and cholesterol levels on the outcome of hepatitis C virus (HCV) treatment in HIV/HCV-coinfected patients. | HIV medicine 20091001 |
| Hepatitis C drug development at a crossroads. | Hepatology (Baltimore, Md.) 20091001 |
| Hepatitis C virus infection and its clearance alter circulating lipids: implications for long-term follow-up. | Hepatology (Baltimore, Md.) 20091001 |
| Nosocomial outbreak of novel arenavirus infection, southern Africa. | Emerging infectious diseases 20091001 |
| [Efficiency of a combined peginterferon alpha-2a and ribavarin therapy in intravenous opiate substances abusers with chronic hepatitis C]. | Vojnosanitetski pregled 20091001 |
| Interferon-induced retinopathy and its risk in patients with diabetes and hypertension undergoing treatment for chronic hepatitis C virus infection. | Alimentary pharmacology & therapeutics 20090915 |
| Treatment of autoimmune thrombocytopenia in a case of chronic hepatitis C with ursodeoxycholic acid. | Journal of infection in developing countries 20090915 |
| Ribavirin enhances interferon signaling via stimulation of mTOR and p53 activities. | FEBS letters 20090903 |
| Synthesis, antiviral and anticancer activity of some novel thioureas derived from N-(4-nitro-2-phenoxyphenyl)-methanesulfonamide. | European journal of medicinal chemistry 20090901 |
| Synthesis and antiviral activity of new pyrazole and thiazole derivatives. | European journal of medicinal chemistry 20090901 |
| In vitro analysis of cidofovir and genetically engineered TK expression as potential approaches for the intervention of ColoAd1-based treatment of cancer. | Gene therapy 20090901 |
| Predictors of antiviral treatment initiation in hepatitis C virus-infected patients: a Danish cohort study. | Journal of viral hepatitis 20090901 |
| Clinical trial: low plasma cholesterol and oxidative stress predict rapid virological response to standard therapy with peginterferon and ribavirin in HCV patients. | Alimentary pharmacology & therapeutics 20090901 |
| Decline in male sexual desire, function, and satisfaction during and after antiviral therapy for chronic hepatitis C. | Gastroenterology 20090901 |
| A phase III study of the safety and efficacy of viramidine versus ribavirin in treatment-naïve patients with chronic hepatitis C: ViSER1 results. | Hepatology (Baltimore, Md.) 20090901 |
| [Interferon-related retinopathy in a man with chronic hepatitis C]. | Journal francais d'ophtalmologie 20090901 |
| Assessment of the efficacy of reducing peginterferon alpha-2a and ribavirin dose on virologic response in Koreans with chronic hepatitis C. | The Korean journal of internal medicine 20090901 |
| Hyalohyphomycosis caused by Paecilomyces lilacinus after kidney transplantation. | Transplantation proceedings 20090901 |
| Successful antiviral and antituberculosis treatment with pegylated interferon-alfa and ribavirin in a chronic hepatitis C patient with pulmonary tuberculosis. | Journal of the Formosan Medical Association = Taiwan yi zhi 20090901 |
| [A case of sudden-onset hearing loss in a patient treated with peginterferon alpha-2b and ribavirin for chronic hepatitis C]. | The Korean journal of hepatology 20090901 |
| Structural modeling of the NS 3 helicase of Tick-borne encephalitis virus and their virtual screening of potent drugs using molecular docking. | Interdisciplinary sciences, computational life sciences 20090901 |
| Bell's palsy and choreiform movements during peginterferon alpha and ribavirin therapy. | World journal of gastroenterology 20090807 |
| Elevation of serum gamma-glutamyltranspeptidase activity is frequent in chronic hepatitis C, and is associated with insulin resistance. | Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20090801 |
| Evidence for action of ribavirin through the hepatitis C virus RNA polymerase. | Journal of viral hepatitis 20090801 |
| Treatment of hepatitis C infection for current or former substance abusers in a community setting. | Journal of viral hepatitis 20090801 |
| The role of ribavirin in the therapy of Crimean-Congo hemorrhagic fever: early use is promising. | European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20090801 |
| Antiviral activity of indole derivatives. | Antiviral research 20090801 |
| Synthesis and antiviral activity of 4,4'-(arylmethylene)bis(1H-pyrazol-5-ols) against peste des petits ruminant virus (PPRV). | Bioorganic & medicinal chemistry letters 20090801 |
| Selective inhibition of nicotinamide adenine dinucleotide kinases by dinucleoside disulfide mimics of nicotinamide adenine dinucleotide analogues. | Bioorganic & medicinal chemistry 20090801 |
| Hepatitis C virus infection and immunomodulatory therapies. | Clinics in liver disease 20090801 |
| Ribavirin analogs. | Clinics in liver disease 20090801 |
| Incidence, risk factors, and outcome of chronic rejection during antiviral therapy for posttransplant recurrent hepatitis C. | Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20090801 |
| Celgosivir, an alpha-glucosidase I inhibitor for the potential treatment of HCV infection. | Current opinion in investigational drugs (London, England : 2000) 20090801 |
| TMC-435, an NS3/4A protease inhibitor for the treatment of HCV infection. | Current opinion in investigational drugs (London, England : 2000) 20090801 |
| Synthesis of novel ribavirin hydrazone derivatives and anti-proliferative activity against A549 lung cancer cells. | Carbohydrate research 20090727 |
| HPLC-MS/MS method for the intracellular determination of ribavirin monophosphate and ribavirin triphosphate in CEM ss cells. | Journal of pharmaceutical and biomedical analysis 20090712 |
| Molecular targeting of the oncogene eIF4E in acute myeloid leukemia (AML): a proof-of-principle clinical trial with ribavirin. | Blood 20090709 |
| Antiviral treatment for hepatitis C virus infection: effectiveness at general population level in a highly endemic area. | Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20090701 |
| Another ten stories in antiviral drug discovery (part C): 'Old' and 'new' antivirals, strategies, and perspectives. | Medicinal research reviews 20090701 |
| Treatment of chronic hepatitis C in sickle cell disease and thalassaemic patients with interferon and ribavirin. | European journal of gastroenterology & hepatology 20090701 |
| CXCR3 expression on peripheral CD4+ T cells as a predictive marker of response to treatment in chronic hepatitis C. | Clinical immunology (Orlando, Fla.) 20090701 |
| A 2-log drop in viral load at 1 month is the best predictor of sustained response in HCV patients with normal ALT: a kinetic prospective study. | Journal of viral hepatitis 20090701 |
| Antiviral and cytotoxic activities of aminoarylazo compounds and aryltriazene derivatives. | Bioorganic & medicinal chemistry 20090701 |
| Rapid suppression of hepatitis C viremia induced by intravenous silibinin plus ribavirin. | Gastroenterology 20090701 |
| Prospects for the development of fusion inhibitors to treat human respiratory syncytial virus infection. | Current opinion in drug discovery & development 20090701 |
| Apolipoprotein B-associated cholesterol is a determinant of treatment outcome in patients with chronic hepatitis C virus infection receiving anti-viral agents interferon-alpha and ribavirin. | Alimentary pharmacology & therapeutics 20090615 |
| Huisgen cycloaddition reaction of C-alkynyl ribosides under micellar catalysis: synthesis of ribavirin analogues. | The Journal of organic chemistry 20090605 |
| Synthesis, antimicrobial and antiviral evaluation of substituted imidazole derivatives. | European journal of medicinal chemistry 20090601 |
| Evolution of hepatic steatosis in patients with advanced hepatitis C: results from the hepatitis C antiviral long-term treatment against cirrhosis (HALT-C) trial. | Hepatology (Baltimore, Md.) 20090601 |
| Successful treatment of human metapneumovirus pneumonia using combination therapy with intravenous ribavirin and immune globulin. | British journal of haematology 20090601 |
| Effect of dietary purines on the pharmacokinetics of orally administered ribavirin. | Journal of clinical pharmacology 20090601 |
| Pioglitazone as adjuvant therapy in chronic hepatitis C: sequential rather than concomitant administration with pegylated interferon and ribavirin? | Journal of hepatology 20090601 |
| Clinical features and effect of antiviral therapy on anti-liver/kidney microsomal antibody type 1 positive chronic hepatitis C. | Journal of hepatology 20090601 |
| Serine protease inhibitors as anti-hepatitis C virus agents. | Expert review of anti-infective therapy 20090601 |
| Treatment of chronic hepatitis C in a slow responder: a case for extended therapy. | Nature reviews. Gastroenterology & hepatology 20090601 |
| Ribavirin acts via multiple pathways in inhibition of leukemic cell proliferation. | Anticancer research 20090601 |
| Pegylated interferon/ribavirin-induced sudden sensorineural hearing loss in a patient with chronic hepatitis C. | Journal of gastrointestinal and liver diseases : JGLD 20090601 |
| Pegylated interferon and ribavirin-induced depression in chronic hepatitis C: role of personality. | The Journal of clinical psychiatry 20090601 |
| Development of ocular myasthenia during pegylated interferon and ribavirin treatment for chronic hepatitis C. | The Korean journal of hepatology 20090601 |
| [Spontaneous and treatment-induced virological dynamic in the plasma, PBMC and liver tissue in a patient with chronic HBV and HCV coinfection]. | Le infezioni in medicina : rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive 20090601 |
| Therapy of rabies encephalitis. | Biomedica : revista del Instituto Nacional de Salud 20090601 |
| Antiviral constituents against respiratory viruses from Mikania micrantha. | Journal of natural products 20090522 |
| Substituted imidazopyridines as potent inhibitors of HCV replication. | Journal of hepatology 20090501 |
| Elevations in alanine aminotransferase levels late in the course of antiviral therapy in hepatitis C virus RNA-negative patients are associated with virological relapse. | Hepatology (Baltimore, Md.) 20090501 |
| Evaluation of Pharmasolve corneal permeability enhancement and its irritation on rabbit eyes. | Drug delivery 20090501 |
| Telaprevir and peginterferon with or without ribavirin for chronic HCV infection. | The New England journal of medicine 20090430 |
| Clinical decisions. Management of incidental hepatitis C virus infection. | The New England journal of medicine 20090430 |
| Peginterferon alfa-2a and ribavirin in Latino and non-Latino whites with hepatitis C. | The New England journal of medicine 20090430 |
| Indolylarylsulfones bearing natural and unnatural amino acids. Discovery of potent inhibitors of HIV-1 non-nucleoside wild type and resistant mutant strains reverse transcriptase and coxsackie B4 virus. | Journal of medicinal chemistry 20090409 |
| Peginterferon plus Ribavirin for chronic hepatitis C in opiate addicts on methadone/buprenorphine maintenance therapy. | Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20090401 |
| Sustained virological response is associated with clearance of hepatitis C virus RNA and a decrease in hepatitis C virus antibody. | Liver international : official journal of the International Association for the Study of the Liver 20090401 |
| Severe hepatocellular injury with apoptosis induced by a hepatitis C polymerase inhibitor. | Journal of clinical gastroenterology 20090401 |
| The role of the equilibrative nucleoside transporter 1 (ENT1) in transport and metabolism of ribavirin by human and wild-type or Ent1-/- mouse erythrocytes. | The Journal of pharmacology and experimental therapeutics 20090401 |
| Facilitated mitochondrial import of antiviral and anticancer nucleoside drugs by human equilibrative nucleoside transporter-3. | American journal of physiology. Gastrointestinal and liver physiology 20090401 |
| Antiviral therapy increases the risk of bacterial infections in HCV-infected cirrhotic patients awaiting liver transplantation: A retrospective study. | Journal of hepatology 20090401 |
| Insulin resistance is not a relevant predictor of sustained virological response to pegylated interferon plus ribavirin in HIV/HCV co-infected patients. | Journal of hepatology 20090401 |
| Treating chronic hepatitis C in recovering opiate addicts: yes, we can. | Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20090401 |
| Gamma glutamyl transferase elevation in HIV/Hepatitis C virus-coinfected patients during interferon-ribavirin combination therapy. | Journal of acquired immune deficiency syndromes (1999) 20090401 |
| Antinuclear antibody positivity in patients with chronic hepatitis C: clinically relevant or an epiphenomenon? | European journal of gastroenterology & hepatology 20090401 |
| Evaluation by survival analysis on effect of traditional Chinese medicine in treating children with respiratory syncytial viral pneumonia of phlegm-heat blocking Fei syndrome. | Chinese journal of integrative medicine 20090401 |
| Antinuclear antibody positivity in patients with chronic hepatitis C: clinically relevant or an epiphenomenon? | European journal of gastroenterology & hepatology 20090401 |
| Granulomatous hepatitis, perihepatic lymphadenopathies, and autoantibody positivity: an unusual association in a child with hepatitis C. | European journal of pediatrics 20090301 |
| [Thrombopoietin-receptor agonists: a revolution in the therapeutic strategies of immune thrombocytopenic purpura?]. | La Revue de medecine interne 20090301 |
| Quantitative tests of liver function measure hepatic improvement after sustained virological response: results from the HALT-C trial. | Alimentary pharmacology & therapeutics 20090301 |
| HCV796: A selective nonstructural protein 5B polymerase inhibitor with potent anti-hepatitis C virus activity in vitro, in mice with chimeric human livers, and in humans infected with hepatitis C virus. | Hepatology (Baltimore, Md.) 20090301 |
| Clinical, virologic, histologic, and biochemical outcomes after successful HCV therapy: a 5-year follow-up of 150 patients. | Hepatology (Baltimore, Md.) 20090301 |
| Effective ribavirin concentration in mice brain using cyclodextrin as a drug carrier: evaluation in a measles encephalitis model. | Antiviral research 20090301 |
| Improved virologic response in chronic hepatitis C genotype 4 treated with nitazoxanide, peginterferon, and ribavirin. | Gastroenterology 20090301 |
| The outcome of patients with Crimean-Congo hemorrhagic fever in Zahedan, southeast of Iran: a comparative study. | Archives of Iranian medicine 20090301 |
| Sequential antiviral and iron chelation treatment in a teenage boy with congenital anemia, chronic hepatitis C, and secondary hemosiderosis. | Journal of pediatric gastroenterology and nutrition 20090301 |
| Autoimmune haemolytic anaemia due to chronic hepatitis C virus infection treated with prednisone, pegylated interferon and ribavirin. | The Netherlands journal of medicine 20090301 |
| Severe autoimmune hemolytic anemia complicated with liver decompensation and invasive aspergillosis in a patient with chronic hepatitis C during treatment with peg-interferon-a and ribavirin. | Journal of gastrointestinal and liver diseases : JGLD 20090301 |
| [ANRS HC 02 RIBAVIC: histo-pathological impact]. | Gastroenterologie clinique et biologique 20090301 |
| [Treatment of chronic hepatitis C in HIV-infected patients]. | Gastroenterologie clinique et biologique 20090301 |
| Discovery of novel arylethynyltriazole ribonucleosides with selective and effective antiviral and antiproliferative activity. | Journal of medicinal chemistry 20090226 |
| Activation of central nervous system inflammatory pathways by interferon-alpha: relationship to monoamines and depression. | Biological psychiatry 20090215 |
| Synthesis of 5-isoxazol-5-yl-2'-deoxyuridines exhibiting antiviral activity against HSV and several RNA viruses. | Bioorganic & medicinal chemistry letters 20090215 |
| Design and synthesis of 1,2-annulated adamantane piperidines with anti-influenza virus activity. | Bioorganic & medicinal chemistry 20090215 |
| Homocysteine levels and sustained virological response to pegylated-interferon alpha2b plus ribavirin therapy for chronic hepatitis C: a prospective study. | Liver international : official journal of the International Association for the Study of the Liver 20090201 |
| Hepatic steatosis in patients with chronic hepatitis C virus genotype 2 or 3 does not affect viral response in patients treated with peginterferon alpha-2a (40KD) (PEGASYS) plus ribavirin (COPEGUS) for 16 or 24 weeks. | Liver international : official journal of the International Association for the Study of the Liver 20090201 |
| Expert opinion on the treatment of patients with chronic hepatitis C. | Journal of viral hepatitis 20090201 |
| Pentoxifylline inhibits replication of Japanese encephalitis virus: a comparative study with ribavirin. | International journal of antimicrobial agents 20090201 |
| The natural history of interferon-alpha2b-induced thyroiditis and its exclusivity in a cohort of patients with chronic hepatitis C infection. | QJM : monthly journal of the Association of Physicians 20090201 |
| Vitamins B depletion, lower iron status and decreased antioxidative defense in patients with chronic hepatitis C treated by pegylated interferon alfa and ribavirin. | Clinical nutrition (Edinburgh, Scotland) 20090201 |
| Determinants of relapse after a short (12 weeks) course of antiviral therapy and re-treatment efficacy of a prolonged course in patients with chronic hepatitis C virus genotype 2 or 3 infection. | Hepatology (Baltimore, Md.) 20090201 |
| Ribavirin: current role in the optimal clinical management of chronic hepatitis C. | Journal of hepatology 20090201 |
| The effect of controlled therapy interruption in chronic HCV infection: enhanced host immune response? A hypothesis. | Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 20090201 |
| Role of growth factors and thrombopoietic agents in the treatment of chronic hepatitis C. | Current gastroenterology reports 20090201 |
| Treatment of chronic hepatitis C: anticipated impact of resistance in patients treated with protease inhibitors. | Current gastroenterology reports 20090201 |
| Treatment of hepatitis C in liver transplant recipients. | Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20090201 |
| Jaundice developing in a patient with hepatitis C4 months after liver transplantation. | Hepatology (Baltimore, Md.) 20090201 |
| Anterior ischemic optic neuropathy complicating interferon alpha and ribavirin therapy in patients with chronic hepatitisC. | Gastroenterologie clinique et biologique 20090201 |
| Effects of combined interferon alpha and ribavirin therapy on thyroid functions in patients with chronic hepatitis C. | Journal of the College of Physicians and Surgeons--Pakistan : JCPSP 20090201 |
| [Novel treatments for hepatitis C viral infection and the hepatic fibrosis]. | Revista medica de Chile 20090201 |
| Peginterferon alfa-2a and ribavirin in Latino and non-Latino whites with hepatitis C. | The New England journal of medicine 20090115 |
| [Effects of supplementation with the antioxidant flavonoid, silymarin, in chronic hepatitis C patients treated with peg-interferon + ribavirin. A placebo-controlled double blind study]. | Orvosi hetilap 20090111 |
| Unchanged plasma levels of dimethylarginines and nitric oxide in chronic hepatitis C. | Scandinavian journal of gastroenterology 20090101 |
| Experience with intravenous ribavirin in the treatment of hemorrhagic fever with renal syndrome in Korea. | Antiviral research 20090101 |
| Mathematical modeling of HCV infection and treatment. | Methods in molecular biology (Clifton, N.J.) 20090101 |
| A case of hearing loss associated with pegylated interferon and ribavirin treatment ameliorated by prednisone. | Nature clinical practice. Gastroenterology & hepatology 20090101 |
| Ocular adnexal lymphoma and infectious agents. | Indian journal of ophthalmology 20090101 |
| Antiviral activity of raoulic acid from Raoulia australis against Picornaviruses. | Phytomedicine : international journal of phytotherapy and phytopharmacology 20090101 |
| Falsely low hemoglobin A1c levels in a patient receiving ribavirin and peginterferon alfa-2b for hepatitis C. | Pharmacotherapy 20090101 |
| Augmented lung inflammation protects against influenza A pneumonia. | PloS one 20090101 |
| Predictors of sustained virological response to a 48-week course of pegylated interferon alfa-2a and ribavirin in patients infected with hepatitis C virus genotype 4. | Annals of Saudi medicine 20090101 |
| Predictors of sustained virologic response in hepatitis C genotype 4: beyond the usual suspects. | Annals of Saudi medicine 20090101 |
| A study of best positive predictors for sustained virologic response to interferon alpha plus ribavirin therapy in naive chronic hepatitis C patients. | BMC gastroenterology 20090101 |
| What are the comorbidities influencing the management of patients and the response to therapy in chronic hepatitis C? | Liver international : official journal of the International Association for the Study of the Liver 20090101 |
| [Chorea during treatment with pegylated interferon and ribavirin in HIV-HCV coinfected patient]. | Enfermedades infecciosas y microbiologia clinica 20090101 |
| [Serious loss of vision in bilateral anterior ischemic optic neuropathy caused by interferon]. | Nippon Ganka Gakkai zasshi 20090101 |
| Pegylated interferon plus ribavirin combination therapy for chronic hepatitis C with high viral load of serum hepatitis C virus RNA, genotype 1b, discontinued on attaining sustained virological response at week 16 after onset of acute pancreatitis. | Digestion 20090101 |
| Applying the Milwaukee protocol to treat canine rabies in Equatorial Guinea. | Scandinavian journal of infectious diseases 20090101 |
| Recurrence of hepatitis C virus genotype-4 infection following orthotopic liver transplantation: natural history and predictors of outcome. | Annals of Saudi medicine 20090101 |
| Factors affecting early viral load decline of Asian chronic hepatitis C patients receiving pegylated interferon plus ribavirin therapy. | Antiviral therapy 20090101 |
| Differential susceptibility of adenovirus clinical isolates to cidofovir and ribavirin is not related to species alone. | Antiviral therapy 20090101 |
| Spotlight on peginterferon-alpha-2a (40 kD) plus ribavirin in the management of chronic hepatitis C mono-infection. | BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 20090101 |
| An open pilot study exploring the efficacy of fluvastatin, pegylated interferon and ribavirin in patients with hepatitis C virus genotype 1b in high viral loads. | Intervirology 20090101 |
| Impact of hepatitis B exposure on sustained virological response rates of highly viremic chronic hepatitis C patients. | Gastroenterology research and practice 20090101 |
| The necrotic signal induced by mycophenolic acid overcomes apoptosis-resistance in tumor cells. | PloS one 20090101 |
| PEG-interferon in acute and chronic hepatitis C: a review. | American journal of therapeutics 20090101 |
| Counteracting quasispecies adaptability: extinction of a ribavirin-resistant virus mutant by an alternative mutagenic treatment. | PloS one 20090101 |
| Optimizing ribavirin dosage: a new challenge to improve treatment efficacy in genotype 1 hepatitis C patients. | Gastroenterologie clinique et biologique 20090101 |
| [Application of ribavirin in patients having hemorrhagic fever with renal syndrome]. | Medicinski pregled 20090101 |
| [Difficulties in treatment of kidney diseases related to HCV infection]. | Przeglad epidemiologiczny 20090101 |
| [Effect of Stimforte in combination with Virazole on infection induced by hepatitis C virus in mice]. | Voprosy virusologii 20090101 |
| HCV antibody response and genotype distribution in different areas and races of China. | International journal of biological sciences 20090101 |
| Immunological and mutagenic actions of ribavirin monotherapy preceding combination therapy with interferon for patients with chronic hepatitis C. | Antiviral therapy 20090101 |
| Liver function under interferon/ribavirin therapy of chronic hepatitis C. | Hepato-gastroenterology 20090101 |
| Influence of body mass index, cholesterol, triglycerides and steatosis on pegylated interferon alfa-2a and ribavirin treatment for recurrent hepatitis C in patients transplanted for HCV and alcoholic cirrhosis. | Hepato-gastroenterology 20090101 |
| Anterior ischemic optic neuropathy associated with pegylated interferon therapy for chronic hepatitis C. | Ocular immunology and inflammation 20090101 |
| Multisystemic sarcoidosis associated with a second therapy for chronic hepatitis C. | Acta gastro-enterologica Belgica 20090101 |
| Peginterferon (PEG-IFN) plus ribavirin combination therapy, but neither interferon nor PGE-IFN alone, induced type 1 diabetes in a patient with chronic hepatitis C. | Internal medicine (Tokyo, Japan) 20090101 |
| [Management of sarcoidosis-associated chronic hepatitis C virus infection: course and treatment]. | Revista clinica espanola 20090101 |
| Iron depletion before HCV antiviral therapy: a pilot, randomized, controlled trial. | Journal of clinical apheresis 20090101 |
| The course of inactive hepatitis B in hepatitis-C-coinfected patients treated with interferon and ribavirin. | Antiviral therapy 20090101 |
| Insulin resistance impairs sustained virological response rate to pegylated interferon plus ribavirin in HIV-hepatitis C virus-coinfected patients: HOMAVIC-ANRS HC02 Study. | Antiviral therapy 20090101 |
| An enhanced single base extension technique for the analysis of complex viral populations. | PloS one 20090101 |
| Prolonged psychosis associated with interferon therapy in a patient with hepatitis C: case study and literature review. | Psychosomatics 20090101 |
| [The 24 May, 2009 isolation of the first A/IIV-Moscow/01/2009 (H1N1)swl strain similar to swine A(H1N1) influenza virus from the first Moscow case detected on May 21, 2009, and its deposit in the state collection of viruses (SCV No. 2452 dated May 24, 2009)]. | Voprosy virusologii 20090101 |
| Ribavirin administration alters ectonucleotidase activities in experimental autoimmune encephalomyelitis. | General physiology and biophysics 20090101 |
| Regulation of influenza virus-caused oxidative stress by Kegan Liyan oral prescription, as monitored by ascorbyl radical ESR signals. | The American journal of Chinese medicine 20090101 |
| Treatment of chronic hepatitis C in a patient affected by systemic sclerosis. | Gastroenterology research and practice 20090101 |
| Clinical and basal aspects of anemia during antiviral therapy for hepatitis C. | Annals of hepatology 20090101 |
| Antiviral strategies: the present and beyond. | Current molecular pharmacology 20090101 |
| [Investigation of susceptibility of influenza viruses A (H1N1), the cause of infection in humans in April-May 2009, to antivirals in MDCK cell culture]. | Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] 20090101 |
| The treatment of chronic hepatitis C virus infection in HIV co-infection. | European journal of medical research 20090101 |
| Combination therapy with interferon and ribavirin for chronic hepatitis C infection in beta-thalassaemia major. | Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit 20090101 |
| Anemia--a complication of antiviral treatment in chronic viral hepatitis C. | Romanian journal of internal medicine = Revue roumaine de medecine interne 20090101 |
| [Anti-adenovirus activity of a substance and medical form of ribamydil in cell culture]. | Mikrobiolohichnyi zhurnal (Kiev, Ukraine : 1993) 20090101 |
| Association of response to combined interferon alpha-2b and ribavirin therapy in patients of chronic hepatitis c with serum alanine aminotransferase levels and severity of the disease on liver biopsy. | Journal of Ayub Medical College, Abbottabad : JAMC 20090101 |
| Contribution of Na+-independent nucleoside transport to ribavirin uptake in the rat intestine and human epithelial LS180 cells. | European journal of pharmacology 20081228 |
| Rapid and sensitive HPLC-MS/MS method for pharmacokinetic assessment of ribavirin in healthy Chinese. | Biomedical chromatography : BMC 20081201 |
| The impact of diet on liver fibrosis and on response to interferon therapy in patients with HCV-related chronic hepatitis. | The American journal of gastroenterology 20081201 |
| Efficacy of pegylated interferon plus ribavirin treatment in HIV/hepatitis C virus co-infected patients receiving abacavir plus lamivudine or tenofovir plus either lamivudine or emtricitabine as nucleoside analogue backbone. | The Journal of antimicrobial chemotherapy 20081201 |
| Taribavirin for the treatment of chronic hepatitis C. | Expert opinion on pharmacotherapy 20081201 |
| Ribavirin mode of action in chronic hepatitis C: from clinical use back to molecular mechanisms. | Liver international : official journal of the International Association for the Study of the Liver 20081201 |
| IFNalpha-induced recurrence of Graves' disease ten years after thyroidectomy in chronic viral hepatitis C. Case report. | Journal of gastrointestinal and liver diseases : JGLD 20081201 |
| A monocentric observational study of darbepoetin alfa in anemic hepatitis-C-virus transplant patients treated with ribavirin. | Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation 20081201 |
| Increase in serum bilirubin in HIV/hepatitis-C virus-coinfected patients on atazanavir therapy following initiation of pegylated-interferon and ribavirin. | AIDS (London, England) 20081130 |
| Induction of IgA and sustained deficiency of cell proliferative response in chronic hepatitis C. | World journal of gastroenterology 20081128 |
| Pegylated interferon-alpha-2a plus ribavirin for treatment-naive Asian patients with hepatitis C virus genotype 1 infection: a multicenter, randomized controlled trial. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20081115 |
| Changes in mood states and biomarkers during peginterferon and ribavirin treatment of chronic hepatitis C. | The American journal of gastroenterology 20081101 |
| Oseltamivir-ribavirin combination therapy for highly pathogenic H5N1 influenza virus infection in mice. | Antimicrobial agents and chemotherapy 20081101 |
| Silibinin is a potent antiviral agent in patients with chronic hepatitis C not responding to pegylated interferon/ribavirin therapy. | Gastroenterology 20081101 |
| Effect of interferon-alpha, ribavirin, pentoxifylline, and interleukin-18 antibody on hepatitis C sera-stimulated hepatic stellate cell proliferation. | Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 20081101 |
| Placebo-controlled trial of 400 mg amantadine combined with peginterferon alfa-2a and ribavirin for 48 weeks in chronic hepatitis C virus-1 infection. | Hepatology (Baltimore, Md.) 20081101 |
| Interferon-alpha-2b/ribavirin-induced vestibulocochlear toxicity with dysautonomia in a chronic hepatitis C patient. | European journal of gastroenterology & hepatology 20081101 |
| Ribavirin targets eIF4E dependent Akt survival signaling. | Biochemical and biophysical research communications 20081024 |
| Interaction of ribavirin with azathioprine metabolism potentially induces myelosuppression. | Alimentary pharmacology & therapeutics 20081015 |
| Transplantation-related thrombotic microangiopathy triggered by preemptive therapy for hepatitis C virus infection. | Transplantation 20081015 |
| Porphyria cutanea tarda as a complication of therapy for chronic hepatitis C. | World journal of gastroenterology 20081014 |
| Incidence of type 2 diabetes mellitus and glucose abnormalities in patients with chronic hepatitis C infection by response to treatment: results of a cohort study. | The American journal of gastroenterology 20081001 |
| Successful treatment of parainfluenza virus 3 pneumonia with oral ribavirin and methylprednisolone in a bone marrow transplant recipient. | International journal of hematology 20081001 |
| Potential for all-trans retinoic acid (tretinoin) to enhance interferon-alpha treatment response in chronic myelogenous leukemia, melanoma, myeloma and renal cell carcinoma. | Cancer biology & therapy 20081001 |
| Sexual dysfunction in chronic hepatitis C virus patients treated with interferon alpha and ribavirin. | Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 20081001 |
| Oral lichenoid lesions in HIV-HCV-coinfected subjects during antiviral therapy: 2 cases and review of the literature. | The American Journal of dermatopathology 20081001 |
| Synthesis and antiviral evaluation of acyclic azanucleosides developed from sulfanilamide as a lead structure. | Bioorganic & medicinal chemistry 20080915 |
| Efficacy and safety of antiviral therapy in patients with Crohn's disease and chronic hepatitis C. | Alimentary pharmacology & therapeutics 20080915 |
| Design and synthesis of bioactive 1,2-annulated adamantane derivatives. | Organic & biomolecular chemistry 20080907 |
| Recurrent myocardial ischaemia during combination antiviral therapy in a patient with chronic hepatitis C and normal aminotransferase levels. | Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20080901 |
| Oral lesions in HIV and HCV co-infected individuals in HAART era. | Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 20080901 |
| In vitro and in vivo investigations on the antiviral activity of a series of mixed-valence rare earth borotungstate heteropoly blues. | European journal of medicinal chemistry 20080901 |
| Expression and hepatobiliary transport characteristics of the concentrative and equilibrative nucleoside transporters in sandwich-cultured human hepatocytes. | American journal of physiology. Gastrointestinal and liver physiology 20080901 |
| Correlation of serum ribavirin concentration with pretreatment renal function estimates in patients with chronic hepatitis C receiving combination antiviral therapy with peginterferon and ribavirin. | Journal of viral hepatitis 20080901 |
| Weight affect relapse rates in latinos with genotype 2/3 chronic hepatitis C (CHC) treated with peg IFN alfa-2a (Pegasys) 180 mcg/week and 800 mg daily of ribavirin for 24 weeks. | Journal of medical virology 20080901 |
| Antiviral activity of cidofovir and ribavirin against the new human adenovirus subtype 14a that is associated with severe pneumonia. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20080901 |
| Effect of antiviral therapy on hepatitis C virus related glomerulopathy. | Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia 20080901 |
| Pneumococcal meningitis during antiviral treatment with interferon and ribavirin in a splenectomized patient with chronic hepatitis C - do not miss vaccination before starting therapy. | Zeitschrift fur Gastroenterologie 20080901 |
| Drug-induced Sweet's syndrome secondary to hepatitis C antiviral therapy. | International journal of dermatology 20080901 |
| Longitudinal effects of hepatitis C virus treatment on hepatic mitochondrial dysfunction assessed by C-methionine breath test. | Alimentary pharmacology & therapeutics 20080815 |
| Clinical trial: peg-interferon alfa-2b and ribavirin for the treatment of genotype-1 hepatitis C recurrence after liver transplantation. | Alimentary pharmacology & therapeutics 20080815 |
| New 1-indanone thiosemicarbazone derivatives active against BVDV. | European journal of medicinal chemistry 20080801 |
| Interferon beta 1a versus interferon beta 1a plus ribavirin for the treatment of chronic hepatitis C in Chinese patients: a randomized, placebo-controlled trial. | Digestive diseases and sciences 20080801 |
| IFN-alpha-induced motor slowing is associated with increased depression and fatigue in patients with chronic hepatitis C. | Brain, behavior, and immunity 20080801 |
| Early and accurate prediction of Peg-IFNs/ribavirin therapy outcome in the individual patient with chronic hepatitis C by modeling the dynamics of the infected cells. | Clinical pharmacology and therapeutics 20080801 |
| Antiviral effects and safety of telaprevir, peginterferon alfa-2a, and ribavirin for 28 days in hepatitis C patients. | Journal of hepatology 20080801 |
| Substitution of amino acid 70 in the hepatitis C virus core region of genotype 1b is an important predictor of elevated alpha-fetoprotein in patients without hepatocellular carcinoma. | Journal of medical virology 20080801 |
| Efficacy of low-dose intermittent interferon-alpha monotherapy in patients infected with hepatitis C virus genotype 1b who were predicted or failed to respond to pegylated interferon plus ribavirin combination therapy. | Journal of medical virology 20080801 |
| Pioglitazone in chronic hepatitis C not responding to pegylated interferon-alpha and ribavirin. | Journal of hepatology 20080801 |
| Safety and efficacy of pegylated interferon alpha-2a and ribavirin for the treatment of hepatitis C in patients with thalassemia. | Haematologica 20080801 |
| R1626 plus peginterferon Alfa-2a provides potent suppression of hepatitis C virus RNA and significant antiviral synergy in combination with ribavirin. | Hepatology (Baltimore, Md.) 20080801 |
| Outcomes of peginterferon alpha-2a and ribavirin hepatitis C therapy in Aboriginal Canadians. | Canadian journal of gastroenterology = Journal canadien de gastroenterologie 20080801 |
| Early predictors of anemia in patients with hepatitis C genotype 1 treated with peginterferon alfa-2a (40KD) plus ribavirin. | The American journal of gastroenterology 20080801 |
| [The 43rd Annual Meeting of the European Association for the Study of the Liver (EASL), Milan, Italy, April 23-27, 2008]. | Orvosi hetilap 20080713 |
| Potent non-nucleoside inhibitors of the measles virus RNA-dependent RNA polymerase complex. | Journal of medicinal chemistry 20080710 |
| [Peginterferon alfa-2b and ribavirin-induced pure red cell aplasia during treatment of chronic hepatitis C treated by cyclosporin A with good response]. | Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine 20080710 |
| CTN-194 (PICCO): design of a trial of citalopram for the prevention of depression and its consequences in HIV-hepatitis C co-infected individuals initiating pegylated interferon/ribavirin therapy. | Contemporary clinical trials 20080701 |
| Pegylated interferon alpha-2b plus ribavirin for naive patients with HCV-related cirrhosis. | Journal of clinical gastroenterology 20080701 |
| Synthesis of 1-beta-D-ribofuranosyl-3-ethynyl-[1,2,4]triazole and its in vitro and in vivo efficacy against Hantavirus. | Antiviral research 20080701 |
| Recovery after L-DOPA treatment in peginterferon and ribavirin induced parkinsonism. | European journal of internal medicine 20080701 |
| Recurrence of HCV infection in a sustained responder after chemotherapy for non-Hodgkin's lymphoma: successful retreatment. | The American journal of the medical sciences 20080701 |
| In vivo antiviral activity of ribavirin/alpha-cyclodextrin complex: evaluation on experimental measles virus encephalitis in mice. | International journal of pharmaceutics 20080605 |
| Inflammation and repair in viral hepatitis C. | Digestive diseases and sciences 20080601 |
| Hepatitis B and C in children. | Nature clinical practice. Gastroenterology & hepatology 20080601 |
| Arylethynyltriazole acyclonucleosides inhibit hepatitis C virus replication. | Bioorganic & medicinal chemistry letters 20080601 |
| Efficacy of interferon in immunocompromised HCV patients after liver transplantation or with HIV co-infection. | European journal of clinical investigation 20080601 |
| Ribavirin in the treatment of chronic hepatitis C. | Journal of gastroenterology and hepatology 20080601 |
| Occurrence of diffuse, poorly differentiated hepatocellular carcinoma during pegylated interferon plus ribavirin combination therapy for chronic hepatitis C. | Journal of chemotherapy (Florence, Italy) 20080601 |
| [Depressive disorders and symptoms accompanying pegylated interferon alpha and ribavirin treatment of chronic hepatitis C patients]. | Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego 20080601 |
| Antiviral treatment in patients with hepatitis C virus-related cirrhosis awaiting liver transplantation. | Therapeutics and clinical risk management 20080601 |
| HCV virological response during treatment of chronic hepatitis C is associated with liver histological improvement in patients with HCV/HIV co-infection. | The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases 20080601 |
| [Role of tenofovir in HIV and hepatitis C virus coinfection]. | Enfermedades infecciosas y microbiologia clinica 20080601 |
| Hepatitis C treatment in patients with drug addiction: clinical management of interferon-alpha-associated psychiatric side effects. | Current drug abuse reviews 20080601 |
| Characterization of intestinal absorption of mizoribine mediated by concentrative nucleoside transporters in rats. | European journal of pharmacology 20080531 |
| Baseline serum low-density lipoprotein cholesterol levels predict response to hepatitis C virus therapy in HIV/hepatitis C virus coinfected patients. | AIDS (London, England) 20080511 |
| Identification of Plasmodium falciparum spermidine synthase active site binders through structure-based virtual screening. | Journal of medicinal chemistry 20080508 |
| Effect of sustained virological response to treatment on the incidence of abnormal glucose values in chronic hepatitis C. | Journal of hepatology 20080501 |
| Facile synthesis of novel mutual derivatives of nucleosides and pyrimidines by regioselectively chemo-enzymatic protocol. | Bioorganic & medicinal chemistry 20080501 |
| Chronic hepatitis C responds poorly to combination therapy in chronic hepatis B carriers. | The Netherlands journal of medicine 20080501 |
| Insulin resistance impairs rapid virologic response in HIV/hepatitis C virus coinfected patients on peginterferon-alfa-2a. | AIDS (London, England) 20080423 |
| Therapeutic effects of combined treatment with ribavirin and tiazofurin on experimental autoimmune encephalomyelitis development: clinical and histopathological evaluation. | Journal of the neurological sciences 20080415 |
| Response of combination therapy on viral load and disease severity in chronic hepatitis C. | Digestive diseases and sciences 20080401 |
| L-carnitine treatment reduces steatosis in patients with chronic hepatitis C treated with alpha-interferon and ribavirin. | Digestive diseases and sciences 20080401 |
| Treatment of yellow fever. | Antiviral research 20080401 |
| The use of different Peg-interferon alpha-2b regimens plus ribavirin in HCV-1b-infected patients after rapid virological response does not affect the achievement of sustained virological response. | Journal of viral hepatitis 20080401 |
| Eicosapentaenoic acid supplementation for chronic hepatitis C patients during combination therapy of pegylated interferon alpha-2b and ribavirin. | Lipids 20080401 |
| Rapidly deteriorating renal function with membranoproliferative glomerulonephritis Type 1 associated with hepatitis C treated successfully with steroids and antiviral therapy: a case report and review of literature. | Clinical nephrology 20080401 |
| Effect of ribavirin, in combination with interferon in patients with hepatitis C, on the bleeding risk associated with selective serotonin reuptake inhibitors. | The Journal of clinical psychiatry 20080401 |
| [Haematologic adverse effects of treatment of chronic viral hepatitis B and C]. | Klinicka mikrobiologie a infekcni lekarstvi 20080401 |
| Limited benefit of biochemical response to combination therapy for patients with recurrent hepatitis C after living-donor liver transplantation. | Transplantation 20080327 |
| Human uridine-cytidine kinase phosphorylation of ribavirin: a convenient method for activation of ribavirin for conjugation to proteins. | Journal of biomedical science 20080301 |
| Peginterferon alfa-2a/ribavirin in hepatitis C virus patients nontolerant or nonresponsive to peginterferon alfa-2b/ribavirin. | Alimentary pharmacology & therapeutics 20080301 |
| Treatment of hepatitis C in patients with haemophilia - the Israeli National Hemophilia Center experience. | Haemophilia : the official journal of the World Federation of Hemophilia 20080301 |
| Interferon-ribavirin-associated ischemic colitis. | Journal of clinical gastroenterology 20080301 |
| [Cryoglobulinemia]. | La Revue de medecine interne 20080301 |
| Progression of fibrosis in HIV and hepatitis C virus-coinfected patients treated with interferon plus ribavirin-based therapy: analysis of risk factors. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20080301 |
| Clinical benefits of antiviral therapy in patients with recurrent hepatitis C following liver transplantation. | American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20080301 |
| Artificially low HbA1c associated with treatment with ribavirin. | BMJ (Clinical research ed.) 20080301 |
| [Effectiveness of peginterferon alpha-2a or -2b plus ribavirin in naïve patients with hepatitis C infection]. | Enfermedades infecciosas y microbiologia clinica 20080301 |
| Synthesis of some novel thiourea derivatives obtained from 5-[(4-aminophenoxy)methyl]-4-alkyl/aryl-2,4-dihydro-3H-1,2,4-triazole-3-thiones and evaluation as antiviral/anti-HIV and anti-tuberculosis agents. | European journal of medicinal chemistry 20080201 |
| Comparison of low-dose pegylated interferon versus standard high-dose pegylated interferon in combination with ribavirin in patients with chronic hepatitis C with genotype 3: an Indian experience. | Journal of gastroenterology and hepatology 20080201 |
| De novo depression and anxiety disorders and influence on adherence during peginterferon-alpha-2a and ribavirin treatment in patients with hepatitis C. | Alimentary pharmacology & therapeutics 20080201 |
| Three-component, one-pot synthesis of novel 2,4-substituted 5-azolylthiopyrimidine library for screening against anti-influenza virus A. | Bioorganic & medicinal chemistry letters 20080201 |
| Efficacy and safety of peginterferon-alpha2b and ribavirin combination therapy in children with chronic hepatitis C infection. | The Pediatric infectious disease journal 20080201 |
| Inferior response of Asian vs non-Asian hepatitis C genotype 3 infection to combination antiviral therapy. | Journal of viral hepatitis 20080201 |
| Hepatic steatosis in chronic hepatitis C: baseline host and viral characteristics and influence on response to therapy with peginterferon alpha-2a plus ribavirin. | Journal of viral hepatitis 20080201 |
| Does a rapid decline in the hematological and biochemical parameters induced by interferon and ribavirin combination therapy for the hepatitis C virus predict a sustained viral response? | Canadian journal of gastroenterology = Journal canadien de gastroenterologie 20080201 |
| [Advance in technical method and treatment for viral hepatitis]. | Rinsho byori. The Japanese journal of clinical pathology 20080201 |
| [Protocol for the treatment of chronic viral hepatitis]. | Orvosi hetilap 20080120 |
| Effects of introduction of hydrophobic group on ribavirin base on mutation induction and anti-RNA viral activity. | Journal of medicinal chemistry 20080110 |
| Early decline of hemoglobin can predict progression of hemolytic anemia during pegylated interferon and ribavirin combination therapy in patients with chronic hepatitis C. | Hepatology research : the official journal of the Japan Society of Hepatology 20080101 |
| Predicting efficacy and safety outcomes in patients with hepatitis C virus genotype 1 and persistently 'normal' alanine aminotransferase levels treated with peginterferon alpha-2a (40KD) plus ribavirin. | Liver international : official journal of the International Association for the Study of the Liver 20080101 |
| Insulin resistance and response to therapy in patients infected with chronic hepatitis C virus genotypes 2 and 3. | Journal of hepatology 20080101 |
| De novo nephrotic syndrome following pegylated interferon alfa 2b/ribavirin therapy for chronic hepatitis C infection. | International urology and nephrology 20080101 |
| High incidence of type 1 diabetes mellitus during or shortly after treatment with pegylated interferon alpha for chronic hepatitis C virus infection. | Liver international : official journal of the International Association for the Study of the Liver 20080101 |
| Exploring differences in response to treatment with peginterferon alpha 2a (40kD) and ribavirin in chronic hepatitis C between genotypes 2 and 3. | Journal of viral hepatitis 20080101 |
| Thyrotoxic periodic paralysis induced by pegylated interferon alpha plus ribavirin for chronic hepatitis C. | Journal of clinical gastroenterology 20080101 |
| Association between exposure to nevirapine and reduced liver fibrosis progression in patients with HIV and hepatitis C virus coinfection. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20080101 |
| Leukocytoclastic vasculitis during pegylated interferon and ribavirin treatment of hepatitis C virus infection. | Indian journal of dermatology, venereology and leprology 20080101 |
| Treatment of hepatitis C with interferon-alpha and ribavirine in a patient with long-term clozapine treatment. | Psychosomatics 20080101 |
| Stability-indicating thin-layer chromatographic method for quantitative determination of ribavirin. | Journal of chromatographic science 20080101 |
| [Acute portal thrombosis in patients with hepatitis C treated with pegylated interferon and ribavirin]. | Gastroenterologia y hepatologia 20080101 |
| Interferon associated retinopathy. | JPMA. The Journal of the Pakistan Medical Association 20080101 |
| [Acute bronchiolitis, an updated review]. | Revista da Associacao Medica Brasileira (1992) 20080101 |
| Type 1 diabetes mellitus provoked by peginterferon alpha-2b plus ribavirin treatment for chronic hepatitis C. | Internal medicine (Tokyo, Japan) 20080101 |
| Ribavirin considerations in treatment optimization. | Antiviral therapy 20080101 |
| Hepatitis C virus diversity and evolution in the full open-reading frame during antiviral therapy. | PloS one 20080101 |
| [The role of ribavirin in the treatment of chronic hepatitis C]. | Przeglad epidemiologiczny 20080101 |
| Serum alpha-fetoprotein predicts treatment outcome in chronic hepatitis C patients regardless of HCV genotype. | PloS one 20080101 |
| Peginterferon-alpha-2a (40 kD) plus ribavirin: a review of its use in the management of chronic hepatitis C mono-infection. | Drugs 20080101 |
| Low response to pegylated interferon plus ribavirin in HIV-infected patients with chronic hepatitis C treated with abacavir. | Antiviral therapy 20080101 |
| Peginterferon- and ribavirin-induced bipolar episode successfully treated with lamotrigine without discontinuation of antiviral therapy. | General hospital psychiatry 20080101 |
| Combinations of 2'-C-methylcytidine analogues with interferon-alpha2b and triple combination with ribavirin in the hepatitis C virus replicon system. | Antiviral chemistry & chemotherapy 20080101 |
| Correlation between pre-treatment quasispecies complexity and treatment outcome in chronic HCV genotype 3a. | Virology journal 20080101 |
| The precipitation of mania by citalopram in a patient with interferon-induced depression. | Psychosomatics 20080101 |
| Topology of evolving, mutagenized viral populations: quasispecies expansion, compression, and operation of negative selection. | BMC evolutionary biology 20080101 |
| [Cytokine assessment in untreated hepatitis C virus infected patients and during interferon alpha +ribavirine therapy]. | Wiadomosci lekarskie (Warsaw, Poland : 1960) 20080101 |
| Serum 90K/Mac-2 binding protein (Mac-2BP) as a response predictor to peginterferon and ribavirin combined treatment in HCV chronic patients. | Immunopharmacology and immunotoxicology 20080101 |
| [Antiviral activity of arbidol and its derivatives against the pathogen of severe acute respiratory syndrome in the cell cultures]. | Voprosy virusologii 20080101 |
| Synthesis and antiviral evaluation of 4-fluoropyrazole-3-carboxamide nucleoside derivatives. | Nucleic acids symposium series (2004) 20080101 |
| Large intestine histopathology of pegylated-interferon-alpha plus ribavirin treated chronic hepatitis C patients. | Gastroenterology research and practice 20080101 |
| Neuraminidase activity provides a practical read-out for a high throughput influenza antiviral screening assay. | Virology journal 20080101 |
| Factors influencing the participation of gastroenterologists and hepatologists in clinical research. | BMC health services research 20080101 |
| [Immunomodulators in the 'gold standard' of the chronic viral hepatitis C therapy]. | Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] 20080101 |
| [Comparative estimation of pharmacokinetics of generic ribavirin-containing drugs]. | Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] 20080101 |
| Hepatitis C virus infection protein network. | Molecular systems biology 20080101 |
| Cyclic changes in gene expression induced by Peg-interferon alfa-2b plus ribavirin in peripheral blood monocytes (PBMC) of hepatitis C patients during the first 10 weeks of treatment. | Journal of translational medicine 20080101 |
| Treatment of late stage disease in a model of arenaviral hemorrhagic fever: T-705 efficacy and reduced toxicity suggests an alternative to ribavirin. | PloS one 20080101 |
| Efficacy of triple therapy with thymalfasin, peginterferon alpha-2a, and ribavirin for the treatment of hispanic chronic HCV nonresponders. | Annals of hepatology 20080101 |
| Abacavir does not influence the rate of virological response in HIV-HCV-coinfected patients treated with pegylated interferon and weight-adjusted ribavirin. | Antiviral therapy 20080101 |
| [Comparative efficiency and side effects of combined antiviral therapy of chronic hepatitis C]. | Klinicheskaia meditsina 20080101 |
| Central retinal vein occlusion in hypertensive patients with chronic hepatitis C treated with interferon alpha and ribavirin. | Japanese journal of ophthalmology 20080101 |
| Ribavirin priming in patients with chronic hepatitis C and normal ALT: a pilot study. | Hepato-gastroenterology 20080101 |
| [Anti-virus response and interferon, cytokine systems in patients with chronic hepatitis C]. | Terapevticheskii arkhiv 20080101 |
| Future treatment options for HCV: double, triple, what is the optimal combination? | Best practice & research. Clinical gastroenterology 20080101 |
| IP-10 correlates with hepatitis C viral load, hepatic inflammation and fibrosis and predicts hepatitis C virus relapse or non-response in HIV-HCV coinfection. | Antiviral therapy 20080101 |
| Serum transaminase elevations during pegylated interferon treatment of chronic HCV hepatitis probably induced by polyethylene glycol. | Intervirology 20080101 |
| [Cognitive disturbances observed in chronic hepatitis C patients during pegylated interferon alpha and ribavirin therapy]. | Psychiatria polska 20080101 |
| Antemortem diagnosis and prevention of human rabies. | Annals of Indian Academy of Neurology 20080101 |
| Predictive factors for interferon and ribavirin combination therapy in patients with chronic hepatitis C. | World journal of gastroenterology 20071214 |
| Grapevine vitivirus A eradication in Vitis vinifera explants by antiviral drugs and thermotherapy. | Journal of virological methods 20071201 |
| Hepatitis-C patients have reduced growth hormone (GH) secretion which improves during long-term therapy with pegylated interferon-alpha. | The American journal of gastroenterology 20071201 |
| The antiviral drug ribavirin is a selective inhibitor of S-adenosyl-L-homocysteine hydrolase from Trypanosoma cruzi. | Bioorganic & medicinal chemistry 20071201 |
| Influence of concomitant antiretroviral therapy on the rate of sustained virological response to pegylated interferon plus ribavirin in hepatitis C virus/HIV-coinfected patients. | The Journal of antimicrobial chemotherapy 20071201 |
| [Development of a myasthenia crisis during interferon treatment for chronic C hepatitis]. | Gastroenterologie clinique et biologique 20071201 |
| High dose of erythropoietin in management of interferon/ribavirin induced anemia. | Hepato-gastroenterology 20071201 |
| Hepatitis C for addiction professionals. | Addiction science & clinical practice 20071201 |
| Cryoglobulinemia revealed by a Purtscher-like retinopathy. | Clinical ophthalmology (Auckland, N.Z.) 20071201 |
| What now? Responding to relapse in hepatitis C. | Advance for nurse practitioners 20071201 |
| 5'-O-masked 2'-deoxyadenosine analogues as lead compounds for hepatitis C virus (HCV) therapeutic agents. | Bioorganic & medicinal chemistry 20071115 |
| Ester prodrugs of cyclic 1-(S)-[3-hydroxy-2-(phosphonomethoxy)propyl]-5-azacytosine: synthesis and antiviral activity. | Journal of medicinal chemistry 20071115 |
| Probing binding requirements of type I and type II isoforms of inosine monophosphate dehydrogenase with adenine-modified nicotinamide adenine dinucleotide analogues. | Journal of medicinal chemistry 20071115 |
| [Toxicity of the treatment of chronic hepatitis C with peginterferon alpha (2a or 2b) plus ribavirin in patients not previously treated]. | Medicina clinica 20071103 |
| A randomized trial of paroxetine to prevent interferon-alpha-induced depression in patients with hepatitis C. | Journal of affective disorders 20071101 |
| Predictors of viral kinetics to peginterferon plus ribavirin combination therapy in Japanese patients infected with hepatitis C virus genotype 1b. | Journal of medical virology 20071101 |
| Iron and hepatitis C: beginning to make sense. | Journal of gastroenterology and hepatology 20071101 |
| Hepatic iron accumulation is associated with disease progression and resistance to interferon/ribavirin combination therapy in chronic hepatitis C. | Journal of gastroenterology and hepatology 20071101 |
| Safety, tolerability and efficacy of peginterferon alpha-2a and ribavirin in chronic hepatitis C in clinical practice: The German Open Safety Trial. | Journal of viral hepatitis 20071101 |
| Anti-erythropoietin antibody-mediated pure red cell aplasia in a living donor liver transplant recipient treated for hepatitis C virus. | Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20071101 |
| Immunodeficiency and intrinsic IFN resistance are associated with viral breakthrough to HCV therapy in HIV-coinfected patients. | AIDS research and human retroviruses 20071101 |
| Sudden hearing loss associated with peginterferon and ribavirin combination therapy during hepatitis C treatment. | World journal of gastroenterology 20071028 |
| [Drug-induced hemolytic anemia]. | Nihon rinsho. Japanese journal of clinical medicine 20071028 |
| Ribavirin: analytical determinations since the origin until today. | Journal of pharmaceutical and biomedical analysis 20071018 |
| Rapid fibrosis progression among HIV/hepatitis C virus-co-infected adults. | AIDS (London, England) 20071018 |
| Preventing relapse of major depression during interferon-alpha therapy for hepatitis C--A pilot study. | Digestive diseases and sciences 20071001 |
| Phase 2 study of the combination of merimepodib with peginterferon-alpha2b, and ribavirin in nonresponders to previous therapy for chronic hepatitis C. | Journal of hepatology 20071001 |
| Hepatitis C treatment in 'difficult-to-treat' psychiatric patients with pegylated interferon-alpha and ribavirin: response and psychiatric side effects. | Hepatology (Baltimore, Md.) 20071001 |
| Adverse effects during the treatment with pegylated interferon and ribavirin in children with chronic hepatitis C. | Pharmacoepidemiology and drug safety 20071001 |
| Incidence of psychiatric side effects during pegylated interferon- alpha retreatment in nonresponder hepatitis C virus-infected patients. | Liver international : official journal of the International Association for the Study of the Liver 20071001 |
| Recruitment and follow-up of injecting drug users in the setting of early hepatitis C treatment: insights from the ATAHC study. | The International journal on drug policy 20071001 |
| Does protracted antiviral therapy impact on HCV-related liver cirrhosis progression? | World journal of gastroenterology 20070928 |
| Induction of antiviral genes, Mx and vig-1, by dsRNA and Chum salmon reovirus in rainbow trout monocyte/macrophage and fibroblast cell lines. | Fish & shellfish immunology 20070901 |
| The GNB3 C825T polymorphism affects response to HCV therapy with pegylated interferon in HCV/HIV co-infected but not in HCV mono-infected patients. | Journal of hepatology 20070901 |
| Measurement of ribavirin and evaluation of its stability in human plasma by high-performance liquid chromatography with UV detection. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20070901 |
| Removal of phenylurea herbicide monuron via riboflavin-mediated photosensitization. | Chemosphere 20070901 |
| Studies of therapy with thymosin alpha1 in combination with pegylated interferon alpha2a and ribavirin in nonresponder patients with chronic hepatitis C. | Annals of the New York Academy of Sciences 20070901 |
| Thymalfasin for the treatment of chronic hepatitis C infection. | Annals of the New York Academy of Sciences 20070901 |
| In vitro and in vivo activities of T-705 against arenavirus and bunyavirus infections. | Antimicrobial agents and chemotherapy 20070901 |
| Quantitative temporal-spatial distribution of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) in post-mortem tissues. | Journal of medical virology 20070901 |
| Synthesis and anti-influenza activities of carboxyl alkoxyalkyl esters of 4-guanidino-Neu5Ac2en (zanamivir). | Bioorganic & medicinal chemistry letters 20070901 |
| Hepatotoxicity of antiretroviral drugs is reduced after successful treatment of chronic hepatitis C in HIV-infected patients. | The Journal of infectious diseases 20070901 |
| Benzylphenethylamine alkaloids from Hosta plantaginea with inhibitory activity against tobacco mosaic virus and acetylcholinesterase. | Journal of natural products 20070901 |
| [Ocular complications of hepatitis C treatment]. | Journal francais d'ophtalmologie 20070901 |
| Prophylaxis and treatment of recurrent viral hepatitis after liver transplantation. | Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20070901 |
| [A case of vasculitis in chronic hepatitis C patient treated with pegylated interferon alpha-2a and ribavirin]. | The Korean journal of hepatology 20070901 |
| HCV patients, psychopathology and tryptophan metabolism: analysis of the effects of pegylated interferon plus ribavirin treatment. | Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20070901 |
| New insights into purinergic receptor signaling in neuronal differentiation, neuroprotection, and brain disorders. | Purinergic signalling 20070901 |
| Fulminant hepatic failure in a case of autoimmune hepatitis in hepatitis C during peg-interferon-alpha 2b plus ribavirin treatment. | World journal of gastroenterology 20070828 |
| Synthesis and antiviral and cytostatic evaluations of the new C-5 substituted pyrimidine and furo[2,3-d]pyrimidine 4',5'-didehydro-L-ascorbic acid derivatives. | Journal of medicinal chemistry 20070823 |
| Formulations of biodegradable Nanogel carriers with 5'-triphosphates of nucleoside analogs that display a reduced cytotoxicity and enhanced drug activity. | Journal of controlled release : official journal of the Controlled Release Society 20070816 |
| Phenotypic and structural analyses of hepatitis C virus NS3 protease Arg155 variants: sensitivity to telaprevir (VX-950) and interferon alpha. | The Journal of biological chemistry 20070803 |
| Synthesis and antitumour activity of new tiazofurin analogues bearing a 2,3-anhydro functionality in the furanose ring. | Bioorganic & medicinal chemistry letters 20070801 |
| Design and synthesis of bioactive adamantane spiro heterocycles. | Bioorganic & medicinal chemistry letters 20070801 |
| Randomized trial of interferon beta-1a with or without ribavirin in Asian patients with chronic hepatitis C. | Hepatology (Baltimore, Md.) 20070801 |
| Selective decrease in hepatitis C virus-specific immunity among African Americans and outcome of antiviral therapy. | Hepatology (Baltimore, Md.) 20070801 |
| Adverse skin reactions due to pegylated interferon alpha 2b plus ribavirin combination therapy in a patient with chronic hepatitis C virus. | The Journal of dermatology 20070801 |
| [Therapy and prognosis in subacute sclerosing panencephalitis]. | Nihon rinsho. Japanese journal of clinical medicine 20070801 |
| Crystal structure of human nicotinamide riboside kinase. | Structure (London, England : 1993) 20070801 |
| Role of weight-based ribavirin dosing and extended duration of therapy in chronic hepatitis C in HIV-infected patients: the PRESCO trial. | AIDS research and human retroviruses 20070801 |
| [Recent developments in the treatment of chronic hepatitis B and C]. | Nederlands tijdschrift voor tandheelkunde 20070801 |
| Chronic ductopenic rejection in patients with recurrent hepatitis C virus treated with pegylated interferon alfa-2a and ribavirin. | Transplantation 20070727 |
| Ribavirin with either standard or pegylated interferon to treat recurrent hepatitis C after liver transplantation. | Alimentary pharmacology & therapeutics 20070715 |
| Peginterferon alfa-2a and ribavirin for 16 or 24 weeks in HCV genotype 2 or 3. | The New England journal of medicine 20070712 |
| Direct evidence for immunomodulatory properties of ribavirin on T-cell reactivity to hepatitis C virus. | Antiviral research 20070701 |
| Early ribavirin pharmacokinetics, HCV RNA and alanine aminotransferase kinetics in HIV/HCV co-infected patients during treatment with pegylated interferon and ribavirin. | Journal of hepatology 20070701 |
| Efficacy of an escalating dose regimen of pegylated interferon alpha-2a plus ribavirin in the early phase of HCV reinfection after liver transplantation. | Transplant international : official journal of the European Society for Organ Transplantation 20070701 |
| Virological response and safety outcomes in therapy-nai ve patients treated for chronic hepatitis C with taribavirin or ribavirin in combination with pegylated interferon alfa-2a: a randomized, phase 2 study. | Journal of hepatology 20070701 |
| Association of polymorphisms in the first exon of mannose binding lectin gene (MBL2) in Brazilian patients with HCV infection. | Clinical immunology (Orlando, Fla.) 20070701 |
| Predictors of response of US veterans to treatment for the hepatitis C virus. | Hepatology (Baltimore, Md.) 20070701 |
| Anemia in liver transplant recipients undergoing antiviral treatment for recurrent hepatitis C. | Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20070701 |
| Selective serotonin reuptake inhibitors in the context of hepatitis C infection: reexamining the risks of bleeding. | The Journal of clinical psychiatry 20070701 |
| Novel C-6 fluorinated acyclic side chain pyrimidine derivatives: synthesis, (1)H and (13)C NMR conformational studies, and antiviral and cytostatic evaluations. | Journal of medicinal chemistry 20070628 |
| 5-alkynyl analogs of arabinouridine and 2'-deoxyuridine: cytostatic activity against herpes simplex virus and varicella-zoster thymidine kinase gene-transfected cells. | Journal of medicinal chemistry 20070614 |
| Intraocular complications of IFN-alpha and ribavirin therapy in patients with chronic viral hepatitis C. | World journal of gastroenterology 20070614 |
| Structural effects on the phosphorylation of 3-substituted 1-beta-D-ribofuranosyl-1,2,4-triazoles by human adenosine kinase. | Bioorganic & medicinal chemistry letters 20070601 |
| Antiviral response of HCV genotype 1 to consensus interferon and ribavirin versus pegylated interferon and ribavirin. | Digestive diseases and sciences 20070601 |
| Therapeutic issues in HIV/HCV-coinfected patients. | Journal of viral hepatitis 20070601 |
| [A case of peripheral facial nerve palsy with cryoglobulinemia and chronic thyroiditis occurring during interferon plus ribavirin therapy for chronic hepatitis C]. | Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20070601 |
| The cost of treating ribavirin-induced anemia in hepatitis C: the impact of using recombinant human erythropoietin. | Current medical research and opinion 20070601 |
| Scleritis and peripheral ulcerative keratitis with hepatitis C virus-related cryoglobulinemia. | Archives of ophthalmology (Chicago, Ill. : 1960) 20070601 |
| Early virological response in children with chronic hepatitis C treated with pegylated interferon and ribavirin. | Infection 20070601 |
| Chronic hepatitis C: viral clearance several months after discontinuation of therapy in two non-responders. | Infection 20070601 |
| Pharmacologic treatment of SARS: current knowledge and recommendations. | Annals of the Academy of Medicine, Singapore 20070601 |
| Zinc supplementation prevents the increase of transaminase in chronic hepatitis C patients during combination therapy with pegylated interferon alpha-2b and ribavirin. | Journal of nutritional science and vitaminology 20070601 |
| Assessment of the inhibitory effect of ribavirin on the rainbow trout rhabdovirus VHSV by real-time reverse-transcription PCR. | Veterinary microbiology 20070516 |
| Paroxetine for prevention of depressive symptoms induced by interferon-alpha and ribavirin for hepatitis C. | Alimentary pharmacology & therapeutics 20070515 |
| [Experiences in antiviral treatment of chronic viral hepatitis B and C in Hungary (1998-2004)]. | Orvosi hetilap 20070506 |
| Synthesis and biological evaluation of nucleoside analogues having 6-chloropurine as anti-SARS-CoV agents. | Bioorganic & medicinal chemistry letters 20070501 |
| Combination therapy with ribavirin and amantadine in renal transplant patients with chronic hepatitis C virus infection is not superior to ribavirin alone. | Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 20070501 |
| Clinical responders to antiviral therapy of chronic HCV infection show elevated antiviral CD4+ and CD8+ T-cell responses. | Journal of viral hepatitis 20070501 |
| Predictors of alpha-fetoprotein elevation in patients with chronic hepatitis C, but not hepatocellular carcinoma, and its normalization after pegylated interferon alfa 2a-ribavirin combination therapy. | Journal of gastroenterology and hepatology 20070501 |
| Early virologic failure in HIV-coinfected hepatitis C patients treated with the peginterferon-ribavirin combination: does abacavir play a role? | Journal of acquired immune deficiency syndromes (1999) 20070501 |
| Cognitive function does not worsen during pegylated interferon and ribavirin retreatment of chronic hepatitis C. | Hepatology (Baltimore, Md.) 20070501 |
| Efficacy of antiviral therapy on hepatitis C recurrence after liver transplantation: a randomized controlled study. | Gastroenterology 20070501 |
| An extremely rare case of delusional parasitosis in a chronic hepatitis C patient during pegylated interferon alpha-2b and ribavirin treatment. | World journal of gastroenterology 20070428 |
| Initial-rate kinetics of human NMN-adenylyltransferases: substrate and metal ion specificity, inhibition by products and multisubstrate analogues, and isozyme contributions to NAD+ biosynthesis. | Biochemistry 20070424 |
| Referral for chronic hepatitis C treatment from a drug dependency treatment setting. | Drug and alcohol dependence 20070417 |
| Structure-activity relationship studies on anti-HCV activity of ring-expanded ('fat') nucleobase analogues containing the imidazo[4,5-e][1,3]diazepine-4,8-dione ring system. | Bioorganic & medicinal chemistry letters 20070415 |
| Hepatology may have problems with putative surrogate outcome measures. | Journal of hepatology 20070401 |
| Adverse events associated with high-dose ribavirin: evidence from the Toronto outbreak of severe acute respiratory syndrome. | Pharmacotherapy 20070401 |
| Peginterferon alpha-2b plus ribavirin vs interferon alpha-2b plus ribavirin for chronic hepatitis C in HIV-coinfected patients. | Journal of viral hepatitis 20070401 |
| Strategies for managing anemia in hepatitis C patients undergoing antiviral therapy. | The American journal of gastroenterology 20070401 |
| Cosmetic permanent fillers for soft tissue augmentation: a new contraindication for interferon therapies. | Archives of dermatology 20070401 |
| Influenza: evolving strategies in treatment and prevention. | Seminars in respiratory and critical care medicine 20070401 |
| Effective treatment of hepatitis C-associated immune-complex nephritis with cryoprecipitate apheresis and antiviral therapy. | Clinical nephrology 20070401 |
| Lamotrigine-associated Stevens-Johnson syndrome after discontinuation of interferon, ribavirin, and filgrastim: a case report. | The Journal of clinical psychiatry 20070401 |
| Splenic marginal zone lymphoma with and without villous lymphocytes. | Current treatment options in oncology 20070401 |
| Peginterferon and ribavirin for hepatitis C. | The New England journal of medicine 20070322 |
| Antiviral activity of triazine analogues of 1-(S)-[3-hydroxy-2-(phosphonomethoxy)propyl]cytosine (cidofovir) and related compounds. | Journal of medicinal chemistry 20070308 |
| Ribavirin and mycophenolic acid markedly potentiate the anti-hepatitis B virus activity of entecavir. | Antiviral research 20070301 |
| Antiviral activity of tiazofurin and mycophenolic acid against Grapevine leafroll-associated virus 3 in Vitis vinifera explants. | Antiviral research 20070301 |
| Predictive factors of early and sustained responses to peginterferon plus ribavirin combination therapy in Japanese patients infected with hepatitis C virus genotype 1b: amino acid substitutions in the core region and low-density lipoprotein cholesterol levels. | Journal of hepatology 20070301 |
| Efficacy of orally administered T-705 on lethal avian influenza A (H5N1) virus infections in mice. | Antimicrobial agents and chemotherapy 20070301 |
| A dengue fever viremia model in mice shows reduction in viral replication and suppression of the inflammatory response after treatment with antiviral drugs. | The Journal of infectious diseases 20070301 |
| Viusid, a nutritional supplement, in combination with interferon alpha-2b and ribavirin in patients with chronic hepatitis C. | Liver international : official journal of the International Association for the Study of the Liver 20070301 |
| The effects of HCV infection and management on health-related quality of life. | Hepatology (Baltimore, Md.) 20070301 |
| Mechanism of action of ribavirin in the treatment of chronic hepatitis C. | Gastroenterology & hepatology 20070301 |
| [Drugs for hepatitis B and C infection]. | Nihon rinsho. Japanese journal of clinical medicine 20070227 |
| [Mechanisms of drug resistance in hepatitis viruses B and C]. | Nihon rinsho. Japanese journal of clinical medicine 20070227 |
| LC-MS/MS method for simultaneous determination of viramidine and ribavirin levels in monkey red blood cells. | Journal of pharmaceutical and biomedical analysis 20070219 |
| High incidence of allograft dysfunction in liver transplanted patients treated with pegylated-interferon alpha-2b and ribavirin for hepatitis C recurrence: possible de novo autoimmune hepatitis? | Gut 20070201 |
| Simultaneous determination of ribavirin and ribavirin base in monkey plasma by high performance liquid chromatography with tandem mass spectrometry. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20070201 |
| Comparison of the inhibitory effects of interferon alfacon-1 and ribavirin on yellow fever virus infection in a hamster model. | Antiviral research 20070201 |
| Impaired filterability of erythrocytes from patients with chronic hepatitis C and effects of eicosapentaenoic acid on the filterability. | The journal of physiological sciences : JPS 20070201 |
| Hepatic oxidative DNA damage correlates with iron overload in chronic hepatitis C patients. | Free radical biology & medicine 20070201 |
| Clinical implications of hepatic steatosis in patients with chronic hepatitis C: a multicenter study of U.S. veterans. | Digestive diseases and sciences 20070201 |
| Treatment with pegylated interferon and ribavirin for hepatitis C virus-associated severe cryoglobulinemia in a liver/kidney transplant recipient. | Journal of clinical gastroenterology 20070201 |
| Future therapies for hepatitis C: where do we go from here? | Nature clinical practice. Gastroenterology & hepatology 20070201 |
| Improved outcome from invasive adenovirus infection in pediatric patients after hemopoietic stem cell transplantation using intensive clinical surveillance and early intervention. | Journal of pediatric hematology/oncology 20070201 |
| Cinnamacrins A-C, cinnafragrin D, and cytostatic metabolites with alpha-glucosidase inhibitory activity from Cinnamosma macrocarpa. | Journal of natural products 20070201 |
| Hepatic steatosis in hepatitis C: comparison of diabetic and nondiabetic patients in the hepatitis C antiviral long-term treatment against cirrhosis trial. | Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20070201 |
| Use of hematopoietic growth factors as adjuvant therapy for anemia and neutropenia in the treatment of hepatitis C. | The Annals of pharmacotherapy 20070201 |
| Prediction of sustained virological response in chronic hepatitis C patients treated with peginterferon alfa-2a (40KD) and ribavirin. | Scandinavian journal of gastroenterology 20070201 |
| Recent i.v.-drug users with chronic hepatitis C can be efficiently treated with daily high dose induction therapy using consensus interferon: an open-label pilot study. | World journal of gastroenterology 20070128 |
| N-methylimidazole significantly improves lipase-catalysed acylation of ribavirin. | Chemical communications (Cambridge, England) 20070121 |
| The novel C-5 aryl, alkenyl, and alkynyl substituted uracil derivatives of L-ascorbic acid: synthesis, cytostatic, and antiviral activity evaluations. | Bioorganic & medicinal chemistry 20070115 |
| A cell-based luminescence assay is effective for high-throughput screening of potential influenza antivirals. | Antiviral research 20070101 |
| Design, synthesis, and biological evaluation of novel iso-D-2',3'-dideoxy-3'-fluorothianucleoside derivatives. | Bioorganic & medicinal chemistry 20070101 |
| Tolerability of Peg interferon-alpha2b and Ribavirin therapy in patients with chronic hepatitis C and glucose-6-phosphate dehydrogenase deficiency. | Journal of hepatology 20070101 |
| Ribavirin inhibits angiogenesis by tetrahydrobiopterin depletion. | FASEB journal : official publication of the Federation of American Societies for Experimental Biology 20070101 |
| Effects of mitogen-activated protein kinase inhibitors on tumor necrosis factor-alpha gene expression and apoptosis induction in cultured human fetal membrane chorion cells infected with influenza virus. | Intervirology 20070101 |
| Anti-Helicobacter pylori seropositivity: influence on severity and treatment response in patients with chronic hepatitis C. | Journal of viral hepatitis 20070101 |
| New paradigms in the management of hepatitis C virus co-infections. | Nature clinical practice. Gastroenterology & hepatology 20070101 |
| Natural history of anemia associated with interferon/ribavirin therapy for patients with HIV/HCV coinfection. | AIDS research and human retroviruses 20070101 |
| Liver transplant and hepatitis C in methadone maintenance therapy: a case report. | Substance abuse treatment, prevention, and policy 20070101 |
| Genetic distance and heterogenecity between quasispecies is a critical predictor to IFN response in Egyptian patients with HCV genotype-4. | Virology journal 20070101 |
| Adult systemic cat scratch disease associated with therapy for hepatitis C. | BMC infectious diseases 20070101 |
| Replicative homeostasis III: implications for antiviral therapy and mechanisms of response and non-response. | Virology journal 20070101 |
| [The peculiarities of the clinical picture and the effectiveness of antiviral therapy of chronic hepatitis related to alcohol consumption plus hepatitis C virus effect]. | Klinicheskaia meditsina 20070101 |
| ['Epidemiological profile of chronic hepatitis C virus patients and his early virological response to pegylated interferon plus ribavirin therapy. Gastroenterology Service, HNCASE EsSALUD Arequipa']. | Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru 20070101 |
| Granulomatous adenohypophysitis after interferon and ribavirin therapy. | Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 20070101 |
| Antiviral therapy effects upon hepatitis C cholestatic syndrome. | Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie 20070101 |
| An assessment of serum leptin levels in patients with chronic viral hepatitis: a prospective study. | BMC gastroenterology 20070101 |
| A novel unsupervised method to identify genes important in the anti-viral response: application to interferon/ribavirin in hepatitis C patients. | PloS one 20070101 |
| The magnitude of week 4 HCV RNA decay on pegylated interferon/ribavirin accurately predicts virological failure in patients with genotype 1. | Antiviral therapy 20070101 |
| Manic episode associated with citalopram therapy for interferon-induced depression in a patient with chronic hepatitis C infection. | General hospital psychiatry 20070101 |
| Early viral kinetics during treatment of chronic hepatitis C virus infection with pegylated interferon alpha plus ribavirin in Taiwan. | Intervirology 20070101 |
| Premature treatment discontinuation in HIV/HCV-coinfected patients receiving pegylated interferon plus weight-based ribavirin. | Antiviral therapy 20070101 |
| Update on the treatment of chronic hepatitis C in HIV-infected patients. | AIDS reviews 20070101 |
| Infant of 22 months of age with no anomalies born from a HCV- and HIV-infected mother under treatment with pegylated interferon, ribavirin and antiretroviral therapy during the first 16 weeks of pregnancy. | Reproductive toxicology (Elmsford, N.Y.) 20070101 |
| [Treatment with natural interferon (alfaferone) in clinical practice--our experience]. | Przeglad epidemiologiczny 20070101 |
| Dynamics of apoptotic activity during antiviral treatment of patients with chronic hepatitis C. | Antiviral therapy 20070101 |
| A health economic model to assess the cost-effectiveness of pegylated interferon alpha-2a and ribavirin in patients with moderate chronic hepatitis C and persistently normal alanine aminotransferase levels. | Acta gastro-enterologica Belgica 20070101 |
| [The in vitro antiviral activity against the causative agent of hemorrhagic fever with renal syndrome]. | Voprosy virusologii 20070101 |
| Hepatitis C virus with normal transaminase levels. | Digestive diseases (Basel, Switzerland) 20070101 |
| Hepatitis C treatment of opioid dependants receiving maintenance treatment: results of a Norwegian pilot study. | European addiction research 20070101 |
| Hepatitis C in schizophrenia: screening experience in a community-dwelling clozapine cohort. | Psychosomatics 20070101 |
| Development of Myasthenia gravis due to treatment of chronic hepatitis C with a combination of interferon-alpha and ribavirin. | Digestion 20070101 |
| [Insulin resistance in chronic hepatitits C]. | Arquivos de gastroenterologia 20070101 |
| [Chronic hepatitis C: management of side effects of treatment]. | Gastroenterologie clinique et biologique 20070101 |
| Combined therapy with danazol, pegilated interferon, and ribavirin improves thrombocytopenia and liver injury in rats with fibrosis. | Annals of hepatology 20070101 |
| Autoimmune hemolytic anemia in HCV/HIV coinfected patients during treatment with pegylated alpha-2a interferon plus ribavirin. | Revista da Sociedade Brasileira de Medicina Tropical 20070101 |
| Early monitoring of ribavirin serum concentration is not useful to optimize hepatitis C virus treatment in HIV-coinfected patients. | Antiviral therapy 20070101 |
| Predictors of severe haematological toxicity secondary to pegylated interferon plus ribavirin treatment in HIV-HCV-coinfected patients. | Antiviral therapy 20070101 |
| Eicosapentaenoic acid could permit maintenance of the original ribavirin dose in chronic hepatitis C virus patients during the first 12 weeks of combination therapy with pegylated interferon-alpha and ribavirin. A prospective randomized controlled trial. | Intervirology 20070101 |
| Peginterferon alfa-2b plus ribavirin for the treatment of hepatitis C recurrence following combined liver and kidney transplantation. | Annals of transplantation 20070101 |
| Intentional conversion from tacrolimus to cyclosporine for HCV-positive patients on preemptive interferon therapy after living donor liver transplantation. | Annals of transplantation 20070101 |
| Targeted strategies for henipavirus therapeutics. | The open virology journal 20070101 |
| Effect of ribavirin alone or combined with silymarin on carbon tetrachloride induced hepatic damage in rats. | Drug target insights 20070101 |
| Efficacy and long-term follow up of combination therapy with interferon alpha and ribavirin for chronic hepatitis C in Korea. | Yonsei medical journal 20061231 |
| Synthesis, in vitro antiviral evaluation, and stability studies of novel alpha-borano-nucleotide analogues of 9-[2-(phosphonomethoxy)ethyl]adenine and (R)-9-[2-(phosphonomethoxy)propyl]adenine. | Journal of medicinal chemistry 20061228 |
| [Protocol for the treatment of chronic viral hepatitis]. | Orvosi hetilap 20061224 |
| [Treatment of chronic hepatitis C within a heroine-assisted treatment program]. | Deutsche medizinische Wochenschrift (1946) 20061215 |
| Evaluation by Q-RTPCR of the efficacy of ribavirin complexed with beta-cyclodextrin against measles virus in a mouse encephalitis model. | Pathologie-biologie 20061201 |
| A 24-week course of high-dose interferon-alpha plus ribavirin for Taiwanese chronic hepatitis C patients with persistently normal or near-normal alanine aminotransferase levels. | Liver international : official journal of the International Association for the Study of the Liver 20061201 |
| Pretreatment assessment and predictors of hepatitis C virus treatment in US veterans coinfected with HIV and hepatitis C virus. | Journal of viral hepatitis 20061201 |
| Steroid-responsive demyelinating motor neuropathy with conduction block associated with hepatitis C infection and treatment with interferon alpha. | Journal of the peripheral nervous system : JPNS 20061201 |
| Predicting sustained virological response and anaemia in chronic hepatitis C patients treated with peginterferon alfa-2a (40KD) plus ribavirin. | British journal of clinical pharmacology 20061201 |
| Cost-effectiveness of hematologic growth factors for anemia occurring during hepatitis C combination therapy. | Hepatology (Baltimore, Md.) 20061201 |
| Clinical and histological efficacy of pegylated interferon and ribavirin therapy of recurrent hepatitis C after liver transplantation. | Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20061201 |
| A case of deep venous thrombosis associated with pegylated interferon alpha2b plus ribavirin treatment of chronic hepatitis C. | Journal of gastroenterology 20061201 |
| Psychosis during peginterferon-alpha 2a and ribavirin therapy: case report. | The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases 20061201 |
| Pegylated interferon (PEG-IFN) alfa-2b and ribavirin for recurrent hepatitis C (genotype 1) after liver transplantation: relationship with steatosis. | Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20061101 |
| Peripheral insulin resistance during treatment of chronic hepatitis C with peguilated interferon plus ribavirin. | Journal of medical virology 20061101 |
| Interferon and ribavirin treatment results of patients with HBV-HCV co-infection cured of childhood malignancies. | International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 20061101 |
| Anemia associated with antiviral therapy in chronic hepatitis C: incidence, risk factors, and impact on treatment response. | Liver international : official journal of the International Association for the Study of the Liver 20061101 |
| Impact of liver steatosis on the antiviral response in the hepatitis C virus-associated chronic hepatitis. | Liver international : official journal of the International Association for the Study of the Liver 20061101 |
| Anti-Golgi complex antibodies during pegylated-interferon therapy for hepatitis C. | Liver international : official journal of the International Association for the Study of the Liver 20061101 |
| A simple noninvasive index for predicting long-term outcome of chronic hepatitis C after interferon-based therapy. | Hepatology (Baltimore, Md.) 20061101 |
| HCV kinetics, quasispecies, and clearance in treated HCV-infected and HCV/HIV-1-coinfected patients with hemophilia. | Hepatology (Baltimore, Md.) 20061101 |
| Effects of isopropyl palmitate on the skin permeation of drugs. | Biological & pharmaceutical bulletin 20061101 |
| In vitro and in vivo studies of ribavirin action on Brazilian Orthobunyavirus. | The American journal of tropical medicine and hygiene 20061101 |
| [Hepatitis C and liver transplantation: fibrosis progression and treatment. Or how to improve management]. | Gastroenterologie clinique et biologique 20061101 |
| Synthesis and antiviral activity of 5-substituted cytidine analogues: identification of a potent inhibitor of viral RNA-dependent RNA polymerases. | Journal of medicinal chemistry 20061019 |
| [Acute hepatitis C virus infection--clinical manifestations, diagnosis and treatment]. | Ugeskrift for laeger 20061016 |
| 2-(3-Amino-3-deoxy-beta-D-xylofuranosyl)thiazole-4-carboxamide: a new tiazofurin analogue with potent antitumour activity. | Bioorganic & medicinal chemistry letters 20061015 |
| Review article: management of patients with chronic hepatitis C virus infection and 'normal' alanine aminotransferase activity. | Alimentary pharmacology & therapeutics 20061015 |
| Impact on adherence and sustained virological response of psychiatric side effects during peginterferon and ribavirin therapy for chronic hepatitis C. | Alimentary pharmacology & therapeutics 20061015 |
| A rapid quantitative PCR-based assay for testing antiviral agents against human adenoviruses demonstrates type specific differences in ribavirin activity. | Antiviral research 20061001 |
| Hepatitis C recurrence after liver transplantation: Viral and histologic response to full-dose PEG-interferon and ribavirin. | American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20061001 |
| Antiviral effect of artemisinin from Artemisia annua against a model member of the Flaviviridae family, the bovine viral diarrhoea virus (BVDV). | Planta medica 20061001 |
| Syncytial giant cell hepatitis in human immunodeficiency virus-infected patients with chronic hepatitis C: 2 cases and review of the literature. | Human pathology 20061001 |
| Zidovudine use but not weight-based ribavirin dosing impacts anaemia during HCV treatment in HIV-infected persons. | Journal of viral hepatitis 20061001 |
| Accurate model predicting sustained response at week 4 of therapy with pegylated interferon with ribavirin in patients with chronic hepatitis C. | Journal of viral hepatitis 20061001 |
| [Treatment of viral hepatitis (II). Treatment of chronic hepatitis C]. | Enfermedades infecciosas y microbiologia clinica 20061001 |
| High efficacy of combined therapy with pegylated interferon plus ribavirin in patients with hemophilia and chronic hepatitis C. | Haematologica 20061001 |
| Antiviral treatment of hepatitis C. | Expert opinion on pharmacotherapy 20061001 |
| Effect of ribavirin in genotype 1 patients with hepatitis C responding to pegylated interferon alfa-2a plus ribavirin. | Gastroenterology 20061001 |
| Antiviral treatment of hepatitis C: present status and future prospects. | Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 20061001 |
| [Difficult-to-treat patients with chronic hepatitis C]. | Praxis 20060920 |
| Antiviral therapy for adenovirus infections. | Antiviral research 20060901 |
| Decline in haemoglobin A1c values in diabetic patients receiving interferon-alpha and ribavirin for chronic hepatitis C. | Journal of viral hepatitis 20060901 |
| Pegylated interferon alpha-2b as monotherapy or in combination with ribavirin in chronic hepatitis delta. | Hepatology (Baltimore, Md.) 20060901 |
| [A case of exacerbation of ulcerative colitis induced by combination therapy with PEG-interferon alpha-2b and ribavirin for chronic hepatitis C]. | Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20060901 |
| [A case of Bell's palsy associated with peginterferon Alfa-2a and ribavirin therapy for chronic hepatitis C virus infection]. | The Korean journal of hepatology 20060901 |
| Elderly patients are at greater risk of cytopenia during antiviral therapy for hepatitis C. | Canadian journal of gastroenterology = Journal canadien de gastroenterologie 20060901 |
| Early decline of hemoglobin correlates with progression of ribavirin-induced hemolytic anemia during interferon plus ribavirin combination therapy in patients with chronic hepatitis C. | Journal of gastroenterology 20060901 |
| Retinal vein thrombosis associated with pegylated-interferon and ribavirin combination therapy for chronic hepatitis C. | World journal of gastroenterology 20060814 |
| CCR5Delta32 mutation does not influence the susceptibility to HCV infection, severity of liver disease and response to therapy in patients with chronic hepatitis C. | World journal of gastroenterology 20060807 |
| Enhancement of the infectivity of SARS-CoV in BALB/c mice by IMP dehydrogenase inhibitors, including ribavirin. | Antiviral research 20060801 |
| Vitamin B12 reduces ribavirin-induced genotoxicity in phytohemaglutinin-stimulated human lymphocytes. | The Tohoku journal of experimental medicine 20060801 |
| Correlation between beta-lipoprotein levels and outcome of hepatitis C treatment. | Hepatology (Baltimore, Md.) 20060801 |
| Metabolic factors involved in the therapeutic response of patients with hepatitis C virus-related chronic hepatitis. | Journal of gastroenterology and hepatology 20060801 |
| Alpha-tocopherol [corrected] and ascorbic acid attenuates the ribavirin [corrected] induced decrease of eicosapentaenoic acid in erythrocyte membrane in chronic hepatitis C patients. | Journal of gastroenterology and hepatology 20060801 |
| Peginterferon and ribavirin treatment in African American and Caucasian American patients with hepatitis C genotype 1. | Gastroenterology 20060801 |
| Plasma ribavirin concentrations during treatment of recurrent hepatitis C with peginterferon alpha-2b and ribavirin combination after liver transplantation. | Journal of viral hepatitis 20060801 |
| The results of a randomized trial looking at 24 weeks vs 48 weeks of treatment with peginterferon alpha-2a (40 kDa) and ribavirin combination therapy in patients with chronic hepatitis C genotype 1. | Journal of viral hepatitis 20060801 |
| Autoimmune thrombocytopenia induced by PEG-IFN-alpha plus ribavirin in hepatitis C. | Platelets 20060801 |
| Ifn/Rbv treatment induced anemia and its correction with epoetin alpha in patients with hepatitis C. | Georgian medical news 20060801 |
| Branch retinal vein thrombosis and visual loss probably associated with pegylated interferon therapy of chronic hepatitis C. | World journal of gastroenterology 20060728 |
| Markedly enhancing lipase-catalyzed synthesis of nucleoside drugs' ester by using a mixture system containing organic solvents and ionic liquid. | Bioorganic & medicinal chemistry letters 20060715 |
| Distribution of hepatitis C virus genotypes in the Middle East. | International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 20060701 |
| Inhibition of dengue virus replication by mycophenolic acid and ribavirin. | The Journal of general virology 20060701 |
| Effects of bezafibrate in patients with chronic hepatitis C virus infection: combination with interferon and ribavirin. | Journal of viral hepatitis 20060701 |
| Serum alanine aminotransferase level and response to interferon-ribavirin combination therapy in patients with chronic hepatitis C. | Journal of the College of Physicians and Surgeons--Pakistan : JCPSP 20060701 |
| Genetic predisposition of responsiveness to therapy for chronic hepatitis C. | Pharmacogenomics 20060701 |
| Respiratory syncytial virus: disease, development and treatment. | British journal of nursing (Mark Allen Publishing) 20060701 |
| Chronic Hepatitis B and C--current treatment and future therapeutic prospects. | Wiener medizinische Wochenschrift (1946) 20060701 |
| [The anti-respiratory syncytial virus effect of active compound of Glycyrrhiza GD4 in vitro]. | Zhong yao cai = Zhongyaocai = Journal of Chinese medicinal materials 20060701 |
| Risk factors for retinopathy associated with interferon alpha-2b and ribavirin combination therapy in patients with chronic hepatitis C. | World journal of gastroenterology 20060621 |
| Novel approaches for therapy of chronic hepatitis C. | Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 20060601 |
| Analysis of risk-factors among patients with Crimean-Congo haemorrhagic fever virus infection: severity criteria revisited. | Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20060601 |
| Central hypothyroidism and hypophysitis during treatment of chronic hepatitis C with pegylated interferon alpha and ribavirin. | European journal of gastroenterology & hepatology 20060601 |
| Treatment of interferon-alpha for chronic hepatitis C. | Expert opinion on pharmacotherapy 20060601 |
| Anti-RNA virus activity of polyoxometalates. | Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 20060601 |
| Treatment of cryoglobulinemia associated peripheral neuropathy with rituximab. | The Journal of rheumatology 20060601 |
| Hepatitis C in 6,865 patients 65 yr or older: a severe and neglected curable disease? | The American journal of gastroenterology 20060601 |
| Hepatitis C eradication and improvement of cryoglobulinemia-associated rash and membranoproliferative glomerulonephritis with interferon and ribavirin after kidney transplantation. | Canadian journal of gastroenterology = Journal canadien de gastroenterologie 20060601 |
| Severe autoimmune hemolytic anemia in a patient with chronic hepatitis C during treatment with peginterferon alfa-2a and ribavirin. | Haematologica 20060601 |
| Management of hepatitis C virus coinfection in HIV-infected persons. | The AIDS reader 20060601 |
| The impact of nonalcoholic fatty liver disease and the metabolic syndrome on progression of fibrosis in patients with recurrent HCV after liver transplantation. | Transplantation proceedings 20060601 |
| The economics of treating chronic hepatitis C patients with peginterferon alpha-2a (40 kDa) plus ribavirin presenting with persistently normal aminotransferase. | Journal of viral hepatitis 20060601 |
| Combined antiherpetic effect of complex preparation 'Viferon-eye drops' and modified nucleosides. | Bulletin of experimental biology and medicine 20060601 |
| Synthesis and antiproliferative activity of two new tiazofurin analogues with 2'-amido functionalities. | Bioorganic & medicinal chemistry letters 20060515 |
| Discovery of bitriazolyl compounds as novel antiviral candidates for combating the tobacco mosaic virus. | Bioorganic & medicinal chemistry letters 20060515 |
| Ischaemic jejunal vasculitis during treatment with pegylated interferon-alpha 2b and ribavirin for hepatitis C virus related cirrhosis. | Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20060501 |
| [Autoimmune hepatitis in a HIV-HCV co-infected patient: diagnostic ant therapeutic difficulties]. | La Revue de medecine interne 20060501 |
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. | Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501 |
| Definition and management of anemia in patients infected with hepatitis C virus. | Liver international : official journal of the International Association for the Study of the Liver 20060501 |
| Role of individualization of hepatitis C virus (HCV) therapy duration in HIV/HCV-coinfected individuals. | HIV medicine 20060501 |
| Pegylated interferon and ribavirin treatment for hepatitis C in haemodialysis patients. | Journal of viral hepatitis 20060501 |
| Absence of clinically relevant pharmacokinetic interaction between ribavirin and tenofovir in healthy subjects. | Journal of clinical pharmacology 20060501 |
| Alcohol use and treatment of hepatitis C virus: results of a national multicenter study. | Gastroenterology 20060501 |
| Antiviral flavans from the leaves of Pithecellobium clypearia. | Journal of natural products 20060501 |
| [Severe thrombocytopenia with probable autoimmune mechanism associated with interferon therapy in a patient with chronic hepatitis C]. | Gastroenterologia y hepatologia 20060501 |
| Treatment of chronic hepatitis C in patients with glucose-6-phosphate dehydrogenase deficiency: is ribavirin harmful? | Blood 20060415 |
| Effect of anti-viral therapy for occult hepatitis C virus infection. | Alimentary pharmacology & therapeutics 20060415 |
| [New trend in treatment in patients with chronic hepatitis C]. | Orvosi hetilap 20060409 |
| The anti-yellow fever virus activity of ribavirin is independent of error-prone replication. | Molecular pharmacology 20060401 |
| Viral and metabolic factors influencing alanine aminotransferase activity in patients with chronic hepatitis C. | Journal of hepatology 20060401 |
| Synthesis and biological activity of some new 5'-O-acyl tiazofurin derivatives. | European journal of medicinal chemistry 20060401 |
| Interferon alpha-2b with and without ribavirin in the treatment of hepatitis B e antigen-positive chronic hepatitis B: a randomized study. | Hepatology (Baltimore, Md.) 20060401 |
| Modulation of the anti-inflammatory interleukin 10 and of proapoptotic IL-18 in patients with chronic hepatitis C treated with interferon alpha and ribavirin. | Journal of viral hepatitis 20060401 |
| Black patients with chronic hepatitis C have a lower sustained viral response rate than non-Blacks with genotype 1, but the same with genotypes 2/3, and this is not explained by more frequent dose reductions of interferon and ribavirin*. | Journal of viral hepatitis 20060401 |
| Interferon-induced depression in chronic hepatitis C: a review of its prevalence, risk factors, biology, and treatment approaches. | Journal of clinical gastroenterology 20060401 |
| Autoimmune disorders during interferon therapy in a patient with chronic hepatitis C infection: how many of them can be observed in a single patient? | Journal of clinical gastroenterology 20060401 |
| [How to use viral genomic analysis in clinical practice: chronic hepatitis B and C]. | Rinsho byori. The Japanese journal of clinical pathology 20060401 |
| Response to treatment with interferon-alpha and ribavirin in patients with chronic Hepatitis C virus genotypes 2 and 3 depends on the degree of hepatic fibrosis. | The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases 20060401 |
| Identification of compounds with anti-West Nile Virus activity. | Journal of medicinal chemistry 20060323 |
| Sustained virological response rates and health-related quality of life after interferon and ribavirin therapy in patients with chronic hepatitis C virus infection and persistently normal alanine aminotransferase levels. | Alimentary pharmacology & therapeutics 20060315 |
| [Therapy with peginterferon alfa in a patient with polyneuropathy caused by hepatitis C-associated vasculitis]. | Medizinische Klinik (Munich, Germany : 1983) 20060315 |
| Crimean-Congo hemorrhagic fever in Eastern Turkey: clinical features, risk factors and efficacy of ribavirin therapy. | The Journal of infection 20060301 |
| Respiratory syncytial virus fusion inhibitors. Part 3: Water-soluble benzimidazol-2-one derivatives with antiviral activity in vivo. | Bioorganic & medicinal chemistry letters 20060301 |
| Depression, anemia and health-related quality of life in chronic hepatitis C. | Journal of hepatology 20060301 |
| Fatal cardiomyopathy associated with pegylated interferon/ribavirin in a patient with chronic hepatitis C. | European journal of gastroenterology & hepatology 20060301 |
| Resolution of diabetes in type 2 diabetic patient treated with IFN-alpha and ribavirin for hepatitis C. | European journal of gastroenterology & hepatology 20060301 |
| A prospective assessment of an 'a la carte' regimen of PEG-interferon alpha2b and ribavirin combination in patients with chronic hepatitis C using biochemical markers. | Journal of viral hepatitis 20060301 |
| [Agranulocytosis induced by interferon-alpha and ribavirin in a patient with schizophrenia using clozapine]. | Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999) 20060301 |
| Synthesis of AZT analogues: 7-(3-azido-2-hydroxypropyl)-, 7-(3-amino-2-hydroxypropyl)-,7-(3-triazolyl-2-hydroxypropyl)theophylline. | Nucleosides, nucleotides & nucleic acids 20060301 |
| [Development of porphyria cutanea tarda in a chronic hepatitis C patient with indetectable viremia under treatment with peg-interferon plus ribavirin]. | Acta gastroenterologica Latinoamericana 20060301 |
| [Prevalence of hepatitis C virus among HIV-infected patients in Area 2 of Madrid]. | Anales de medicina interna (Madrid, Spain : 1984) 20060301 |
| Chronic hepatitis C in HIV-infected patients: those who more need therapy are those who respond less. | Infectious disorders drug targets 20060301 |
| Triple therapy of interferon and ribavirin with zinc supplementation for patients with chronic hepatitis C: a randomized controlled clinical trial. | World journal of gastroenterology 20060227 |
| [Side effect of pegylated-interferon treatment in chronic C hepatitis: agranulocytosis]. | Orvosi hetilap 20060219 |
| Sensitive and specific LC-MS/MS method for the simultaneous measurements of viramidine and ribavirin in human plasma. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20060217 |
| Long-term follow-up of chronic hepatitis C patients with sustained virological response to various forms of interferon-based anti-viral therapy. | Alimentary pharmacology & therapeutics 20060215 |
| Vogt-Koyanagi-Harada disease associated with interferon-A and ribavirin therapy for chronic hepatitis C infection. | The Journal of infection 20060201 |
| Ribavirin and cysteinyl leukotriene-1 receptor blockade as treatment for severe bronchiolitis. | Antiviral research 20060201 |
| Similar compliance and effect of treatment in chronic hepatitis C resulting from intravenous drug use in comparison with other infection causes. | European journal of gastroenterology & hepatology 20060201 |
| Pure red cell aplasia associated with concomitant use of mycophenolate mofetil and ribavirin in post-transplant recurrent hepatitis C. | Transplant international : official journal of the European Society for Organ Transplantation 20060201 |
| Thalidomide in the treatment of chronic hepatitis C unresponsive to alfa-interferon and ribavirin. | The American journal of gastroenterology 20060201 |
| Vitamin E and C supplementation prevents decrease of eicosapentaenoic acid in mononuclear cells in chronic hepatitis C patients during combination therapy of interferon alpha-2b and ribavirin. | Nutrition (Burbank, Los Angeles County, Calif.) 20060201 |
| Serotonin transporter mRNA expression is decreased by lamivudine and ribavirin and increased by interferon in immune cells. | Scandinavian journal of immunology 20060201 |
| Newer therapeutic approaches to the vasculitides: biologic agents. | Rheumatic diseases clinics of North America 20060201 |
| Treatment of chronic hepatitis C patients with persistently normal alanine aminotransferase levels with the combination of peginterferon alpha-2a (40 kDa) plus ribavirin: impact on health-related quality of life. | Journal of gastroenterology and hepatology 20060201 |
| Antinociceptive and behavioral effects of ribavirin in mice. | Pharmacology, biochemistry, and behavior 20060201 |
| [Complementary treatments of chronic viral hepatitis C]. | Gastroenterologie clinique et biologique 20060201 |
| Peginterferon alfa-2a (40KD) (PEGASYS) plus ribavirin (COPEGUS) in retreatment of chronic hepatitis C patients, nonresponders and relapsers to previous conventional interferon plus ribavirin therapy. | The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases 20060201 |
| Treatment of condylomata acuminata with pegylated interferon alfa-2b in HIV-infected patients. | European journal of medical research 20060131 |
| Synthesis and biological activity of isoxazolidinyl polycyclic aromatic hydrocarbons: potential DNA intercalators. | Journal of medicinal chemistry 20060126 |
| Response to combined interferon and ribavirin is better in patients infected with hepatitis C virus genotype 6 than genotype 1 in Hong Kong. | Intervirology 20060101 |
| Mechanisms of action of ribavirin against distinct viruses. | Reviews in medical virology 20060101 |
| Treating HCV with ribavirin analogues and ribavirin-like molecules. | The Journal of antimicrobial chemotherapy 20060101 |
| Predictive factors of virological non-response to interferon-ribavirin combination therapy for patients infected with hepatitis C virus of genotype 1b and high viral load. | Journal of medical virology 20060101 |
| Hemolytic anemia during 24 weeks of ribavirin and interferon-alpha2b combination therapy does not influence the cardiac function of patients with viral hepatitis C. | Journal of clinical gastroenterology 20060101 |
| Development and validation of two models for early prediction of response to therapy in genotype 1 chronic hepatitis C. | Hepatology (Baltimore, Md.) 20060101 |
| Effects of Transcutol P on the corneal permeability of drugs and evaluation of its ocular irritation of rabbit eyes. | The Journal of pharmacy and pharmacology 20060101 |
| Ribavirin levels and haemoglobin decline in early virological responders and non-responders to hepatitis C virus combination therapy. | Pharmacology 20060101 |
| Thyroid dysfunction in patients with chronic hepatitis C receiving a combined therapy of interferon and ribavirin: incidence, associated factors and prognosis. | Journal of gastroenterology and hepatology 20060101 |
| [Antiretroviral drugs in severe acute respiratory syndrome]. | Presse medicale (Paris, France : 1983) 20060101 |
| Synthesis and characterization of a hemoglobin-ribavirin conjugate for targeted drug delivery. | Bioconjugate chemistry 20060101 |
| Conversion of viramidine to ribavirin in vivo by adenosine deaminase and its inhibition by 2'-deoxycoformycin. | Antiviral chemistry & chemotherapy 20060101 |
| [Comutagen interaction of verapamil and ribavirin]. | Eksperimental'naia i klinicheskaia farmakologiia 20060101 |
| Treatment of chronic HCV infection in special populations. | International journal of medical sciences 20060101 |
| Intracerebral hemorrhage in a patient receiving combination therapy of pegylated interferon alpha-2b and ribavirin for chronic hepatitis C. | Internal medicine (Tokyo, Japan) 20060101 |
| Depressive symptoms and physical/mental functioning with interferon/ribavirin treatment of posttransplant recurrent hepatitis C. | Psychosomatics 20060101 |
| Improvement in quality of life measures in patients with refractory hepatitis C, responding to re-treatment with Pegylated interferon alpha -2b and ribavirin. | Health and quality of life outcomes 20060101 |
| Treatment of chronic hepatitis C in non-responsive patients with pegylated interferon associated with ribavirin and thalidomide: report of six cases of total remission. | Revista do Instituto de Medicina Tropical de Sao Paulo 20060101 |
| [Retinopathy in a patient with hepatitis C treated with pegylated interferon and ribavirin: case report]. | Arquivos brasileiros de oftalmologia 20060101 |
| Rosacea fulminans related to pegylated interferon alpha-2b and ribavirin therapy. | Acta dermato-venereologica 20060101 |
| [In vitro effects of antiviral drugs on the reproduction of highly pathogenic influenza A/H5N1 virus strains that induce epizooty among poultry in the summer of 2005]. | Voprosy virusologii 20060101 |
| Spectrophotometric determination of acyclovir and ribavirin in their dosage forms. | Journal of AOAC International 20060101 |
| Influenza virus inhibitors available for the chemotherapy and/or chemoprophylaxis of influenza virus infections. | Verhandelingen - Koninklijke Academie voor Geneeskunde van Belgie 20060101 |
| Metabolic regulation and chemotherapy. | Advances in enzyme regulation 20060101 |
| Vascular ophthalmological side effects associated with antiviral therapy for chronic hepatitis C are related to vascular endothelial growth factor levels. | Antiviral therapy 20060101 |
| Modulation of cancer pathways by inhibitors of guanylate metabolism. | Advances in enzyme regulation 20060101 |
| [Study of drugs against neoplastic metastasis]. | Magyar onkologia 20060101 |
| Variations in the viral NS5B region in Japanese patients with chronic hepatitis C virus genotype 1b infection. No specific amino acid substitution was identified as determinants of treatment response to interferon/ribavirin combination therapy. | Intervirology 20060101 |
| [The treatment of HCV infection with interferon alpha and ribavirin in a child with diabetes I type]. | Przeglad epidemiologiczny 20060101 |
| Choroidal neovascularization with interferon associated retinopathy: case report and review of literature. | Annals of hepatology 20060101 |
| Resveratrol, an ingredient of wine, acts synergistically with Ara-C and tiazofurin in HL-60 human promyelocytic leukemia cells. | Nucleosides, nucleotides & nucleic acids 20060101 |
| Activities of oseltamivir and ribavirin used alone and in combination against infections in mice with recent isolates of influenza A (H1N1) and B viruses. | Antiviral chemistry & chemotherapy 20060101 |
| [Depressive symptoms during treatment with interferon alpha for HCV infection--preliminary report]. | Psychiatria polska 20060101 |
| [New therapeutic strategies in chronic hepatitis C]. | Gastroenterologie clinique et biologique 20060101 |
| [Antiviral etiotropic chemicals: efficacy against influenza A viruses A subtype H5N1]. | Voprosy virusologii 20060101 |
| Chronic hepatitis C virus infection in renal transplant: treatment and outcome. | Clinical transplantation 20060101 |
| [Central vein occlusion in a patient using interferon and ribavirin: case report]. | Arquivos brasileiros de oftalmologia 20060101 |
| Case study on drug-related adverse effects of hepatitis C therapy. | Advances in therapy 20060101 |
| The lesson of supplementary treatment with Chinese medicine on severe laboratory-confirmed SARS patients. | The American journal of Chinese medicine 20060101 |
| Ribavirin-induced anemia: mechanisms, risk factors and related targets for future research. | Current medicinal chemistry 20060101 |
| Report from the 2nd International Workshop on HIV and Hepatitis Co-Infection, January 12-14, 2006, Amsterdam, Netherlands. Early treatment of sexually transmitted hepatitis C. | TreatmentUpdate 20060101 |
| [Study of the efficacy of combined therapy with interferon alfacon-1 and ribavirin for chronic hepatitis C]. | Przeglad epidemiologiczny 20060101 |
| Indomethacin has a potent antiviral activity against SARS coronavirus. | Antiviral therapy 20060101 |
| Case report of 3 patients with severe mental illness and chronic hepatitis C virus infection treated with interferon-alpha. | International journal of psychiatry in medicine 20060101 |
| Synthesis and in vitro anti-hepatitis B and C virus activities of ring-expanded ('fat') nucleobase analogues containing the imidazo[4,5-e][1,3]diazepine-4,8-dione ring system. | Bioorganic & medicinal chemistry letters 20051215 |
| Spontaneous hepatic decompensation in patients coinfected with HIV and hepatitis C virus during interferon-ribavirin combination treatment. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20051215 |
| Synthesis and biological evaluation of novel bisheterocycle-containing compounds as potential anti-influenza virus agents. | Bioorganic & medicinal chemistry letters 20051201 |
| New paradigms in the management of HIV and hepatitis C virus coinfection. | Current opinion in infectious diseases 20051201 |
| Chronic hepatitis C in patients with HIV/AIDS: a new challenge in antiviral therapy. | The Journal of antimicrobial chemotherapy 20051201 |
| Accelerated hepatitis C virus kinetics but similar survival rates in recipients of liver grafts from living versus deceased donors. | Hepatology (Baltimore, Md.) 20051201 |
| Changes in serum and red blood cell membrane lipids in patients treated with interferon ribavirin for chronic hepatitis C. | Clinical and experimental medicine 20051201 |
| Intravenous ribavirin is a safe and cost-effective treatment for respiratory syncytial virus infection after lung transplantation. | The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 20051201 |
| Pegylated interferon alfa-2a and ribavirin for recurrent hepatitis C after liver transplantation. | Transplantation proceedings 20051201 |
| Hepatitis C and didanosine: risk of lactic acidosis. | Prescrire international 20051201 |
| Treatment of hepatitis C in HIV-infected patients: regularly reassess the benefits and risks. | Prescrire international 20051201 |
| Pegylated interferon alfa-2b (peg-intron) plus ribavirin (rebetol) in the treatment of chronic hepatitis C: a local experience. | The Medical journal of Malaysia 20051201 |
| Effects of eicosapentaenoic acid supplementation in the treatment of chronic hepatitis C patients. | Journal of nutritional science and vitaminology 20051201 |
| [Drug therapy in chronic liver disease]. | Praxis 20051130 |
| Hepatic steatosis in chronic hepatitis C: impact on response to anti-viral treatment with peg-interferon and ribavirin. | Alimentary pharmacology & therapeutics 20051115 |
| Broad-spectrum inhibitor of viruses in the Flaviviridae family. | Antiviral research 20051101 |
| Vogt-Koyanagi-Harada disease in patients with chronic hepatitis C. | American journal of ophthalmology 20051101 |
| Hepatitis C treatment in an HIV-HCV-coinfected patient with drug addiction and psychiatric illness: a case report. | The AIDS reader 20051101 |
| [Retinopathy during interferon treatment in combination with ribavirin for chronic hepatitis C]. | Nippon Ganka Gakkai zasshi 20051101 |
| Pegylated interferon and ribavirin for the recurrence of chronic hepatitis C genotype 1 in transplant patients. | Transplantation proceedings 20051101 |
| [Effect of anti-influenza virus of Arctigenin in vivo]. | Zhong yao cai = Zhongyaocai = Journal of Chinese medicinal materials 20051101 |
| Zinc(II) triflate-controlled 1,3-dipolar cycloadditions of C-(2-thiazolyl)nitrones: application to the synthesis of a novel isoxazolidinyl analogue of tiazofurin. | The Journal of organic chemistry 20051028 |
| The impact of past alcohol use on treatment response rates in patients with chronic hepatitis C. | Alimentary pharmacology & therapeutics 20051015 |
| In vitro and in vivo influenza virus-inhibitory effects of viramidine. | Antiviral research 20051001 |
| The antiviral drug ribavirin does not mimic the 7-methylguanosine moiety of the mRNA cap structure in vitro. | RNA (New York, N.Y.) 20051001 |
| Feasibility and outcome of HCV treatment in a Canadian federal prison population. | American journal of public health 20051001 |
| Antiviral therapy after non-surgical tumor ablation in patients with hepatocellular carcinoma associated with hepatitis C virus. | Journal of gastroenterology and hepatology 20051001 |
| Chronic hepatitis C in Latinos: natural history, treatment eligibility, acceptance, and outcomes. | The American journal of gastroenterology 20051001 |
| Glutathione peroxidase, thioredoxin, and membrane protein changes in erythrocytes predict ribavirin-induced anemia. | Clinical pharmacology and therapeutics 20051001 |
| Erythropoietic growth factors for treatment-induced anemia in hepatitis C: a cost-effectiveness analysis. | Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20051001 |
| Efficient route to C2 symmetric heterocyclic backbone modified cyclic peptides. | Organic letters 20050929 |
| Improvement of quantitative testing of liver function in patients with chronic hepatitis C after installment of antiviral therapy. | World journal of gastroenterology 20050921 |
| Acute sensorineural hearing loss associated with peginterferon and ribavirin combination therapy during hepatitis C treatment: outcome after resumption of therapy. | World journal of gastroenterology 20050914 |
| The time-course of ribavirin-provoked changes of basal and AMPH-induced motor activities in rats. | Experimental brain research 20050901 |
| Chronic hepatitis C and 'normal' ALT levels: treat the disease not the test. | Journal of hepatology 20050901 |
| Gamma-glutamyl transferase (GGT) as an independent predictive factor of sustained virologic response in patients with hepatitis C treated with interferon-alpha and ribavirin. | Journal of clinical gastroenterology 20050901 |
| Rationale and design of the REPEAT study: a phase III, randomized, clinical trial of peginterferon alfa-2a (40 kDa) plus ribavirin in non-responders to peginterferon alfa-2b (12 kDa) plus ribavirin. | European journal of gastroenterology & hepatology 20050901 |
| Major depressive episode with psychotic features induced by pegylated interferon-alpha-2b and ribavirin treatment. | International clinical psychopharmacology 20050901 |
| Transmission of hepatitis C virus among HIV-positive homosexual men and response to a 24-week course of pegylated interferon and ribavirin. | Journal of acquired immune deficiency syndromes (1999) 20050901 |
| Risk factors for symptomatic mitochondrial toxicity in HIV/hepatitis C virus-coinfected patients during interferon plus ribavirin-based therapy. | Journal of acquired immune deficiency syndromes (1999) 20050901 |
| [Ischemic neuroretinopathy associated with use of interferon]. | Archivos de la Sociedad Espanola de Oftalmologia 20050901 |
| Ribavirin levels in post liver transplant patients treated for recurrent hepatitis C viral infection. | Transplantation proceedings 20050901 |
| Non-interferon-based therapy: an option for amelioration of necro-inflammation in hepatitis C patients who cannot afford interferon therapy. | Liver international : official journal of the International Association for the Study of the Liver 20050801 |
| Early monitoring of ribavirin plasma concentrations may predict anemia and early virologic response in HIV/hepatitis C virus-coinfected patients. | Journal of acquired immune deficiency syndromes (1999) 20050801 |
| Epoetin alfa once weekly improves anemia in HIV/hepatitis C virus-coinfected patients treated with interferon/ribavirin: a randomized controlled trial. | Journal of acquired immune deficiency syndromes (1999) 20050801 |
| Use of growth factors with antiviral therapy for chronic hepatitis C. | Clinics in liver disease 20050801 |
| Ribavirin is not a functional mimic of the 7-methyl guanosine mRNA cap. | RNA (New York, N.Y.) 20050801 |
| International, multicenter, randomized, controlled study comparing dynamically individualized versus standard treatment in patients with chronic hepatitis C. | Journal of hepatology 20050801 |
| [Type 2 diabetes mellitus with histological finding of nonalcoholic steatohepatitis following combination therapy with interferon and ribavirin for chronic hepatitis C]. | Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20050801 |
| 5'-Homoneplanocin A inhibits hepatitis B and hepatitis C. | Journal of medicinal chemistry 20050728 |
| Herbal medicine Ninjinyoeito ameliorates ribavirin-induced anemia in chronic hepatitis C: a randomized controlled trial. | World journal of gastroenterology 20050714 |
| Combined treatment with pegylated interferon (alpha-2b) and ribavirin in the acute phase of hepatitis C virus recurrence after liver transplantation. | Journal of hepatology 20050701 |
| The effect of zinc supplementation on the treatment of chronic hepatitis C patients with interferon and ribavirin. | Clinical biochemistry 20050701 |
| Helper T cell cytokine response to ribavirin priming before combined treatment with interferon alpha and ribavirin for patients with chronic hepatitis C. | Antiviral research 20050701 |
| Selective granulocyte and monocyte apheresis as a new adjunct to enhance the efficacy of interferon-alpha + ribavirin in patients with high plasma hepatitis C virus. | Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20050701 |
| Insulin resistance plays a significant role in liver fibrosis in chronic hepatitis C and in the response to antiviral therapy. | The American journal of gastroenterology 20050701 |
| Pegylated interferon-alpha 2b-ribavirin combination in Egyptian patients with genotype 4 chronic hepatitis. | Journal of viral hepatitis 20050701 |
| Adverse effects of ribavirin and outcome in severe acute respiratory syndrome: experience in two medical centers. | Chest 20050701 |
| Factor VIII inhibitor associated with peginterferon. | Haemophilia : the official journal of the World Federation of Hemophilia 20050701 |
| New drug targets for HIV and hepatitis C virus coinfection. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20050701 |
| Survival after treatment of rabies with induction of coma. | The New England journal of medicine 20050616 |
| Prevention of interferon-alpha associated depression in psychiatric risk patients with chronic hepatitis C. | Journal of hepatology 20050601 |
| Inhibitory effect of mizoribine and ribavirin on the replication of severe acute respiratory syndrome (SARS)-associated coronavirus. | Antiviral research 20050601 |
| Peginterferon and ribavirin in patients with HCV cirrhosis after liver transplantation. | Transplantation proceedings 20050601 |
| Effectiveness and tolerability of pegylated Interferon alpha-2a and ribavirin combination therapy in Romanian patients with chronic hepatitis C: from clinical trials to clinical practice. | Romanian journal of gastroenterology 20050601 |
| Unilateral oculomotor nerve palsy induced by combination therapy of interferon-alpha2b and ribavirin. | Internal medicine (Tokyo, Japan) 20050601 |
| Downregulation of glial scarring after brain injury: the effect of purine nucleoside analogue ribavirin. | Annals of the New York Academy of Sciences 20050601 |
| Combination of nucleoside analogues tiazofurin and ribavirin downregulates experimental autoimmune encephalomyelitis. | Annals of the New York Academy of Sciences 20050601 |
| Different effects of adenosine A1 agonist ribavirin on amphetamine-induced total locomotor and stereotypic activities in rats. | Annals of the New York Academy of Sciences 20050601 |
| Mizoribine inhibits hepatitis C virus RNA replication: effect of combination with interferon-alpha. | Biochemical and biophysical research communications 20050513 |
| Factors accelerating liver fibrosis progression in renal transplant patients receiving ribavirin monotherapy for chronic hepatitis C. | Journal of medical virology 20050501 |
| Peginterferon alfa-2b plus ribavirin treatment in children and adolescents with chronic hepatitis C. | Hepatology (Baltimore, Md.) 20050501 |
| Immunomodulatory effects of selective leucocytapheresis as a new adjunct to interferon-alpha2b plus ribavirin combination therapy: a prospective study in patients with high plasma HCV viraemia. | Journal of viral hepatitis 20050501 |
| Interferon-stimulated gene expression in black and white hepatitis C patients during peginterferon alfa-2a combination therapy. | Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20050501 |
| [Ischemic anterior optic neuropathy complicating interferon alpha-2a and ribavirin treatment for acute hepatitis C]. | Gastroenterologie clinique et biologique 20050501 |
| Regioselective enzymatic acylation of ribavirin to give potential multifunctional derivatives. | Biotechnology letters 20050501 |
| The antiviral drug ribavirin reversibly affects the reproductive parameters in the male Wistar rat. | Folia morphologica 20050501 |
| FDA approves Pegasys and Copegus for hepatitis C in patients with HIV co-infection. | The Hopkins HIV report : a bimonthly newsletter for healthcare providers 20050501 |
| Occurrence of porphyria cutanea tarda during peginterferon/ribavirin therapy for chronic viral hepatitis C. | Journal of hepatology 20050401 |
| Search of chemical scaffolds for novel antituberculosis agents. | Journal of biomolecular screening 20050401 |
| Usefulness of combined measurement of serum bile acids and ferritin as additional prognostic markers to predict failure to reach sustained response to antiviral treatment in chronic hepatitis C. | Journal of gastroenterology and hepatology 20050401 |
| Peginterferon alpha-2a combination therapies in chronic hepatitis C patients who relapsed after or had a viral breakthrough on therapy with standard interferon alpha-2b plus ribavirin: a pilot study of efficacy and safety. | Digestive diseases and sciences 20050401 |
| Interferon alfacon-1 and ribavirin versus interferon alpha-2b and ribavirin in the treatment of chronic hepatitis C. | Digestive diseases and sciences 20050401 |
| Retinal toxicity during pegylated alpha-interferon therapy for chronic hepatitis C: a multifocal electroretinogram investigation. | Alimentary pharmacology & therapeutics 20050315 |
| Lanreotide treatment in a patient with interferon-associated Graves' ophthalmopathy. | Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 20050301 |
| Pilot study of low-dose interleukin-2, pegylated interferon-alpha 2b, and ribavirin for the treatment of hepatitis C virus infection in patients with HIV infection. | The Journal of infectious diseases 20050301 |
| Treatment of acute hepatitis C infection in HIV-infected patients: a retrospective analysis of eleven cases. | Journal of viral hepatitis 20050301 |
| Viral kinetics during antiviral therapy in patients with chronic hepatitis C and persistently normal ALT levels. | Hepatology (Baltimore, Md.) 20050301 |
| Mechanism of action of T-705 against influenza virus. | Antimicrobial agents and chemotherapy 20050301 |
| Antiadenovirus activities of several classes of nucleoside and nucleotide analogues. | Antimicrobial agents and chemotherapy 20050301 |
| Synergistic action of resveratrol, an ingredient of wine, with Ara-C and tiazofurin in HL-60 human promyelocytic leukemia cells. | Experimental hematology 20050301 |
| Treatment of parainfluenza virus 3 pneumonia in a cardiac transplant recipient with intravenous ribavirin and methylprednisolone. | The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 20050301 |
| Dynamic decision analysis to determine optimal treatment duration in chronic hepatitis C. | Alimentary pharmacology & therapeutics 20050301 |
| Interferon alpha-2b and ribavirin for patients with chronic hepatitis C and normal ALT. | The American journal of gastroenterology 20050301 |
| Sarcoidosis in patients with chronic hepatitis C virus infection: analysis of 68 cases. | Medicine 20050301 |
| Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients. | Gastroenterology 20050301 |
| Steroid-free induction and preemptive antiviral therapy for liver transplant recipients with hepatitis C: a preliminary report from a prospective randomized study. | Transplantation proceedings 20050301 |
| Can Peg-IFN alpha-2a plus ribavirin be used to treat patients with chronic hepatitis C and normal alanine aminotransferase levels? | Nature clinical practice. Gastroenterology & hepatology 20050301 |
| Triple antiviral therapy with amantadine for IFN-ribavirin nonresponders with recurrent posttransplantation hepatitis C. | Transplantation 20050215 |
| High-dose hydrocortisone reduces expression of the pro-inflammatory chemokines CXCL8 and CXCL10 in SARS coronavirus-infected intestinal cells. | International journal of molecular medicine 20050201 |
| Metabolism and antiviral activity of ribavirin. | Virus research 20050201 |
| Action of mutagenic agents and antiviral inhibitors on foot-and-mouth disease virus. | Virus research 20050201 |
| High-dose ribavirin in combination with standard dose peginterferon for treatment of patients with chronic hepatitis C. | Hepatology (Baltimore, Md.) 20050201 |
| Towards more individualised management of hepatitis C virus patients with initially or persistently normal alanineaminotransferase levels. | Journal of hepatology 20050201 |
| Erythropoietic response to anemia in chronic hepatitis C patients receiving combination pegylated interferon/ribavirin. | The American journal of gastroenterology 20050201 |
| Complicated lichenoid drug eruption. | The Australasian journal of dermatology 20050201 |
| Early hepatitis C virus changes and sustained response in patients with chronic hepatitis C treated with peginterferon alpha-2b and ribavirin. | Liver international : official journal of the International Association for the Study of the Liver 20050201 |
| Treatment of chronic hepatitis C in human immunodeficiency virus/hepatitis C virus-coinfected patients in the era of pegylated interferon and ribavirin. | Seminars in liver disease 20050201 |
| Interferon-induced depression: prevalence and management. | Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20050201 |
| Antisense approaches for inhibiting respiratory syncytial virus. | Expert opinion on biological therapy 20050201 |
| Genetic analysis and functional characterization of polymorphisms in the human concentrative nucleoside transporter, CNT2. | Pharmacogenetics and genomics 20050201 |
| Synthesis and antiviral activity against Coxsackie virus B3 of some novel benzimidazole derivatives. | Bioorganic & medicinal chemistry letters 20050117 |
| Role of human nucleoside transporters in the cellular uptake of two inhibitors of IMP dehydrogenase, tiazofurin and benzamide riboside. | Molecular pharmacology 20050101 |
| The use of growth factors to manage the hematologic side effects of PEG-interferon alfa and ribavirin. | Journal of clinical gastroenterology 20050101 |
| Applicability, tolerability and efficacy of preemptive antiviral therapy in hepatitis C-infected patients undergoing liver transplantation. | American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20050101 |
| Neurocognitive changes in patients with hepatitis C receiving interferon alfa-2b and ribavirin. | Clinical pharmacology and therapeutics 20050101 |
| Enhancement of antiviral activity against hepatitis C virus in vitro by interferon combination therapy. | Antiviral research 20050101 |
| Prophylactic SSRI during interferon alpha re-therapy in patients with chronic hepatitis C and a history of interferon-induced depression. | Journal of viral hepatitis 20050101 |
| Depression during pegylated interferon-alpha plus ribavirin therapy: prevalence and prediction. | The Journal of clinical psychiatry 20050101 |
| Renal hypouricemia is an ominous sign in patients with severe acute respiratory syndrome. | American journal of kidney diseases : the official journal of the National Kidney Foundation 20050101 |
| [Advances in the diagnosis and treatment of hepatitis C virus infection in patients with and without HIV infection]. | Enfermedades infecciosas y microbiologia clinica 20050101 |
| Peginterferon alpha-2a (40KD) plus ribavirin: a review of its use in the management of patients with chronic hepatitis C and persistently 'normal' ALT levels. | Drugs 20050101 |
| Colorimetric lactate dehydrogenase (LDH) assay for evaluation of antiviral activity against bovine viral diarrhoea virus (BVDV) in vitro. | Antiviral chemistry & chemotherapy 20050101 |
| Viral interaction and responses in chronic hepatitis C and B coinfected patients with interferon-alpha plus ribavirin combination therapy. | Antiviral therapy 20050101 |
| Citalopram-induced diplopia. | Psychosomatics 20050101 |
| Treatment of genotype 1b HCV-related chronic hepatitis: efficacy and toxicity of three different interferon alfa-2b/ribavirin combined regimens in naive patients. | The new microbiologica 20050101 |
| Pharmacokinetic/pharmacodynamic and time-to-event models of ribavirin-induced anaemia in chronic hepatitis C. | Clinical pharmacokinetics 20050101 |
| Ribavirin in the treatment of hepatitis C. | Anticancer research 20050101 |
| In vitro susceptibility of adenovirus to antiviral drugs is species-dependent. | Antiviral therapy 20050101 |
| In vitro combination studies of tenofovir and other nucleoside analogues with ribavirin against HIV-1. | Antiviral therapy 20050101 |
| Life-threatening thyrotoxicosis induced by combination therapy with PEG-interferon and ribavirin in chronic hepatitis C. | Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 20050101 |
| Incidence and risk factors for mitochondrial toxicity in treated HIV/HCV-coinfected patients. | Antiviral therapy 20050101 |
| Simple fluorimetric method for determination of certain antiviral drugs via their oxidation with cerium (IV). | Farmaco (Societa chimica italiana : 1989) 20050101 |
| Effect of interferon, ribavirin and ursodeoxycholic acid in patients with hepatitis C infection. | Hepato-gastroenterology 20050101 |
| Association of amino acid substitution pattern in core protein of hepatitis C virus genotype 1b high viral load and non-virological response to interferon-ribavirin combination therapy. | Intervirology 20050101 |
| The clinical utility of using Catrimox-14-treated whole blood in detecting hepatitis C virus RNA. | Antiviral therapy 20050101 |
| Down-regulation of increased signal transduction capacity in human cancer cells. | Advances in enzyme regulation 20050101 |
| [Effects of antiviral agents on the reproduction of avian influenza virus A/H5 isolated in Russia]. | Voprosy virusologii 20050101 |
| [Hepatitis C, interferon a and depression: main physiopathologic hypothesis]. | L'Encephale 20050101 |
| Improved liver function and decreased hepatitis C viral load after tacrolimus was replaced by cyclosporine. | Transplantation proceedings 20050101 |
| [Effects of treatment with pegylated interferon and ribavirin in children with chronic hepatitis C]. | Przeglad epidemiologiczny 20050101 |
| The concentration of sFasL, ICE and IL-1beta in the serum and the liver tissue of chronic HCV infected patients. | Hepato-gastroenterology 20050101 |
| Irritability rather than depression during interferon treatment is linked to increased tryptophan catabolism. | Psychosomatic medicine 20050101 |
| [Sensitivity of various influenza virus strains to arbidol. Influence of arbidol combination with different antiviral drugs on reproduction of influenza virus A]. | Terapevticheskii arkhiv 20050101 |
| Two-year interferon therapy with or without ribavirin in chronic delta hepatitis. | Antiviral therapy 20050101 |
| Synthesis of 3'-deoxy-3'-C-hydroxymethyl analogues of tiazofurin and ribavirin. | Nucleosides, nucleotides & nucleic acids 20050101 |
| Synthesis of homo-N-nucleoside with 1,2,4-triazole-3-carboxamide. | Nucleosides, nucleotides & nucleic acids 20050101 |
| Photolabeling probes of ribavirin and EICAR. | Nucleosides, nucleotides & nucleic acids 20050101 |
| Hepatic and renal safety profile of tenofovir in HIV-infected patients with hepatitis C, including patients on interferon plus ribavirin. | HIV clinical trials 20050101 |
| Branch retinal artery occlusion combined with branch retinal vein occlusion in a patient with hepatitis C treated with interferon and ribavirin. | European journal of ophthalmology 20050101 |
| [Treatment of viral hepatitis in children]. | Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti 20050101 |
| [Treatment of the side effects of antiviral therapy]. | Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti 20050101 |
| [Treatment of chronic hepatitis C in patients with HIV infection]. | Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti 20050101 |
| The follow-up of the efficacy of antiviral therapy at patients with chronic hepatitis C. | Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie 20050101 |
| Characteristics and prospects for hepatitis C therapy of an HIV-HCV coinfected population followed at a reference HIV center. | HIV clinical trials 20050101 |
| [Quality assurance in patient addiction treated with drug substitution]. | Krankenpflege Journal 20050101 |
| [Efficacy of combination therapy with interferon-alpha and ribavirin for chronic hepatitis C in relation to liver fibrosis and serum aminotransferase activity]. | Wiadomosci lekarskie (Warsaw, Poland : 1960) 20050101 |
| [Sustained virological response in children with chronic hepatitis C treated with interferon alpha and ribavirin]. | Przeglad lekarski 20050101 |
| Differentiation of human prostate cancer PC-3 cells induced by inhibitors of inosine 5'-monophosphate dehydrogenase. | Cancer research 20041215 |
| Clinical picture, diagnosis, treatment and outcome of severe acute respiratory syndrome (SARS) in children. | Paediatric respiratory reviews 20041201 |
| Triple combination of thymalfasin, peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have failed prior interferon and ribavirin treatment: 24-week interim results of a pilot study. | Journal of gastroenterology and hepatology 20041201 |
| Is screening for interferon retinopathy in hepatitis C justified? | The British journal of ophthalmology 20041201 |
| Inhibition of bovine viral diarrhea virus (BVDV) by mizoribine: synergistic effect of combination with interferon-alpha. | Antiviral research 20041201 |
| Viral kinetics during antiviral therapy in patients with chronic hepatitis C and persistently normal ALT levels. | Hepatology (Baltimore, Md.) 20041201 |
| Interferon for hepatitis C patients with psychiatric disorders. | The American journal of psychiatry 20041201 |
| Peginterferon alfa-2a (40 kilodaltons) and ribavirin in patients with chronic hepatitis C and normal aminotransferase levels. | Gastroenterology 20041201 |
| Orally administered Kampo medicine, Juzen-taiho-to, ameliorates anemia during interferon plus ribavirin therapy in patients with chronic hepatitis C. | Journal of gastroenterology 20041201 |
| Triple combination of thymalfasin, peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have failed prior interferon and ribavirin treatment: 24-week interim results of a pilot study. | Journal of gastroenterology and hepatology 20041201 |
| Depressive symptoms after initiation of interferon therapy in human immunodeficiency virus-infected patients with chronic hepatitis C. | Antiviral therapy 20041201 |
| Mitochondrial effects of a 24-week course of pegylated-interferon plus ribavirin in asymptomatic HCV/HIV co-infected patients on long-term treatment with didanosine, stavudine or both. | Antiviral therapy 20041201 |
| Inhibition of B16 mouse melanoma cell growth and induction of apoptotic cell death with 8-chloroadenosine-3',5'-monophosphate and tiazofurin. | Annals of the New York Academy of Sciences 20041201 |
| Interleukin 6 and 12, alanine aminotransferase activity, and HCV viral load in children with chronic hepatitis C treated with interferon and ribavirin. | Inflammation 20041201 |
| High-dose vitamin E supplementation does not diminish ribavirin-associated haemolysis in hepatitis C treatment with combination standard alpha-interferon and ribavirin. | Alimentary pharmacology & therapeutics 20041115 |
| STAT3 induces anti-hepatitis C viral activity in liver cells. | Biochemical and biophysical research communications 20041112 |
| Effects of the IMP-dehydrogenase inhibitor, Tiazofurin, in bcr-abl positive acute myelogenous leukemia. Part I. In vivo studies. | Leukemia research 20041101 |
| Effects of the IMP-dehydrogenase inhibitor, Tiazofurin, in bcr-abl positive acute myelogenous leukemia. Part II. In vitro studies. | Leukemia research 20041101 |
| Factors contributing to ribavirin-induced anemia. | Journal of gastroenterology and hepatology 20041101 |
| Inhibition of subgenomic hepatitis C virus RNA in Huh-7 cells: ribavirin induces mutagenesis in HCV RNA. | Journal of viral hepatitis 20041101 |
| In vitro combination of amdoxovir and the inosine monophosphate dehydrogenase inhibitors mycophenolic acid and ribavirin demonstrates potent activity against wild-type and drug-resistant variants of human immunodeficiency virus type 1. | Antimicrobial agents and chemotherapy 20041101 |
| Chorioretinal involvement in patients with West Nile virus infection. | Ophthalmology 20041101 |
| Outcome of combined interferon-ribavirin in the treatment of chronic hepatitis C. | Journal of the College of Physicians and Surgeons--Pakistan : JCPSP 20041101 |
| Adequate timing of ribavirin reduction in patients with hemolysis during combination therapy of interferon and ribavirin for chronic hepatitis C. | Journal of gastroenterology 20041101 |
| [Chronic hepatitis C with normal level of alanine-aminotransferase]. | Recenti progressi in medicina 20041101 |
| [Epidemiological, clinical and therapeutical aspects of HIV/HCV coinfection in a series of HIV seropositive Umbrian patients]. | Recenti progressi in medicina 20041101 |
| Thymosin alpha 1 in combination with interferon alpha and ribavirin in chronic hepatitis C patients who are non-responders or relapsers to interferon alpha plus ribavirin. | JPMA. The Journal of the Pakistan Medical Association 20041101 |
| Pegylating IFNs at his-34 improves the in vitro antiviral activity through the JAK/STAT pathway. | Antiviral chemistry & chemotherapy 20041101 |
| Tuberculosis in a SARS outbreak. | Journal of the Chinese Medical Association : JCMA 20041101 |
| Nucleoside/nucleotide reverse transcriptase inhibitor drug interactions. | Journal of HIV therapy 20041101 |
| [Incidence of haemolytic anaemia during combination therapy of chronic hepatitis C with interferon alpha-2b and ribavirin]. | Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego 20041101 |
| Synthesis of benzodithiol-2-yl-substituted nucleoside derivatives as lead compounds having anti-bovine viral diarrhea virus activity. | Journal of medicinal chemistry 20041007 |
| Dual-action mechanism of viramidine functioning as a prodrug and as a catabolic inhibitor for ribavirin. | Antimicrobial agents and chemotherapy 20041001 |
| Mycophenolic acid inhibits avian reovirus replication. | Antiviral research 20041001 |
| Takayasu's arteritis and hepatitis C: a new association? | Clinical rheumatology 20041001 |
| Temporal relationship of viral load, ribavirin, interleukin (IL)-6, IL-8, and clinical progression in patients with severe acute respiratory syndrome. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20041001 |
| Respiratory health survey of respiratory therapists. | Chest 20041001 |
| Cost-effectiveness of pegylated IFN-alpha2b and -2a and ribavirin for chronic hepatitis C treatment. | Expert review of pharmacoeconomics & outcomes research 20041001 |
| Histopathologic efficacy of ribavirin monotherapy in kidney allograft recipients with chronic hepatitis C. | Transplantation 20040927 |
| Hepatic artery stenosis in liver transplanted patients treated with pegylated interferon alpha-2b and ribavirin. | Transplantation 20040927 |
| Cryptosporidium parvum IMP dehydrogenase: identification of functional, structural, and dynamic properties that can be exploited for drug design. | The Journal of biological chemistry 20040924 |
| Platelet sparing effect of COX II inhibition used with pegylated interferon alfa-2a for the treatment of chronic hepatitis C: a short term pilot study. | Cytokine 20040921 |
| Risk factors for hepatic decompensation in patients with HIV/HCV coinfection and liver cirrhosis during interferon-based therapy. | AIDS (London, England) 20040903 |
| Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for treatment of HIV/HCV co-infected patients. | AIDS (London, England) 20040903 |
| Serious ophthalmic pathology compromising vision in HCV/HIV co-infected patients treated with peginterferon alpha-2b and ribavirin. | AIDS (London, England) 20040903 |
| In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds. | Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 20040901 |
| Interferon-induced granulomatous lung disease. | Current opinion in pulmonary medicine 20040901 |
| Interferon alfa-2b [correction of alpha-2b]and ribavirin for patients with chronic hepatitis C and normal ALT. | The American journal of gastroenterology 20040901 |
| Chronic hepatitis C and normal ALT: considerations for treatment. | The American journal of gastroenterology 20040901 |
| Peginterferon alfa-2b plus ribavirin for the treatment of chronic hepatitis C genotype 4. | The American journal of gastroenterology 20040901 |
| Interferon-alpha-associated sarcoidosis responsive to infliximab therapy. | The American journal of the medical sciences 20040901 |
| Efficacy of post-exposure treatment of yellow fever with ribavirin in a hamster model of the disease. | The American journal of tropical medicine and hygiene 20040901 |
| [Bilateral AION after the combined therapy of hepatitis C with PEG-interferon alpha2B and ribavirin]. | Klinische Monatsblatter fur Augenheilkunde 20040901 |
| Treatment of mannan-enhanced influenza B virus infections in mice with oseltamivir, ribavirin and viramidine. | Antiviral chemistry & chemotherapy 20040901 |
| Hemorrhagic fever with renal syndrome. | Hawaii medical journal 20040901 |
| [Treatment of chronic hepatitis C]. | Orvosi hetilap 20040808 |
| Ribavirin, but not interferon alpha-2b, is associated with impaired osteoblast proliferation and differentiation in vitro. | Calcified tissue international 20040801 |
| Subnormal rise of erythropoietin in patients receiving interferon and ribavirin combination therapy for hepatitis C. | Journal of clinical gastroenterology 20040801 |
| Treatment of adenovirus infections in the immunocompromised host. | European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20040801 |
| Combination pegylated interferon and ribavirin therapy precipitating acute renal failure and exacerbating IgA nephropathy. | Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20040801 |
| Advancements in the battle against severe acute respiratory syndrome. | Expert opinion on pharmacotherapy 20040801 |
| Investigational use of ribavirin in the treatment of severe acute respiratory syndrome, Singapore, 2003. | Tropical medicine & international health : TM & IH 20040801 |
| Peginterferon alpha-2b plus ribavirin with or without amantadine [correction of amantidine] for the treatment of non-responders to standard interferon and ribavirin. | Antiviral therapy 20040801 |
| Viramidine demonstrates better safety than ribavirin in monkeys but not rats. | Drug and chemical toxicology 20040801 |
| Characteristics of patients with Crimean-Congo hemorrhagic fever in a recent outbreak in Turkey and impact of oral ribavirin therapy. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20040715 |
| Comparison of the inhibition of human metapneumovirus and respiratory syncytial virus by NMSO3 in tissue culture assays. | Antiviral research 20040701 |
| Avascular necrosis of bone in severe acute respiratory syndrome. | Clinical radiology 20040701 |
| Retrospective comparison of convalescent plasma with continuing high-dose methylprednisolone treatment in SARS patients. | Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20040701 |
| Tomato-based functional food as interferon adjuvant in HCV eradication therapy. | Journal of clinical gastroenterology 20040701 |
| Factors contributing to ribavirin dose reduction due to anemia during interferon alfa2b and ribavirin combination therapy for chronic hepatitis C. | Journal of gastroenterology 20040701 |
| [Clinical management of asymptomatic HCV carriers]. | Nihon rinsho. Japanese journal of clinical medicine 20040701 |
| [Therapeutic strategies for hepatitis C]. | Nihon rinsho. Japanese journal of clinical medicine 20040701 |
| [Two-step interferon rebound therapy]. | Nihon rinsho. Japanese journal of clinical medicine 20040701 |
| [Alternative measures for patients with chronic hepatitis C unresponsive to interferon therapy]. | Nihon rinsho. Japanese journal of clinical medicine 20040701 |
| [Clinical aspects of type-C cirrhosis of liver--diagnosis, clinical course, treatment and prognosis]. | Nihon rinsho. Japanese journal of clinical medicine 20040701 |
| [Recurrence of hepatocellular carcinoma associated with hepatitis C virus after tumor ablation]. | Nihon rinsho. Japanese journal of clinical medicine 20040701 |
| [Prevalence and clinical course in HBV and HCV dual chronic infection]. | Nihon rinsho. Japanese journal of clinical medicine 20040701 |
| Improved antiviral activity in vitro of ribavirin against measles virus after complexation with cyclodextrins. | Antiviral research 20040601 |
| Serum hepatic enzyme manifestations in patients with severe acute respiratory syndrome: retrospective analysis. | World journal of gastroenterology 20040601 |
| Hepatitis C with normal liver enzymes: to treat or not to treat. Pro: most patients should be treated. | The American journal of gastroenterology 20040601 |
| Hepatitis C with normal liver enzymes: to treat or not to treat. Con: most patients should not be treated. | The American journal of gastroenterology 20040601 |
| Outcome of coronavirus-associated severe acute respiratory syndrome using a standard treatment protocol. | Respirology (Carlton, Vic.) 20040601 |
| Determination of ribavirin in human serum and plasma by capillary electrophoresis. | Electrophoresis 20040601 |
| Relapsing polychondritis, chronic hepatitis C virus infection, and mixed cryoglobulemia. | Seminars in arthritis and rheumatism 20040601 |
| Perihepatic lymph nodes and antiviral response in chronic HCV-associated hepatitis. | Ultrasound in medicine & biology 20040601 |
| Management of chronic hepatitis C virus infection: a new era of disease control. | Internal medicine journal 20040601 |
| [Effect of integrative Chinese and western medicine on T-lymphocyte subsets in treating patients with severe acute respiratory syndrome]. | Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine 20040601 |
| [Chronic nephritic syndrome]. | Nihon rinsho. Japanese journal of clinical medicine 20040601 |
| Combination therapy with peginterferon alpha-2B and ribavirin in liver transplant recipients with recurrent HCV infection: preliminary results of an open prospective study. | Transplantation proceedings 20040601 |
| Structural and functional analysis of glycosylated Cu/Zn-superoxide dismutase from the fungal strain Humicola lutea 103. | Biochemical and biophysical research communications 20040514 |
| Discoveries of nicotinamide riboside as a nutrient and conserved NRK genes establish a Preiss-Handler independent route to NAD+ in fungi and humans. | Cell 20040514 |
| Necrolytic acral erythema: response to combination therapy with interferon and ribavirin. | Journal of the American Academy of Dermatology 20040501 |
| Epoetin alfa treatment for acute anaemia during interferon plus ribavirin combination therapy for chronic hepatitis C. | Journal of viral hepatitis 20040501 |
| Polymorphisms of NS5B protein relates to early clearance of hepatitis C virus by interferon plus ribavirin: a pilot study. | Journal of viral hepatitis 20040501 |
| Changes in haemoglobin during interferon alpha-2b plus ribavirin combination therapy for chronic hepatitis C virus infection. | Journal of viral hepatitis 20040501 |
| Differential efficacy of corticosteroids and interferon in a patient with chronic hepatitis C-autoimmune hepatitis overlap syndrome. | Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20040501 |
| Effects of four antiviral substances on lethal vaccinia virus (IHD strain) respiratory infections in mice. | International journal of antimicrobial agents 20040501 |
| Low membrane protein sulfhydrils but not G6PD deficiency predict ribavirin-induced hemolysis in hepatitis C. | Hepatology (Baltimore, Md.) 20040501 |
| Sudden hearing loss in patients with chronic hepatitis C treated with pegylated interferon/ribavirin. | The American journal of gastroenterology 20040501 |
| Epoetin alfa maintains ribavirin dose in HCV-infected patients: a prospective, double-blind, randomized controlled study. | Gastroenterology 20040501 |
| Inhibitors of measles virus. | Antiviral chemistry & chemotherapy 20040501 |
| Action of celgosivir (6 O-butanoyl castanospermine) against the pestivirus BVDV: implications for the treatment of hepatitis C. | Antiviral chemistry & chemotherapy 20040501 |
| Retreatment of patients who do not respond to initial therapy for chronic hepatitis C. | Cleveland Clinic journal of medicine 20040501 |
| Managing the hematologic side effects of antiviral therapy for chronic hepatitis C: anemia, neutropenia, and thrombocytopenia. | Cleveland Clinic journal of medicine 20040501 |
| [Progress in the treatment of hepatitis B and C co-infection in HIV patients]. | MMW Fortschritte der Medizin 20040426 |
| [Eliminating the gray zone. What can be done in normal ALT values?]. | MMW Fortschritte der Medizin 20040426 |
| Substitution of the conserved Arg-Tyr dyad selectively disrupts the hydrolysis phase of the IMP dehydrogenase reaction. | Biochemistry 20040420 |
| Bronchiolitis: assessment and evidence-based management. | The Medical journal of Australia 20040419 |
| Respiratory syncytial virus-induced chemokine production: linking viral replication to chemokine production in vitro and in vivo. | The Journal of infectious diseases 20040415 |
| Nucleoside analogues and mitochondrial toxicity. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20040415 |
| Interferon alpha and ribavirin in the treatment of children with chronic hepatitis C. | European journal of pediatrics 20040401 |
| A simple assay for determining antiviral activity against Crimean-Congo hemorrhagic fever virus. | Antiviral research 20040401 |
| Synthesis, characterization and antiviral activity against influenza virus of a series of novel manganese-substituted rare earth borotungstates heteropolyoxometalates. | Antiviral research 20040401 |
| Report of two children with subacute sclerosing panencephalitis displaying an atypical clinical course. | The Journal of emergency medicine 20040401 |
| Synergistic inhibition of intracellular hepatitis C virus replication by combination of ribavirin and interferon- alpha. | The Journal of infectious diseases 20040401 |
| Influence of antiviral therapy in hepatitis C virus-associated cryoglobulinemic MPGN. | American journal of kidney diseases : the official journal of the National Kidney Foundation 20040401 |
| Serum LD1 isoenzyme and blood lymphocyte subsets as prognostic indicators for severe acute respiratory syndrome. | Journal of internal medicine 20040401 |
| Marked elevation of erythrocyte ribavirin levels in interferon and ribavirin-induced anemia. | Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20040401 |
| Cofactor mimics as selective inhibitors of NAD-dependent inosine monophosphate dehydrogenase (IMPDH)--the major therapeutic target. | Current medicinal chemistry 20040401 |
| Antiviral flavonoids from the seeds of Aesculus chinensis. | Journal of natural products 20040401 |
| [Clinical observation on treatment of SARS with combination of chaihu droplet pill and huoxiang zhengqi droplet pill]. | Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine 20040401 |
| Inhibition of SARS coronavirus infection in vitro with clinically approved antiviral drugs. | Emerging infectious diseases 20040401 |
| [Chronic hepatitis and cirrhosis caused by C virus before and after liver transplantation. Report of one case]. | Revista medica de Chile 20040401 |
| A 48-week duration of therapy with pegylated interferon alpha 2b plus ribavirin may be too short to maximize long-term response among patients infected with genotype-1 hepatitis C virus. | The Journal of infectious diseases 20040315 |
| The natural history of respiratory syncytial virus infection in cancer and transplant patients: implications for management. | Blood 20040301 |
| Treatment of interferon non-responsive chronic hepatitis C with triple therapy with interferon, ribavirin, and amantidine can be encouraging. | Gut 20040301 |
| Mania during treatment of chronic hepatitis C with pegylated interferon and ribavirin. | The American journal of psychiatry 20040301 |
| Reversible myopathy during successful treatment with pegylated interferon and ribavirin for acute hepatitis C. | Journal of viral hepatitis 20040301 |
| The effects of tiazofurin on basal and amphetamine-induced motor activity in rats. | Pharmacology, biochemistry, and behavior 20040301 |
| [Retinopathy caused by interferon alpha associated with ribavirin therapy and the importance of the electro-oculogram: a case report]. | Journal francais d'ophtalmologie 20040301 |
| Role of epoetin alfa in maintaining ribavirin dose. | Gastroenterology clinics of North America 20040301 |
| Future trends in managing hepatitis C. | Gastroenterology clinics of North America 20040301 |
| Potent inhibition of respiratory syncytial virus by combination treatment with 2-5A antisense and ribavirin. | Antiviral research 20040301 |
| Effect of interferon-alpha and interferon-inducers on West Nile virus in mouse and hamster animal models. | Antiviral chemistry & chemotherapy 20040301 |
| Effect of antimetabolite immunosuppressants on Flaviviridae, including hepatitis C virus. | Transplantation 20040227 |
| Erythrocytotoxicity of tiazofurin in vivo and in vitro detected by scanning probe microscopy. | Toxicology letters 20040202 |
| In vitro inhibition of Chikungunya and Semliki Forest viruses replication by antiviral compounds: synergistic effect of interferon-alpha and ribavirin combination. | Antiviral research 20040201 |
| Dosage adjustment of ribavirin based on renal function in Japanese patients with chronic hepatitis C. | Therapeutic drug monitoring 20040201 |
| Pharmacologic treatment of bronchiolitis in infants and children: a systematic review. | Archives of pediatrics & adolescent medicine 20040201 |
| Viral clearance in HCV viraemic patients with normal alanine aminotransferase after combination therapy: a controlled, open-labelled study. | Alimentary pharmacology & therapeutics 20040201 |
| Current concepts in SARS treatment. | Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 20040201 |
| [Clinical study on treatment of severe acute respiratory syndrome by integrative Chinese and Western medicine]. | Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine 20040201 |
| High rate of didanosine-related mitochondrial toxicity in HIV/HCV-coinfected patients receiving ribavirin. | Antiviral therapy 20040201 |
| [Advances in pharmacotherapy of respiratory syncytial virus and rhinovirus infections]. | Zhonghua er ke za zhi = Chinese journal of pediatrics 20040201 |
| Soluble CD26/30 levels before and after treatment with interferon-alpha and ribavirin combination therapy in a pediatric hepatitis C patient. | Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi 20040201 |
| Pegylated interferon alpha2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected patients. | AIDS (London, England) 20040102 |
| Pegylated interferon alpha 2b and ribavirin in HIV/hepatitis C virus-co-infected non-responders and relapsers to IFN-based therapy. | AIDS (London, England) 20040102 |
| New agents active against Mycobacterium avium complex selected by molecular topology: a virtual screening method. | The Journal of antimicrobial chemotherapy 20040101 |
| Ribavirin pharmacokinetics in renal and liver transplant patients: evidence that it depends on renal function. | American journal of kidney diseases : the official journal of the National Kidney Foundation 20040101 |
| Activation of integrin alpha IIb beta 3 in the glycoprotein Ib-high population of a megakaryocytic cell line, CMK, by inside-out signaling. | Journal of thrombosis and haemostasis : JTH 20040101 |
| Interferon alfa2a induction therapy in combination with ribavirin and amantadine for the treatment of naive patients with chronic HCV infection. | Journal of viral hepatitis 20040101 |
| Evidence that plasma concentration rather than dose per kilogram body weight predicts ribavirin-induced anaemia. | Journal of viral hepatitis 20040101 |
| Synergistic combination of N-acetylcysteine and ribavirin to protect from lethal influenza viral infection in a mouse model. | International journal of immunopathology and pharmacology 20040101 |
| Cholestatic hepatitis due to hepatitis C virus after a living donor liver transplantation. | Hepato-gastroenterology 20040101 |
| The presence of non-organ-specific autoantibodies is associated with a negative response to combination therapy with interferon and ribavirin for chronic hepatitis C. | BMC infectious diseases 20040101 |
| Intravenous ribavirin for eradication of respiratory syncytial virus (RSV) and adenovirus isolates from the respiratory and/or gastrointestinal tract in recipients of allogeneic hematopoietic stem cell transplants. | The hematology journal : the official journal of the European Haematology Association 20040101 |
| Inhibition of severe acute respiratory syndrome-associated coronavirus (SARSCoV) by calpain inhibitors and beta-D-N4-hydroxycytidine. | Antiviral chemistry & chemotherapy 20040101 |
| Pulmonary sarcoidosis during interferon therapy: a rare or underestimated event? | Annali italiani di medicina interna : organo ufficiale della Societa italiana di medicina interna 20040101 |
| Interferon alpha-2b in combination with ribavirin for the treatment of chronic hepatitis C: assessment of virological, biochemical and histological treatment response. | Medicina (Kaunas, Lithuania) 20040101 |
| [Therapy with interferon plus ribavirin in hemodialysis patient with PCR-positive viral hepatitis C]. | Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia 20040101 |
| The role of ribavirin in the combination therapy of hepatitis C virus infection. | Current pharmaceutical design 20040101 |
| Impact of a designated hepatology nurse on the clinical course and quality of life of patients treated with rebetron therapy for chronic hepatitis C. | Gastroenterology nursing : the official journal of the Society of Gastroenterology Nurses and Associates 20040101 |
| Hepatitis C virus in the setting of HIV or hepatitis B virus coinfection. | Seminars in liver disease 20040101 |
| Lupus pneumonitis or severe acute respiratory syndrome? | Lupus 20040101 |
| New hopes for HIV and HCV coinfection in 2004. | HIV clinical trials 20040101 |
| S-adenosylhomocysteine hydrolase, S-adenosylmethionine, S-adenosylhomocysteine: correlations with ribavirin induced anemia. | Medical hypotheses 20040101 |
| Improvement of liver histopathology in patients with hepatitis C after interferon and ribavirin combination therapy. | Medicina (Kaunas, Lithuania) 20040101 |
| [Antiviral activity of different drugs in vitro against viruses of bovine infectious rhinotracheitis and bovine diarrhea]. | Voprosy virusologii 20040101 |
| Peginterferon-alpha-2a (40kD) plus ribavirin: a review of its use in hepatitis C Virus And HIV co-infection. | Drugs 20040101 |
| [Biotechnological synthesis of ribavirin. Effect of ribavirin and its various combinations on the reproduction of Vaccinia virus]. | Bioorganicheskaia khimiia 20040101 |
| Initial experience with ribavirin plus glycyrrhizin in renal allograft recipients with chronic hepatitis C. | Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology 20040101 |
| [Monitoring of iatrogenic neutropenia: importance of the pharmacovigilance analysis]. | Therapie 20040101 |
| Initial binding of the broad spectrum antiviral nucleoside ribavirin to the hepatitis C virus RNA polymerase. | The Journal of biological chemistry 20031226 |
| High-dose pulse versus nonpulse corticosteroid regimens in severe acute respiratory syndrome. | American journal of respiratory and critical care medicine 20031215 |
| Treatment of severe acute respiratory syndrome in health-care workers. | Lancet (London, England) 20031213 |
| Didanosine-ribavirin combination: synergistic combination in vitro, but high potential risk of toxicity in vivo. | AIDS (London, England) 20031205 |
| Peginterferon-based therapy for chronic hepatitis C virus infection in patients with normal alanine aminotransferase levels. | Annals of internal medicine 20031202 |
| Heterocyclic rimantadine analogues with antiviral activity. | Bioorganic & medicinal chemistry 20031201 |
| Pilot study of pegylated interferon alfa-2b and ribavirin for recurrent hepatitis C after liver transplantation. | Transplantation proceedings 20031201 |
| [Clinical study on effect of jiexiao oral liquid in preventing and curing virus induced asthma in children]. | Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine 20031201 |
| Sustained response to interferon-ribavirin combination therapy predicted by a model of hepatitis C virus dynamics using both HCV RNA and alanine aminotransferase. | Antiviral therapy 20031201 |
| Folic acid supplementation does not prevent ribavirin-induced anemia. | Puerto Rico health sciences journal 20031201 |
| Low daily dosage of interferon for 1 year after HCV-related end-therapy response. A randomized-controlled study. | Liver international : official journal of the International Association for the Study of the Liver 20031201 |
| [Combined interferon-alfa-2b and ribavirin therapy in patients with recurrent chronic hepatitis c after liver transplantation]. | Orvosi hetilap 20031130 |
| HPLC determination of tiazofurin in the rat brain. | Journal of pharmaceutical and biomedical analysis 20031124 |
| Inhibition of caffeine biosynthesis in tea (Camellia sinensis) and coffee (Coffea arabica) plants by ribavirin. | FEBS letters 20031120 |
| Hepatitis C virus (HCV) and human immunodeficiency virus (HIV) dynamics during HCV treatment in HCV/HIV coinfection. | The Journal of infectious diseases 20031115 |
| Successful treatment of hepatitis C after kidney transplantation with combined interferon alpha-2b and ribavirin. | Journal of hepatology 20031101 |
| Outcomes of interferon alpha and ribavirin treatment for chronic hepatitis C in patients with normal serum aminotransaminases. | Gut 20031101 |
| The clinical and immunologic impact of using interferon and ribavirin in the immunosuppressed host. | Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20031101 |
| How can we identify better those with recurrent hepatitis C who will respond to therapy? What are the optimal treatment regimen and treatment duration? | Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20031101 |
| Daily induction combination treatment with alpha 2b interferon and ribavirin or standard combination treatment in naive chronic hepatitis C patients. A multicentre randomized controlled trial. | Journal of viral hepatitis 20031101 |
| Vogt-Koyanagi-Harada disease associated with interferon alpha-2b/ribavirin combination therapy. | Journal of viral hepatitis 20031101 |
| Synthesis of 2-(3'-azido- and 3'-amino-3'-deoxy-beta-D-ribofuranosyl)thiazole-4-carboxamide. | Nucleosides, nucleotides & nucleic acids 20031101 |
| SARS: pharmacotherapy. | Respirology (Carlton, Vic.) 20031101 |
| Synthesis and biological evaluation of thymine nucleosides fused with 3',4'-tetrahydrofuran ring. | Bioorganic & medicinal chemistry letters 20031020 |
| Left ventricular performance in patients with severe acute respiratory syndrome: a 30-day echocardiographic follow-up study. | Circulation 20031014 |
| De novo synthesis of two new cytotoxic tiazofurin analogues with modified sugar moieties. | Bioorganic & medicinal chemistry letters 20031006 |
| Ribavirin, viramidine and adenosine-deaminase-catalysed drug activation: implication for nucleoside prodrug design. | The Journal of antimicrobial chemotherapy 20031001 |
| Identification of a ribavirin-resistant NS5B mutation of hepatitis C virus during ribavirin monotherapy. | Hepatology (Baltimore, Md.) 20031001 |
| Infants born to mothers with severe acute respiratory syndrome. | Pediatrics 20031001 |
| A young infant with severe acute respiratory syndrome. | Pediatrics 20031001 |
| Children hospitalized with severe acute respiratory syndrome-related illness in Toronto. | Pediatrics 20031001 |
| Therapy with interferon-alpha plus ribavirin for membranoproliferative glomerulonephritis induced by hepatitis C virus. | The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases 20031001 |
| Rosacea fulminans associated with pegylated interferon alpha-2B and ribavirin therapy. | Journal of drugs in dermatology : JDD 20031001 |
| [Use of erythropoietin in the treatment of anemia induced by ribavirin/interferon in patients with hepatitis C]. | Pathologie-biologie 20031001 |
| Successful treatment of hepatitis C in a patient with advanced AIDS and decompensated cirrhosis. | The AIDS reader 20031001 |
| [Therapy of viral hepatitis]. | Therapeutische Umschau. Revue therapeutique 20031001 |
| [Cotton-wool spots appearing during the course of treatment with interferon and ribavirin]. | Gastroenterologie clinique et biologique 20031001 |
| [Clinical diagnosis, treatment and prognosis of elderly SARS patients]. | Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae 20031001 |
| Peginterferon-alpha 2a (40 kDa)/ribavirin combination for the treatment of chronic hepatitis C infection. | Expert review of anti-infective therapy 20031001 |
| [Severe acute respiratory syndrome (SARS). The questions raised by the management of a patient in Besançon and Strasbourg]. | Presse medicale (Paris, France : 1983) 20030913 |
| Mutagenic and inhibitory effects of ribavirin on hepatitis C virus RNA polymerase. | Biochemistry 20030909 |
| High body mass index is an independent risk factor for nonresponse to antiviral treatment in chronic hepatitis C. | Hepatology (Baltimore, Md.) 20030901 |
| The effect of early treatment in children with chronic hepatitis. | Journal of pediatric gastroenterology and nutrition 20030901 |
| Intracerebral haemorrhage and hepatitis C treatment. | Journal of viral hepatitis 20030901 |
| Severe acute respiratory syndrome: clinical outcome and prognostic correlates. | Emerging infectious diseases 20030901 |
| HCV in sickle cell disease. | Journal of the National Medical Association 20030901 |
| Severe acute respiratory syndrome: Relapse? Hospital infection? | Emerging infectious diseases 20030901 |
| Synthesis and antiviral activity of novel C-methyl branched cyclopropyl nucleosides. | Archives of pharmacal research 20030901 |
| [Controlled clinical study on 49 patients of SARS treated by integrative Chinese and Western medicine]. | Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine 20030901 |
| [Evaluation on effect of integrative medical treatment on quality of life of rehabilitation stage in 85 patients with SARS]. | Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine 20030901 |
| Effect of antiviral treatment in patients with chronic HCV infection and t(14;18) translocation. | Blood 20030815 |
| Synthesis of 1,2,3-triazolo-carbanucleoside analogues of ribavirin targeting an HCV in replicon. | Bioorganic & medicinal chemistry 20030815 |
| [Hepatitis: associated diseases. Risk groups -- prevention -- treatment]. | Praxis 20030813 |
| Combination therapy in the treatment of chronic viral hepatitis and prevention of hepatocellular carcinoma. | International immunopharmacology 20030801 |
| Current treatment for acute viral bronchiolitis in infants. | Expert opinion on pharmacotherapy 20030801 |
| Interferon and ribavirin treatment in patients with hepatitis C-associated renal disease and renal insufficiency. | Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20030801 |
| Hepatitis C: a review of diagnosis, management, and ocular complications from treatment. | Optometry (St. Louis, Mo.) 20030801 |
| Blood serum glutathione alpha s-transferase (alpha GST) activity during antiviral therapy in patients with chronic hepatitis C. | Medical science monitor : international medical journal of experimental and clinical research 20030801 |
| Cost-effectiveness of treatment for chronic hepatitis C infection in an evolving patient population. | JAMA 20030709 |
| Curing of foot-and-mouth disease virus from persistently infected cells by ribavirin involves enhanced mutagenesis. | Virology 20030705 |
| Synergistic in vitro interactions between alpha interferon and ribavirin against bovine viral diarrhea virus and yellow fever virus as surrogate models of hepatitis C virus replication. | Antimicrobial agents and chemotherapy 20030701 |
| Maintenance therapy with ribavirin in patients with chronic hepatitis C who fail to respond to combination therapy with interferon alfa and ribavirin. | Hepatology (Baltimore, Md.) 20030701 |
| Effect of treatment with peginterferon or interferon alfa-2b and ribavirin on steatosis in patients infected with hepatitis C. | Hepatology (Baltimore, Md.) 20030701 |
| Long-term ribavirin therapy in hepatitis C virus-positive renal transplant patients: effects on renal function and liver histology. | American journal of kidney diseases : the official journal of the National Kidney Foundation 20030701 |
| Severe acute respiratory syndrome in children: experience in a regional hospital in Hong Kong. | Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies 20030701 |
| Current therapies for chronic hepatitis C. Drug combination achieves sustained response in more than half of patients. | Postgraduate medicine 20030701 |
| Fatal lactic acidosis and pancreatitis associated with ribavirin and didanosine therapy. | The AIDS reader 20030701 |
| Editorial comment: drug-drug interactions, hepatitis C, and mitochondrial toxicity. | The AIDS reader 20030701 |
| Advances in clinical diagnosis and treatment of severe acute respiratory syndrome. | World journal of gastroenterology 20030615 |
| In vitro sensitivity of hematopoietic progenitors to tiazofurin in refractory acute myeloid leukemia and in the blast crisis of chronic myeloid leukemia. | Cancer letters 20030610 |
| The effect of ribavirin and IMPDH inhibitors on hepatitis C virus subgenomic replicon RNA. | Virology 20030605 |
| Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area. | JAMA 20030604 |
| A pilot study of eicosapentaenoic acid therapy for ribavirin-related anemia in patients with chronic hepatitis C. | International journal of molecular medicine 20030601 |
| Ribavirin and alpha interferon enhance death receptor-mediated apoptosis and caspase activation in human hepatoma cells. | Antimicrobial agents and chemotherapy 20030601 |
| Severe migraine headaches are caused by ribavirin but not by interferon alpha-2B in combination therapy for chronic hepatitis C. | Journal of hepatology 20030601 |
| Triple therapy with amantadine in treatment-naive patients with chronic hepatitis C: a placebo-controlled trial. | Hepatology (Baltimore, Md.) 20030601 |
| Recurrent allograft HCV presenting as acute cellular rejection: successful management with interferon and ribavirin alone. | Clinical transplantation 20030601 |
| Pretreatment of chronic active hepatitis C in patients coinfected with HIV and hepatitis C virus reduces the hepatotoxicity associated with subsequent antiretroviral therapy. | Journal of acquired immune deficiency syndromes (1999) 20030601 |
| Correlation of sICAM-1 and sVCAM-1 level with biochemical, histological and viral findings in chronic hepatitis C after interferon-alpha + ribavirin therapy. | Romanian journal of gastroenterology 20030601 |
| [52-year-old patient with subcutaneous space-occupying lesion in immunosuppression]. | Der Internist 20030601 |
| Spiro[pyrrolidine-2,2'-adamantanes]: synthesis, anti-influenza virus activity and conformational properties. | Bioorganic & medicinal chemistry letters 20030519 |
| Clinical presentations and outcome of severe acute respiratory syndrome in children. | Lancet (London, England) 20030517 |
| Two distinct phases of virus-induced nuclear factor kappa B regulation enhance tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in virus-infected cells. | The Journal of biological chemistry 20030516 |
| A cluster of cases of severe acute respiratory syndrome in Hong Kong. | The New England journal of medicine 20030515 |
| A major outbreak of severe acute respiratory syndrome in Hong Kong. | The New England journal of medicine 20030515 |
| Interferon-ribavirin in association with stavudine has no impact on plasma human immunodeficiency virus (HIV) type 1 level in patients coinfected with HIV and hepatitis C virus: a CORIST-ANRS HC1 trial. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20030515 |
| Ribavirin in the treatment of SARS: A new trick for an old drug? | CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20030513 |
| Development of a standard treatment protocol for severe acute respiratory syndrome. | Lancet (London, England) 20030510 |
| [SARS--the facts. Transmission, diagnosis and managing suspected cases]. | MMW Fortschritte der Medizin 20030508 |
| Didanosine, interferon-alfa and ribavirin: a highly synergistic combination with potential activity against HIV-1 and hepatitis C virus. | AIDS (London, England) 20030502 |
| Pegylated IFN-alpha2b plus ribavirin as therapy for chronic hepatitis C in HIV-infected patients. | AIDS (London, England) 20030502 |
| Effects of alpha interferon induction plus ribavirin with or without amantadine in the treatment of interferon non-responsive chronic hepatitis C: a randomised trial. | Gut 20030501 |
| Retreatment with interferon and ribavirin vs interferon alone according to viraemia in interferon responder-relapser hepatitis C patients: a prospective multicentre randomized controlled study. | Journal of viral hepatitis 20030501 |
| Combination treatment of IFNalpha2b and ribavirin in patients with chronic hepatitis C and persistently normal ALTs. | Digestive diseases and sciences 20030501 |
| Severe acute respiratory syndrome. The Mount Sinai experience. | The Canadian nurse 20030501 |
| Ribavirin reduces clinical signs and pathological changes of experimental autoimmune encephalomyelitis in Dark Agouti rats. | Journal of neuroscience research 20030415 |
| Hemoglobinuria with ribavirin treatment. | Journal of clinical gastroenterology 20030401 |
| Interferon and ribavirin therapy for chronic hepatitis C virus genotype 6: a comparison with genotype 1. | The Journal of infectious diseases 20030401 |
| Sustained response to combination therapy in patients with chronic hepatitis C who failed to respond to interferon. | Journal of hepatology 20030401 |
| Low mortality rates related to respiratory virus infections after bone marrow transplantation. | Bone marrow transplantation 20030401 |
| Synthesis of carbocyclic 1-[4-(hydroxymethyl)cyclopent-2-enyl]-1,2,4-triazole-3-carboxamide and its derivatives. | Nucleosides, nucleotides & nucleic acids 20030401 |
| [Hepatitis C and alcohol, which is the limit?]. | Revue medicale de la Suisse romande 20030401 |
| Lethal mutagenesis of the prototypic arenavirus lymphocytic choriomeningitis virus (LCMV). | Virology 20030330 |
| Progressive vaccinia. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20030315 |
| Therapy of chronic hepatitis C: a critical review. | Current drug targets. Infectious disorders 20030301 |
| Ribavirin and interferon is effective for hepatitis C virus clearance in hepatitis B and C dually infected patients. | Hepatology (Baltimore, Md.) 20030301 |
| Prediction of treatment outcome in patients with chronic hepatitis C: significance of baseline parameters and viral dynamics during therapy. | Hepatology (Baltimore, Md.) 20030301 |
| Structural analysis of the activation of ribavirin analogs by NDP kinase: comparison with other ribavirin targets. | Molecular pharmacology 20030301 |
| Interferon-alpha 2b plus ribavirin in patients with chronic hepatitis C after liver transplantation: a randomized study. | Gastroenterology 20030301 |
| Discordance between ALT values and fibrosis in liver transplant recipients treated with ribavirin for recurrent hepatitis C. | American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20030301 |
| Interferon, ribavirin, 6-azauridine and glycyrrhizin: antiviral compounds active against pathogenic flaviviruses. | Antiviral research 20030301 |
| Crystal structures of Tritrichomonasfoetus inosine monophosphate dehydrogenase in complex with substrate, cofactor and analogs: a structural basis for the random-in ordered-out kinetic mechanism. | Journal of molecular biology 20030214 |
| Long term histological improvement and clearance of intrahepatic hepatitis C virus RNA following sustained response to interferon-ribavirin combination therapy in liver transplanted patients with hepatitis C virus recurrence. | Gut 20030201 |
| Adherence and mental side effects during hepatitis C treatment with interferon alfa and ribavirin in psychiatric risk groups. | Hepatology (Baltimore, Md.) 20030201 |
| Posterior segment complications in patients with hepatitis C treated with interferon and ribavirin. | Ophthalmology 20030201 |
| Normal erythropoietin response in chronic hepatitis C patients with ribavirin-induced anaemia. | Antiviral therapy 20030201 |
| [Antiviral therapy for chronic viral hepatitis B and C]. | Nihon rinsho. Japanese journal of clinical medicine 20030201 |
| Ribavirin inhibits DNA, RNA, and protein synthesis in PHA-stimulated human peripheral blood mononuclear cells: possible explanation for therapeutic efficacy in patients with chronic HCV infection. | Journal of medical virology 20030101 |
| Management of rabies in humans. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20030101 |
| Hepatitis C virus and human immunodeficiency virus coinfection in an urban population: low eligibility for interferon treatment. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20030101 |
| Successful treatment of giant cell hepatitis with Rebetron (interferon/ribavirin). | The American journal of gastroenterology 20030101 |
| Combination therapy in childhood leukaemia: in vitro studies of thiopurines and inhibitors of purine metabolism on apoptosis. | Annals of clinical biochemistry 20030101 |
| Potential antiviral therapeutics for smallpox, monkeypox and other orthopoxvirus infections. | Antiviral research 20030101 |
| In vitro activity of potential anti-poxvirus agents. | Antiviral research 20030101 |
| [IMP dehydrogenase]. | Nihon rinsho. Japanese journal of clinical medicine 20030101 |
| Effect of ribavirin and amantadine on early hepatitis C virus RNA rebound and clearance in serum during daily high-dose interferon. | Digestive diseases and sciences 20030101 |
| Peginterferon-alpha-2a (40kD) plus ribavirin: a review of its use in the management of chronic hepatitis C. | Drugs 20030101 |
| Ribavirin in cancer immunotherapies: controlling nitric oxide augments cytotoxic lymphocyte function. | Neoplasia (New York, N.Y.) 20030101 |
| [Current treatment options for acute bronchiolitis in children]. | Medicina (Kaunas, Lithuania) 20030101 |
| Triple combination of interferon alpha-2b, ribavirin, and amantadine for treatment of chronic hepatitis C. | Journal of clinical gastroenterology 20030101 |
| [Drug therapy of hepatitis B and C]. | Duodecim; laaketieteellinen aikakauskirja 20030101 |
| [Is there a place for ribavirin in the treatment for renal transplant patients infected by hepatitis C virus?]. | Nephrologie 20030101 |
| [Chronic viral hepatitis]. | Vestnik Rossiiskoi akademii meditsinskikh nauk 20030101 |
| Hepatitis C virus therapies: current treatments, targets and future perspectives. | Antiviral chemistry & chemotherapy 20030101 |
| Ribavirin derivatives with a hexitol moiety: synthesis and antiviral evaluation. | Antiviral chemistry & chemotherapy 20030101 |
| Targeting signal transduction. | Advances in enzyme regulation 20030101 |
| Early HCV RNA changes in patients with chronic hepatitis C treated with peginterferon alfa 2b and ribavirin. | Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion 20030101 |
| [Protective effect of olanzapine in psychotic disorder induced by interferon-alpha]. | Recenti progressi in medicina 20030101 |
| Interferon-alpha (IFN alpha) daily dose versus IFN alpha plus ribavirin for treatment-naive chronic hepatitis c patients infected by genotype 1b. | BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 20030101 |
| Clinical trial results of peginterferons in combination with ribavirin. | Seminars in liver disease 20030101 |
| Retreatment of hepatitis C non-responsive to interferon. A placebo controlled randomized trial of ribavirin monotherapy versus combination therapy with Ribavirin and Interferon in 121 patients in the Benelux [ISRCTN53821378]. | BMC gastroenterology 20030101 |
| Treatment of interferon-induced psychosis in patients with comorbid hepatitis C and HIV. | Psychosomatics 20030101 |
| A severe hepatitis flare in an HBV-HCV coinfected patient during combination therapy with alpha-interferon and ribavirin. | Journal of gastroenterology 20030101 |
| Genetic heterogeneity of hepatitis C virus (HCV) in clinical strains of HIV positive and HIV negative patients chronically infected with HCV genotype 3a. | Journal of biological regulators and homeostatic agents 20030101 |
| Occult HBV infection and suppression of HCV replication in the early phase of combination therapy for chronic hepatitis C. | Journal of biological regulators and homeostatic agents 20030101 |
| Discrepancy in virological and biochemistry response of patients with chronic hepatitis HCV positive on treatment with PEG-IFN plus ribavirin. | Journal of biological regulators and homeostatic agents 20030101 |
| Synthesis and antiviral evaluation of ribavirin congeners containing a hexitol moiety. | Nucleosides, nucleotides & nucleic acids 20030101 |
| A new tiazofurin pronucleotide: synthesis and biological evaluation of cyclosaligenyl-tiazofurin monophosphate. | Nucleosides, nucleotides & nucleic acids 20030101 |
| Anemia in the treatment of hepatitis C virus infection. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20030101 |
| [Therapy with interferon alfa and ribavirin in patients with chronic hepatitis C and normal levels of alanine aminotransferase]. | Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti 20030101 |
| [Is chronic hepatitis C treatment as efficient in the general population as in randomised trials?]. | Gastroenterologie clinique et biologique 20030101 |
| [Benefits of a preventive psychiatric accompaniment in patients Hepatitis C Virus seropositive (HCV): prospective study concerning 39 patients]. | L'Encephale 20030101 |
| Current therapy and new molecular approaches to antiviral treatment and prevention of hepatitis C. | Reviews in medical virology 20030101 |
| Effect of ribavirin, levovirin and viramidine on liver toxicological gene expression in rats. | Journal of applied toxicology : JAT 20030101 |
| Crystal structure of Tritrichomonas foetus inosine monophosphate dehydrogenase in complex with the inhibitor ribavirin monophosphate reveals a catalysis-dependent ion-binding site. | The Journal of biological chemistry 20021227 |
| A thymidine phosphorylase-stable analogue of BVDU with significant antiviral activity. | Journal of medicinal chemistry 20021205 |
| Is delayed normalization of alanine aminotransferase a poor prognostic predictor in chronic hepatitis C patients treated with a combined interferon and ribavirin therapy? | Journal of gastroenterology and hepatology 20021201 |
| Dosage of ribavirin in patients with hepatitis C should be based on renal function: a population pharmacokinetic analysis. | Therapeutic drug monitoring 20021201 |
| Normalization of markedly elevated alpha-fetoprotein in a virologic nonresponder with HCV-related cirrhosis. | Digestive diseases and sciences 20021201 |
| [Hepatitis C virus infection--after 12 years. Advances in the management of chronic hepatitis C]. | Orvosi hetilap 20021201 |
| [Novel mode of action of ribavirin (Rebetol), a drug for the treatment of chronic hepatitis C: inducting the mutation of RNA viruses]. | Nihon yakurigaku zasshi. Folia pharmacologica Japonica 20021201 |
| [ROC curve analysis of factors predictive of response to treatment with interferon plus ribavirin in patients with chronic hepatitis C relapse after previous interferon treatment]. | Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia 20021201 |
| The linkage of glucose to tiazofurin decreases in vitro uptake into rat glioma C6 cells. | Journal of drug targeting 20021201 |
| New warning for ddI. | AIDS patient care and STDs 20021201 |
| Simultaneous LC determination of tiazofurin, its acetyl and benzoyl esters and their active metabolite thiazole-4-carboxamide adenine dinucleotide in biological samples. | Journal of pharmaceutical and biomedical analysis 20021107 |
| Specific, sensitive and accurate liquid chromatographic-tandem mass spectrometric method for the measurement of ribavirin in rat and monkey plasma. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20021105 |
| Conformational restraint is a critical determinant of unnatural nucleotide recognition by protein kinases. | Bioorganic & medicinal chemistry letters 20021104 |
| Ribavirin increases mitogen- and antigen-induced expression of CD40L on CD4+ T cells in vivo. | Clinical and experimental immunology 20021101 |
| A pilot study of interferon alfa and ribavirin combination in liver transplant recipients with recurrent hepatitis C. | Hepatology (Baltimore, Md.) 20021101 |
| Effect of combination therapy (ribavirin and interferon) in HCV-related glomerulopathy. | Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20021101 |
| Optimal therapy of hepatitis C. | Hepatology (Baltimore, Md.) 20021101 |
| Treatment of patients with hepatitis C and normal serum aminotransferase levels. | Hepatology (Baltimore, Md.) 20021101 |
| Combination of interferon alfa-2b and ribavirin in liver transplant recipients with histological recurrent hepatitis C. | Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20021101 |
| Ribavirin dose modification based on renal function is necessary to reduce hemolysis in liver transplant patients with hepatitis C virus infection. | Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20021101 |
| New saponins from the starfish Certonardoa semiregularis. | Journal of natural products 20021101 |
| Viramidine (Ribapharm). | Current opinion in investigational drugs (London, England : 2000) 20021101 |
| [Role of interferons in the treatment of hepatitis B and hepatitis C virus infections]. | La Revue de medecine interne 20021101 |
| The quest for an efficacious antiviral for respiratory syncytial virus. | Antiviral chemistry & chemotherapy 20021101 |
| Inhibitors of the IMPDH enzyme as potential anti-bovine viral diarrhoea virus agents. | Antiviral chemistry & chemotherapy 20021101 |
| Inhibition of the replication of a hepatitis C virus-like RNA template by interferon and 3'-deoxycytidine. | Antiviral chemistry & chemotherapy 20021101 |
| [Acute hepatitis C: response to treatment with interferon-alpha plus ribavirin]. | Gastroenterologia y hepatologia 20021001 |
| Comparison of colorimetric, fluorometric, and visual methods for determining anti-influenza (H1N1 and H3N2) virus activities and toxicities of compounds. | Journal of virological methods 20021001 |
| Bioactive constituents from Iryanthera megistophylla. | Journal of natural products 20021001 |
| Mechanism of cytotoxicity of ribavirin in the rat bone marrow and testis. | Indian journal of physiology and pharmacology 20021001 |
| [Treatment of chronic hepatitis C in patients coinfected with HIV-HCV/HBV]. | Revista de gastroenterologia de Mexico 20021001 |
| [Chronic hepatitis C virus infection: always treat!--Contra]. | Deutsche medizinische Wochenschrift (1946) 20020906 |
| Specific, sensitive and accurate LC-MS/MS method for the measurement of levovirin in rat and monkey plasma. | Journal of pharmaceutical and biomedical analysis 20020905 |
| Urticarial vasculitis with asymptomatic chronic hepatitis C infection: response to doxepin, interferon-alfa, and ribavirin. | Journal of clinical gastroenterology 20020901 |
| Meta-analysis: ribavirin-induced haemolytic anaemia in patients with chronic hepatitis C. | Alimentary pharmacology & therapeutics 20020901 |
| Premature discontinuation of interferon plus ribavirin for adverse effects: a multicentre survey in 'real world' patients with chronic hepatitis C. | Alimentary pharmacology & therapeutics 20020901 |
| Down-regulation of experimental allergic encephalomyelitis in DA rats by tiazofurin. | Journal of neuroimmunology 20020901 |
| Combination therapy/prophylaxis with interferon and ribavirin for recurrent hepatitis C after liver transplantation: long-term effects on graft function and morphology. | Transplantation proceedings 20020901 |
| U.S. veterans' experience with rebetron in a nonstudy environment: success or failure? | The American journal of gastroenterology 20020901 |
| Treatment of subacute sclerosing panencephalitis with interferon-alpha, ribavirin, and inosiplex. | Journal of child neurology 20020901 |
| Non-transferrin-bound iron in untreated and ribavirin-treated chronic hepatitis C patients. | Alimentary pharmacology & therapeutics 20020801 |
| Cytoprotective features of selenazofurin in hematopoietic cells. | International journal of clinical pharmacology and therapeutics 20020801 |
| Synthesis and antiviral evaluation of a mutagenic and non-hydrogen bonding ribonucleoside analogue: 1-beta-D-Ribofuranosyl-3-nitropyrrole. | Biochemistry 20020723 |
| Interferons specifically suppress the translation from the internal ribosome entry site of hepatitis C virus through a double-stranded RNA-activated protein kinase-independent pathway. | The Journal of infectious diseases 20020715 |
| Cytotoxicity and cellular differentiation activity of methylenebis(phosphonate) analogs of tiazofurin and mycophenolic acid adenine dinucleotide in human cancer cell lines. | Cancer letters 20020708 |
| Cidofovir in the treatment of poxvirus infections. | Antiviral research 20020701 |
| Identification of active antiviral compounds against a New York isolate of West Nile virus. | Antiviral research 20020701 |
| Treatment of hepatitis C virus genotype 4-related cirrhosis: ribavirin and interferon combination compared with interferon alone. | Journal of clinical gastroenterology 20020701 |
| Nephrotoxicity of interferon alfa-ribavirin therapy for chronic hepatitis C. | Journal of clinical gastroenterology 20020701 |
| Intravenous ribavirin treatment for severe adenovirus disease in immunocompromised children. | Pediatrics 20020701 |
| Treating hepatitis C in methadone maintenance patients: an interim analysis. | Drug and alcohol dependence 20020701 |
| Genetic diversity and response to IFN of the NS3 protease gene from clinical strains of the hepatitis C virus. | Archives of virology 20020701 |
| Severe respiratory syncytial virus pneumonia complicating fludarabine and cyclophosphamide treatment of chronic lymphocytic leukemia. | European journal of haematology 20020701 |
| Development and validation of a liquid chromatography/tandem mass spectrometry (LC/MS/MS) method for the determination of ribavirin in human plasma and serum. | Journal of pharmaceutical and biomedical analysis 20020620 |
| [Treatment of hepatitis C. Consensus conference]. | Presse medicale (Paris, France : 1983) 20020615 |
| 1-beta-D-arabinofuranosylcytosine inhibits borna disease virus replication and spread. | Journal of virology 20020601 |
| Analysis of sequence configurations of the ISDR, PKR-binding domain, and V3 region as predictors of response to induction interferon-alpha and ribavirin therapy in chronic hepatitis C infection. | Digestive diseases and sciences 20020601 |
| Effect of interferon alpha-ribavirin bitherapy on cytochrome P450 1A2 and 2D6 and N-acetyltransferase-2 activities in patients with chronic active hepatitis C. | Clinical pharmacology and therapeutics 20020601 |
| NIH Consensus Statement on Management of Hepatitis C: 2002. | NIH consensus and state-of-the-science statements 20020601 |
| Approach to the patient with chronic hepatitis C virus infection. | Annals of internal medicine 20020521 |
| Heterocyclic nucleoside analogues: design and synthesis of antiviral, modified nucleosides containing isoxazole heterocycles. | Bioorganic & medicinal chemistry letters 20020520 |
| Needlestick transmission of hepatitis C. | JAMA 20020508 |
| Characterization of wild-type and cidofovir-resistant strains of camelpox, cowpox, monkeypox, and vaccinia viruses. | Antimicrobial agents and chemotherapy 20020501 |
| Mechanism of action of ribavirin in the combination treatment of chronic HCV infection. | Hepatology (Baltimore, Md.) 20020501 |
| Treatment of ribavirin/interferon-induced anemia with erythropoietin in patients with hepatitis C. | Hepatology (Baltimore, Md.) 20020501 |
| Daily or three times a week interferon alfa-2b in combination with ribavirin or interferon alone for the treatment of patients with chronic hepatitis C. | Journal of hepatology 20020501 |
| Combination treatment of influenza A virus infections in cell culture and in mice with the cyclopentane neuraminidase inhibitor RWJ-270201 and ribavirin. | Chemotherapy 20020501 |
| High sustained response to daily dosing of interferon with ribavirin in chronic hepatitis C patients naïve to therapy. | Journal of gastroenterology and hepatology 20020501 |
| Sustained ER Ca2+ depletion suppresses protein synthesis and induces activation-enhanced cell death in mast cells. | The Journal of biological chemistry 20020419 |
| Structure of human nicotinamide/nicotinic acid mononucleotide adenylyltransferase. Basis for the dual substrate specificity and activation of the oncolytic agent tiazofurin. | The Journal of biological chemistry 20020412 |
| In vitro and in vivo activities of anti-influenza virus compound T-705. | Antimicrobial agents and chemotherapy 20020401 |
| Enhanced inhibition of orthopoxvirus replication in vitro by alkoxyalkyl esters of cidofovir and cyclic cidofovir. | Antimicrobial agents and chemotherapy 20020401 |
| The chemistry of nicotinamide adenine dinucleotide (NAD) analogues containing C-nucleosides related to nicotinamide riboside. | Current medicinal chemistry 20020401 |
| Studies on the mechanism of action of benzamide riboside: a novel inhibitor of IMP dehydrogenase. | Current medicinal chemistry 20020401 |
| Benzamide riboside, a recent inhibitor of inosine 5'-monophosphate dehydrogenase induces transferrin receptors in cancer cells. | Current medicinal chemistry 20020401 |
| Metabolism of the novel IMP dehydrogenase inhibitor benzamide riboside. | Current medicinal chemistry 20020401 |
| Toxicity and efficacy of benzamide riboside in cancer chemotherapy models. | Current medicinal chemistry 20020401 |
| [Impact of HIV on HCV, GBV-C/HGV, and HBV infection]. | Nihon rinsho. Japanese journal of clinical medicine 20020401 |
| Hepatic iron concentration does not influence response to therapy with interferon plus ribavirin in chronic HCV infection. | Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 20020401 |
| [Hepatitis C and alcohol]. | Gastroenterologie clinique et biologique 20020401 |
| [Evaluation of response to treatment in chronic hepatitis C]. | Gastroenterologie clinique et biologique 20020401 |
| [Treatment of chronic hepatitis C in patients coinfected with HIV: tolerability, drug interactions, therapeutic indications]. | Gastroenterologie clinique et biologique 20020401 |
| [Chronic hepatitis C: what to do if the first treatment failed?]. | Gastroenterologie clinique et biologique 20020401 |
| New 2-(1-adamantylcarbonyl)pyridine and 1-acetyladamantane thiosemicarbazones-thiocarbonohydrazones: cell growth inhibitory, antiviral and antimicrobial activity evaluation. | Bioorganic & medicinal chemistry letters 20020311 |
| Hepatic HCV RNA before and after treatment with interferon alone or combined with ribavirin. | Hepatology (Baltimore, Md.) 20020301 |
| Evaluation of the antiviral activity against Junin virus of macrocyclic trichothecenes produced by the hypocrealean epibiont of Baccharis coridifolia. | Planta medica 20020301 |
| [Treatment strategies for viral hepatitis]. | [Hokkaido igaku zasshi] The Hokkaido journal of medical science 20020301 |
| A survey of Australian general practice management of hepatitis C-infected patients from non-English-speaking backgrounds. | Journal of gastroenterology and hepatology 20020301 |
| HIV and hepatitis C. | The Hopkins HIV report : a bimonthly newsletter for healthcare providers 20020301 |
| Interferon-alpha induced transient thyroid dysfunction in hepatitis C. | Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva 20020301 |
| Drugs for non-HIV viral infections. | The Medical letter on drugs and therapeutics 20020204 |
| High-dose interferon alfa-2b and ribavirin in patients previously treated with interferon: results of a prospective, randomized, controlled trial. | Journal of clinical gastroenterology 20020201 |
| Sustained suppression of hepatitis C virus by interferon and ribavirin in hemophilic patients not responding to interferon monotherapy. | Blood 20020201 |
| Treatment of hepatitis B and C following liver transplantation. | Current gastroenterology reports 20020201 |
| New approaches to respiratory infections in children. Bronchiolitis and croup. | Emergency medicine clinics of North America 20020201 |
| [Hepatic transplantation and HBV reinfection]. | Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 20020201 |
| Interferon-alpha plus ribavirin for 12 months increases the sustained response rates in chronic hepatitis C relapsers. | Alimentary pharmacology & therapeutics 20020201 |
| Interferon-induced depression treated with citalopram. | The Journal of clinical psychiatry 20020201 |
| Serum tumour necrosis factor-alpha and transforming growth factor-beta levels in chronic hepatitis C patients are immunomodulated by therapy. | Cytokine 20020121 |
| Ribavirin-induced sperm shape abnormalities in Wistar rat. | Mutation research 20020115 |
| Efficacy of interferon alpha-2b and ribavirin against West Nile virus in vitro. | Emerging infectious diseases 20020101 |
| Inhibition of warfarin activity by ribavirin. | The Annals of pharmacotherapy 20020101 |
| Apoptosis in cultured human fetal membrane cells infected with influenza virus. | Biological & pharmaceutical bulletin 20020101 |
| Monitoring of clinical and laboratory data in two cases of imported Lassa fever. | Microbes and infection 20020101 |
| Viral dynamics and pharmacokinetics in combined interferon alfa-2b and ribavirin therapy for patients infected with hepatitis C virus of genotype 1b and high pretreatment viral load. | Intervirology 20020101 |
| Interferon-alpha in combination with ribavirin for the treatment of chronic hepatitis C in patients with persistently normal aminotransferase levels. | Digestion 20020101 |
| Effect of ribavirin on epididymal sperm count in rat. | Indian journal of physiology and pharmacology 20020101 |
| [Study of the effect of antiviral drugs on the reproduction of the respiratory syncytial virus by enzyme immunoassay]. | Voprosy virusologii 20020101 |
| Management of hepatitis C virus infections in intravenous drug users. | Acta gastro-enterologica Belgica 20020101 |
| [Steroids, interferon-alpha and ribavirin treatment of cryoglobulinemic glomerulonephritis concurrent with HCV infection]. | Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia 20020101 |
| Coumarins and pyranocoumarins, potential novel pharmacophores for inhibition of measles virus replication. | Antiviral chemistry & chemotherapy 20020101 |
| Antiviral activity of brassinosteroids derivatives against measles virus in cell cultures. | Antiviral chemistry & chemotherapy 20020101 |
| Clinical experiences with interferon as monotherapy or in combination with ribavirin in patients co-infected with HIV and HCV. | HIV clinical trials 20020101 |
| [Study of the antiviral mechanism of action of ribavirin in the bovine viral diarrhea virus model]. | Gastroenterologie clinique et biologique 20020101 |
| Emotional distress during interferon-alpha-2B and ribavirin treatment of chronic hepatitis C. | Psychosomatics 20020101 |
| High rate of sustained response to consensus interferon plus ribavirin in chronic hepatitis C patients resistant to alpha-interferon and ribavirin: a pilot study. | Journal of gastroenterology 20020101 |
| Treatment of acute hepatitis C virus infection with interferon-alpha 2b and ribavirin: case report and review of the literature. | Annals of clinical microbiology and antimicrobials 20020101 |
| Evaluation of ribavirin efficacy and tolerance in subjects with chronic hepatitis C virus infection. | Vojnosanitetski pregled 20020101 |
| Pleiotropic mechanisms of ribavirin antiviral activities. | Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques 20020101 |
| Ribavirin in cancer immunotherapies: controlling nitric oxide helps generate cytotoxic lymphocyte. | Cancer biology & therapy 20020101 |
| Search of antimicrobial activity of selected non-antibiotic drugs. | Acta poloniae pharmaceutica 20020101 |
| Chronic hepatitis C--treatment results in northern India. | Tropical gastroenterology : official journal of the Digestive Diseases Foundation 20020101 |
| [Acute hepatitis C]. | Przeglad epidemiologiczny 20020101 |
| [Application of tiazofurin in the study of regulation of AMP deaminase in intact malignant cells]. | Glas. Srpska akademija nauka i umetnosti. Odeljenje medicinskih nauka 20020101 |
| [Chronic liver diseases. The nihilism has gone]. | MMW Fortschritte der Medizin 20011213 |
| Effect on treatment outcome of coinfection with SEN viruses in patients with hepatitis C. | Lancet (London, England) 20011208 |
| Hepatitis C virus RNA-dependent RNA polymerase (NS5B) as a mediator of the antiviral activity of ribavirin. | The Journal of biological chemistry 20011207 |
| The impact of HIV therapy on co-infection with hepatitis B and hepatitis C viruses. | Current opinion in infectious diseases 20011201 |
| The mechanism of action of ribavirin: lethal mutagenesis of RNA virus genomes mediated by the viral RNA-dependent RNA polymerase. | Current opinion in infectious diseases 20011201 |
| Treatment of chronic hepatitis. | BMJ (Clinical research ed.) 20011117 |
| Long-term efficacy of combination therapy with interferon-alpha 2b and ribavirin for severe chronic hepatitis C in HIV-infected patients. | AIDS (London, England) 20011109 |
| Interferon and ribavirin combination therapy for chronic hepatitis C in human immunodeficiency virus-infected patients with congenital coagulation disorders. | Hepatology (Baltimore, Md.) 20011101 |
| Management of interferon therapy nonresponders. | Clinics in liver disease 20011101 |
| Treatment of hepatitis C virus and HIV co-infections. | Clinics in liver disease 20011101 |
| Predicting response to initial therapy with interferon plus ribavirin in chronic hepatitis C using serum HCV RNA results during therapy. | Journal of viral hepatitis 20011101 |
| In vitro evaluation of secoiridoid glucosides from the fruits of Ligustrum lucidum as antiviral agents. | Chemical & pharmaceutical bulletin 20011101 |
| Interferon-alpha plus ribavirin and amantadine in patients with post-transplant hepatitis C: results of a pilot study. | Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20011101 |
| Antiviral activity and mode of action studies of ribavirin and mycophenolic acid against orthopoxviruses in vitro. | Antiviral chemistry & chemotherapy 20011101 |
| Utilization of alpha-1-acid glycoprotein levels in the serum as a parameter for in vivo assay of influenza virus inhibitors. | Antiviral chemistry & chemotherapy 20011101 |
| Retinopathy in chronic hepatitis C patients during interferon treatment with ribavirin. | The British journal of ophthalmology 20011001 |
| Recurrent hepatitis C after liver transplantation: a nonrandomized trial of interferon alfa alone versus interferon alfa and ribavirin. | Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20011001 |
| Combined therapy with interferon and low-dose ribavirin in posttransplantation recurrent hepatitis C: a pragmatic study. | Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20011001 |
| Comparative effects of different doses of ribavirin plus interferon-alpha2b for therapy of chronic hepatitis C: results of a controlled, randomized trial. | Digestive diseases and sciences 20011001 |
| Cell adhesion molecules and hyaluronic acid as markers of inflammation, fibrosis and response to antiviral therapy in chronic hepatitis C patients. | Mediators of inflammation 20011001 |
| Pre-emptive oral ribavirin therapy of paramyxovirus infections after haematopoietic stem cell transplantation: a pilot study. | Bone marrow transplantation 20011001 |
| Therapeutic advances in the management of hepatitis B and hepatitis C. | Current opinion in infectious diseases 20011001 |
| Chronic hepatitis C in HIV infection: feasibility and sustained efficacy of therapy with interferon alfa-2b and tribavirin. | AIDS (London, England) 20010928 |
| Novel carbocyclic nucleosides containing a cyclobutyl ring: adenosine analogues. | Chemical & pharmaceutical bulletin 20010901 |
| A preliminary study of erythropoietin for anemia associated with ribavirin and interferon-alpha. | The American journal of gastroenterology 20010901 |
| Treatment of viral hepatitis--2001. | Annals of medicine 20010901 |
| Ribavirin: recent insights into antiviral mechanisms of action. | Current opinion in drug discovery & development 20010901 |
| Novel 3-(2-adamantyl)pyrrolidines with potent activity against influenza A virus-identification of aminoadamantane derivatives bearing two pharmacophoric amine groups. | Bioorganic & medicinal chemistry letters 20010820 |
| Synthesis, mechanism of action, and antiviral activity of a new series of covalent mechanism-based inhibitors of S-adenosyl-L-homocysteine hydrolase. | Journal of medicinal chemistry 20010816 |
| Design, synthesis, DNA binding, and biological evaluation of water-soluble hybrid molecules containing two pyrazole analogues of the alkylating cyclopropylpyrroloindole (CPI) subunit of the antitumor agent CC-1065 and polypyrrole minor groove binders. | Journal of medicinal chemistry 20010802 |
| Impairment of metabolic function in chronic hepatitis C is related to factors associated with resistance to therapy. | The American journal of gastroenterology 20010801 |
| Changes in serum lipoprotein profile during interferon therapy in chronic hepatitis C. | The American journal of gastroenterology 20010801 |
| Ribavirin--current status of a broad spectrum antiviral agent. | Expert opinion on pharmacotherapy 20010801 |
| Digestive disease week 2001. American association for the study of liver diseases. 19-23 May 2001, Atlanta, GA, USA. | IDrugs : the investigational drugs journal 20010801 |
| A randomized 4-arm multicenter study of interferon alfa-2b plus ribavirin in the treatment of patients with chronic hepatitis C not responding to interferon alone. | Hepatology (Baltimore, Md.) 20010701 |
| Treatment of hepatitis C infection in injection drug users. | Hepatology (Baltimore, Md.) 20010701 |
| Ribavirin treatment in dialysis patients with chronic hepatitis C virus infection--a pilot study. | Journal of viral hepatitis 20010701 |
| [Combination therapy of IFN and ribavirin]. | Nihon rinsho. Japanese journal of clinical medicine 20010701 |
| Inhibition of measles virus replication by 5'-nor carbocyclic adenosine analogues. | Antiviral chemistry & chemotherapy 20010701 |
| Mitochondrial toxic effects and ribavirin. | Lancet (London, England) 20010602 |
| Mitochondrial toxic effects and ribavirin. | Lancet (London, England) 20010602 |
| A rapid assay for evaluation of antiviral activity against coxsackie virus B3, influenza virus A, and herpes simplex virus type 1. | Journal of virological methods 20010601 |
| Treatment of patients with chronic hepatitis C not responding to interferon with high-dose interferon alpha with or without ribavirin: final results of a prospective randomized trial. Austrian Hepatitis Study Group. | European journal of gastroenterology & hepatology 20010601 |
| Factors influencing ribavirin-induced hemolysis. | Journal of hepatology 20010601 |
| Treatment of adenovirus infections in patients undergoing allogeneic hematopoietic stem cell transplantation. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20010501 |
| Management of recurrent hepatitis C after liver transplantation. | Journal of viral hepatitis 20010501 |
| Pilot study of interferon-alpha and ribavirin treatment in patients with chronic hepatitis C and normal transaminase values. | Journal of viral hepatitis 20010501 |
| Current and future therapies of hepatitis C. | Clinics in liver disease 20010501 |
| Cytokines as predictors for sustained response and as markers for immunomodulation in patients with chronic hepatitis C. | Clinical biochemistry 20010501 |
| Cytokine network in nonresponding chronic hepatitis C patients with genotype 1: role of triple therapy with interferon alpha, ribavirin, and ursodeoxycholate. | Clinical biochemistry 20010501 |
| Vaccinia virus inhibitors as a paradigm for the chemotherapy of poxvirus infections. | Clinical microbiology reviews 20010401 |
| Synthesis and anti-influenza virus activity of tricyclic compounds with a unique amine moiety. | Chemical & pharmaceutical bulletin 20010401 |
| [Chronic hepatitis--new therapeutic options]. | Der Internist 20010401 |
| Uric acid nephrolithiasis associated with interferon and ribavirin treatment of hepatitis C. | Digestive diseases and sciences 20010401 |
| Tumor cell-specific inhibition of inducible nitric oxide synthase activation by tiazofurin. | International immunopharmacology 20010401 |
| Respiratory tract infections caused by respiratory syncytial virus in children. Diagnosis and treatment. | Minerva pediatrica 20010401 |
| Interferon-alpha and ribavirin for the treatment of recurrent hepatitis C after liver transplantation. | Transplantation 20010315 |
| Cyclopentane neuraminidase inhibitors with potent in vitro anti-influenza virus activities. | Antimicrobial agents and chemotherapy 20010301 |
| In vivo influenza virus-inhibitory effects of the cyclopentane neuraminidase inhibitor RJW-270201. | Antimicrobial agents and chemotherapy 20010301 |
| Treatment of chronic hepatitis C with amantadine hydrochloride in patients who had not responded to previous treatment with interferon-alpha and/or ribavirin. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20010301 |
| Combination of interferon and ribavirin in chronic hepatitis C: re-treatment of nonresponders to interferon. | Hepatology (Baltimore, Md.) 20010301 |
| Efficacy of 5 MU of interferon in combination with ribavirin for naïve patients with chronic hepatitis C virus: a randomized controlled trial. | Journal of hepatology 20010301 |
| Conformations of nucleoside analogue 1-(2'-deoxy-beta-D-ribofuranosyl)-1,2,4-triazole-3-carboxamide in different DNA sequence contexts. | Biochemistry 20010213 |
| Time course of serum hepatitis C virus-RNA during chronic hepatitis C treatment accurately predicts the type of response. | Alimentary pharmacology & therapeutics 20010201 |
| Should patients with chronic hepatitis C who have normal ALT levels be treated? | Current gastroenterology reports 20010201 |
| Increased mitochondrial toxicity with ribavirin in HIV/HCV coinfection. | Lancet (London, England) 20010127 |
| A new C-nucleoside analogue of tiazofurin: synthesis and biological evaluation of 2-beta-D-ribofuranosylimidazole-4-carboxamide (imidazofurin). | Bioorganic & medicinal chemistry letters 20010108 |
| Hepatitis B virus-specific T-cell proliferation and cytokine secretion in chronic hepatitis B e antibody-positive patients treated with ribavirin and interferon alpha. | Hepatology (Baltimore, Md.) 20010101 |
| Combination therapy with ribavirin and alpha interferon for the treatment of chronic hepatitis C refractory to interferon. | Alimentary pharmacology & therapeutics 20010101 |
| Current treatment strategies for chronic hepatitis B and C. | Annual review of medicine 20010101 |
| The effects of interferon alpha-2b in combination with ribavirin on health related quality of life and work productivity. | Journal of hepatology 20010101 |
| Sir Hans A. Krebs Centenary Lecture: cancer and clinical targeting. | Advances in enzyme regulation 20010101 |
| A new synthetic methodology for tiazofurin. | Nucleosides, nucleotides & nucleic acids 20010101 |
| Targets of anti-influenza chemotherapy other than neuraminidase and proton pump. | Antiviral chemistry & chemotherapy 20010101 |
| Management strategies for ribavirin-induced hemolytic anemia in the treatment of hepatitis C: clinical and economic implications. | Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 20010101 |
| The in vitro study of influence of four novel platinum compounds on rodent melanoma cells. | Acta poloniae pharmaceutica 20010101 |
| [HVB and HVC infections in nephrology]. | Nephrologie 20010101 |
| [Prevention and treatment of viral hepatitis in renal insufficiency conditions]. | Nephrologie 20010101 |
| Ribavirin and mycophenolic acid potentiate the activity of guanine- and diaminopurine-based nucleoside analogues against hepatitis B virus. | Antiviral research 20001101 |
| [Effect of ribavirin on dynamics of hepatitis C viremia in interferon alpha-treated patiens with response or no response]. | Zeitschrift fur Gastroenterologie 20001101 |
| Antiviral activity of mixed-valence rare earth borotungstate heteropoly blues against influenza virus in mice. | Antiviral chemistry & chemotherapy 20001101 |
| Antiviral activity of NMSO3 against respiratory syncytial virus infection in vitro and in vivo. | Antiviral research 20000701 |
| Treatment of cowpox virus respiratory infections in mice with ribavirin as a single agent or followed sequentially by cidofovir. | Antiviral chemistry & chemotherapy 20000701 |
| Ribavirin: new preparation. An advance, but still no cure-all. | Prescrire international 20000601 |
| The ribavirin analog ICN 17261 demonstrates reduced toxicity and antiviral effects with retention of both immunomodulatory activity and reduction of hepatitis-induced serum alanine aminotransferase levels. | Antimicrobial agents and chemotherapy 20000501 |
| Hematological toxicity associated with tiazofurin-influence on erythropoiesis. | Toxicology letters 20000403 |
| Broad-spectrum antiviral activity of the IMP dehydrogenase inhibitor VX-497: a comparison with ribavirin and demonstration of antiviral additivity with alpha interferon. | Antimicrobial agents and chemotherapy 20000401 |
| Hemolytic anemia induced by ribavirin therapy in patients with chronic hepatitis C virus infection: role of membrane oxidative damage. | Hepatology (Baltimore, Md.) 20000401 |
| Novel approaches to the treatment of hepatitis C virus infection. | Antiviral chemistry & chemotherapy 20000301 |
| Synthesis of 2-(2-adamantyl)piperidines and structure anti-influenza virus A activity relationship study using a combination of NMR spectroscopy and molecular modeling. | Bioorganic & medicinal chemistry letters 19991220 |
| A novel approach to antiviral therapy for influenza. | The Journal of antimicrobial chemotherapy 19991101 |
| Nucleoside and non-nucleoside IMP dehydrogenase inhibitors as antitumor and antiviral agents. | Current medicinal chemistry 19990701 |
| The synthesis and antiviral activity of 4-fluoro-1-beta-D-ribofuranosyl-1H-pyrazole-3-carboxamide. | Nucleosides & nucleotides 19990201 |
| Carboxy terminal variants of Epstein-Barr virus-encoded latent membrane protein 1 during long-term human immunodeficiency virus infection: reliable markers for individual strain identification. | The Journal of infectious diseases 19990101 |
| Treatment of severe recurrent hepatitis C after liver transplantation with ribavirin plus interferon alpha. | Transplantation proceedings 19990101 |
| Effect of ribavirin on zidovudine efficacy and toxicity in vitro: a concentration-dependent interaction. | AIDS research and human retroviruses 19981220 |
| The antiherpesvirus activity of H2G [(R)-9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine] is markedly enhanced by the novel immunosuppressive agent mycophenolate mofetil. | Antimicrobial agents and chemotherapy 19981201 |
| Interferon-alpha-2B and ribavirin in combination for chronic hepatitis C patients not responding to interferon-alpha alone: an Italian multicenter, randomized, controlled, clinical study. | The American journal of gastroenterology 19981201 |
| Severe anemia following combined alpha-interferon/ribavirin therapy of chronic hepatitis C. | Journal of hepatology 19981201 |
| Efficacy of select antivirals against Cryptosporidium parvum in vitro. | FEMS microbiology letters 19981101 |
| Inactivation of S-adenosyl-L-homocysteine hydrolase and antiviral activity with 5',5',6',6'-tetradehydro-6'-deoxy-6'-halohomoadenosine analogues (4'-haloacetylene analogues derived from adenosine). | Journal of medicinal chemistry 19980924 |
| Novel anti-respiratory syncytial(RS) viral compounds: benzodithiin derivatives. | Biochemical and biophysical research communications 19980828 |
| Effects of the ribavirin-interferon alpha combination on cultured peripheral blood mononuclear cells from chronic hepatitis C patients. | Cytokine 19980801 |
| Inhibitory effects of novel nucleoside and nucleotide analogues on Epstein-Barr virus replication. | Antiviral chemistry & chemotherapy 19980501 |
| Inhibition of influenza virus infections in mice by GS4104, an orally effective influenza virus neuraminidase inhibitor. | Antiviral research 19980201 |
| The cooperative effect of interferon-alpha and ribavirin on subacute sclerosing panencephalitis (SSPE) virus infections, in vitro and in vivo. | Antiviral research 19980101 |
| Synergistic anti-influenza virus A (H1N1) activities of PM-523 (polyoxometalate) and ribavirin in vitro and in vivo. | Antimicrobial agents and chemotherapy 19970701 |
| Effects of cirrhosis, interferon and azathioprine on adverse events in patients with chronic hepatitis C treated with ribavirin. | Journal of viral hepatitis 19970701 |
| Liver targeting of nucleoside analogues coupled to galactosyl terminating macromolecules: a new approach to the treatment of a chronic viral hepatitis. | Italian journal of gastroenterology and hepatology 19970601 |
| Carbocyclic oxetanocins lacking the C-3' methylene. | Journal of medicinal chemistry 19970425 |
| Novel 3'-C/N-substituted 2',3'-beta-D-dideoxynucleosides as potential chemotherapeutic agents. 1. Thymidine derivatives: synthesis, structure, and broad spectrum antiviral properties. | Journal of medicinal chemistry 19970214 |
| Regulation of the signal transduction program by drugs. | Advances in enzyme regulation 19970101 |
| Inhibition of sandfly fever Sicilian virus (Phlebovirus) replication in vitro by antiviral compounds. | Research in virology 19970101 |
| Interferon-ribavirin combination therapy for chronic hepatitis C. | Digestive diseases and sciences 19961201 |
| Inhibitory effects of recombinant manganese superoxide dismutase on influenza virus infections in mice. | Antimicrobial agents and chemotherapy 19961101 |
| Prolonged therapy of chronic hepatitis C with ribavirin. | Journal of viral hepatitis 19960901 |
| Synthesis and antiviral activity evaluation of some new aminoadamantane derivatives. 2. | Journal of medicinal chemistry 19960816 |
| Two new naphthoquinones with antiviral activity from Rhinacanthus nasutus. | Journal of natural products 19960801 |
| Synthesis of acyclo-C-nucleosides in the imidazo[1,2-a]pyridine and pyrimidine series as antiviral agents. | Journal of medicinal chemistry 19960705 |
| Antiviral activities of nucleotide heterodimers against human immunodeficiency virus type 1 in vitro. | Antiviral research 19960601 |
| [Ribavirin treatment in patients with chronic hepatitis C refractory to interferon-alpha]. | Gastroenterologia y hepatologia 19960501 |
| Tiazofurin: molecular and clinical action. | Anticancer research 19960101 |
| Synthesis, antiviral activity and enzymatic phosphorylation of 9-phosphonopentenyl derivatives of guanine. | Antiviral research 19950601 |
| Enhancement by 2'-deoxycoformycin of the 5'-phosphorylation and anti-human immunodeficiency virus activity of 2',3'-dideoxyadenosine and 2'-beta-fluoro-2',3'-dideoxyadenosine. | Molecular pharmacology 19941101 |
| Inhibition of influenza virus replication in mice by GG167 (4-guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid) is consistent with extracellular activity of viral neuraminidase (sialidase). | Antimicrobial agents and chemotherapy 19941001 |
| Antiviral and immunomodulating inhibitors of experimentally-induced Punta Toro virus infections. | Antiviral research 19941001 |
| Tricyclic analogues of acyclovir and ganciclovir. Influence of substituents in the heterocyclic moiety on the antiviral activity. | Journal of medicinal chemistry 19940916 |
| Synthesis and antiviral activity evaluation of some aminoadamantane derivatives. | Journal of medicinal chemistry 19940902 |
| Synthesis and antiviral activities of 8-alkynyl-, 8-alkenyl-, and 8-alkyl-2'-deoxyadenosine analogues. | Journal of medicinal chemistry 19940429 |
| Effect of ribavirin on subacute sclerosing panencephalitis virus infections in hamsters. | Antimicrobial agents and chemotherapy 19940401 |
| In vitro and in vivo inhibition of ortho- and paramyxovirus infections by a new class of sulfonic acid polymers interacting with virus-cell binding and/or fusion. | Antimicrobial agents and chemotherapy 19940201 |
| Synthesis and antiviral activity of 5'-deoxypyrazofurin. | Journal of medicinal chemistry 19931112 |
| Antiviral activity of C-alkylated purine nucleosides obtained by cross-coupling with tetraalkyltin reagents. | Journal of medicinal chemistry 19931001 |
| Comparative anti-influenza virus activity of 2'-deoxy-2'-fluororibosides in vitro. | Antiviral research 19930801 |
| Synthesis, antifungal, antibacterial and antiviral effects of some adamantaneketoxime ethers. | Farmaco (Societa chimica italiana : 1989) 19930801 |
| Inhibitory activity of S-adenosylhomocysteine hydrolase inhibitors against human cytomegalovirus replication. | Antiviral research 19930701 |
| 4-Guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid is a highly effective inhibitor both of the sialidase (neuraminidase) and of growth of a wide range of influenza A and B viruses in vitro. | Antimicrobial agents and chemotherapy 19930701 |
| Rational design of potent sialidase-based inhibitors of influenza virus replication. | Nature 19930603 |
| Treatment of lethal Pichinde virus infections in weanling LVG/Lak hamsters with ribavirin, ribamidine, selenazofurin, and ampligen. | Antiviral research 19930101 |
| Synthesis and antiviral activity of some new S-adenosyl-L-homocysteine derivatives. | Journal of medicinal chemistry 19921127 |
| Synthesis and antiviral properties of (+/-)-5'-noraristeromycin and related purine carbocyclic nucleosides. A new lead for anti-human cytomegalovirus agent design. | Journal of medicinal chemistry 19920904 |
| A pilot study of ribavirin therapy for chronic hepatitis C. | Hepatology (Baltimore, Md.) 19920901 |
| Antiviral and antitumor structure-activity relationship studies on tetracyclic eudistomines. | Journal of medicinal chemistry 19920821 |
| Synthesis and antiviral evaluation of N-carboxamidine-substituted analogues of 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamidine hydrochloride. | Journal of medicinal chemistry 19920821 |
| (+-)-carbocyclic 5'-nor-2'-deoxyguanosine and related purine derivatives: synthesis and antiviral properties. | Journal of medicinal chemistry 19920612 |
| Selective inhibition of arthropod-borne and arenaviruses in vitro by 3'-fluoro-3'-deoxyadenosine. | Antiviral research 19920601 |
| Antiviral activities of ribavirin, 5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide, and 6'-(R)-6'-C-methylneplanocin A against several ortho- and paramyxoviruses. | Antimicrobial agents and chemotherapy 19920201 |
| Novobiocin-induced anti-proliferative and differentiating effects in melanoma B16. | British journal of cancer 19920201 |
| Prospective, double-blind, concurrent, placebo-controlled clinical trial of intravenous ribavirin therapy of hemorrhagic fever with renal syndrome. | The Journal of infectious diseases 19911201 |
| Differential inhibitory effects of sulfated polysaccharides and polymers on the replication of various myxoviruses and retroviruses, depending on the composition of the target amino acid sequences of the viral envelope glycoproteins. | Antimicrobial agents and chemotherapy 19911201 |
| Mechanism of the potentiating effect of ribavirin on the activity of 2',3'-dideoxyinosine against human immunodeficiency virus. | The Journal of biological chemistry 19911115 |
| 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (ribavirin) and 5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide (EICAR) markedly potentiate the inhibitory effect of 2',3'-dideoxyinosine on human immunodeficiency virus in peripheral blood lymphocytes. | Biochemical and biophysical research communications 19910731 |
| Broad-spectrum antiviral and cytocidal activity of cyclopentenylcytosine, a carbocyclic nucleoside targeted at CTP synthetase. | Biochemical pharmacology 19910615 |
| Antiviral activities of 5-ethynyl-1-beta-D-ribofuranosylimidazole-4- carboxamide and related compounds. | Antimicrobial agents and chemotherapy 19910401 |
| Antiviral immunotoxins: antibody-mediated delivery of gelonin inhibits Pichinde virus replication in vitro. | Antiviral research 19910201 |
| Ribavirin is an inhibitor of human immunodeficiency virus reverse transcriptase. | Molecular pharmacology 19901201 |
| Inhibitors of IMP dehydrogenase stimulate the phosphorylation of the antiviral nucleoside 2' ,3'-dideoxyguanosine. | Biochemical and biophysical research communications 19900928 |
| Comparative activities of several nucleoside analogs against duck hepatitis B virus in vitro. | Antimicrobial agents and chemotherapy 19900701 |
| Virucidal activity of hypericin against enveloped and non-enveloped DNA and RNA viruses. | Antiviral research 19900601 |
| Inhibition of hepatitis A virus replication in vitro by antiviral compounds. | Journal of medical virology 19900601 |
| Stereospecific synthesis and antiviral properties of different enantiomerically pure carbocyclic 2'-deoxyribonucleoside analogues derived from common chiral pools: (+)-(1R,5S)- and (-)-(1S,5R)-2-oxabicyclo[3.3.0]oct-6-en-3-one. | Journal of medicinal chemistry 19900501 |
| Clinical toxicity associated with tiazofurin. | Investigational new drugs 19900501 |
| Synthesis and biological evaluation of carbocyclic analogues of lyxofuranosides of 2-amino-6-substituted-purines and 2-amino-6-substituted-8-azapurines. | Journal of medicinal chemistry 19900401 |
| Broad-spectrum antiviral activity of carbodine, the carbocyclic analogue of cytidine. | Biochemical pharmacology 19900115 |
| Evaluation of the toxicity and antiviral activity of carbocyclic 3-deazaadenosine against respiratory syncytial and parainfluenza type 3 viruses in tissue culture and in cotton rats. | Antiviral research 19900101 |
| Toxicity and antiviral activity of LY253963 against respiratory syncytial and parainfluenza type 3 viruses in tissue culture and in cotton rats. | Antiviral research 19900101 |
| Inhibitory effect of selected antiviral compounds on arenavirus replication in vitro. | Antiviral research 19900101 |
| Potentiating effect of ribavirin on the in vitro and in vivo antiretrovirus activities of 2',3'-dideoxyinosine and 2',3'-dideoxy-2,6-diaminopurine riboside. | Journal of acquired immune deficiency syndromes 19900101 |
| Antiviral and cytotoxicity evaluation of 3-nitro-3-deazauridine. | Antiviral research 19891201 |
| Novel linked antiviral and antitumor agents related to netropsin and distamycin: synthesis and biological evaluation. | Journal of medicinal chemistry 19891001 |
| Inhibitory effect of selected antiviral compounds on measles (SSPE) virus replication in vitro. | Antiviral research 19890901 |
| Synthesis and antiviral activity of 3'-C-cyano-3'-deoxynucleosides. | Journal of medicinal chemistry 19890801 |
| Synthesis of 3-deazaneplanocin A, a powerful inhibitor of S-adenosylhomocysteine hydrolase with potent and selective in vitro and in vivo antiviral activities. | Journal of medicinal chemistry 19890701 |
| In vitro evaluation of mismatched double-stranded RNA (ampligen) for combination therapy in the treatment of acquired immunodeficiency syndrome. | AIDS research and human retroviruses 19890401 |
| Potentiating effect of ribavirin on the anti-retrovirus activity of 3'-azido-2,6-diaminopurine-2',3'-dideoxyriboside in vitro and in vivo. | Antiviral research 19890101 |
| Prospects for treatment of viral hemorrhagic fevers with ribavirin, a broad-spectrum antiviral drug. | Reviews of infectious diseases 19890101 |
| Marked in vivo antiretrovirus activity of 9-(2-phosphonylmethoxyethyl)adenine, a selective anti-human immunodeficiency virus agent. | Proceedings of the National Academy of Sciences of the United States of America 19890101 |
| Effects of ribamidine, a 3-carboxamidine derivative of ribavirin, on experimentally induced Phlebovirus infections. | Antiviral research 19881201 |
| A newly developed immunofluorescent assay for determining the Pichinde virus-inhibitory effects of selected nucleoside analogues. | Antiviral research 19881101 |
| In vitro and in vivo Phlebovirus inhibition by ribavirin. | Antimicrobial agents and chemotherapy 19880301 |
| Reversible cerebral lesions associated with tiazofurin usage: MR demonstration. | Journal of computer assisted tomography 19880101 |
| A 'new' generation of more potent synthetic antirhinovirus compounds: comparison of their MICs and their synergistic interactions. | Antiviral research 19871101 |
| Ribavirin antagonizes inhibitory effects of pyrimidine 2',3'-dideoxynucleosides but enhances inhibitory effects of purine 2',3'-dideoxynucleosides on replication of human immunodeficiency virus in vitro. | Antimicrobial agents and chemotherapy 19871001 |
| Inhibitory effects of antiviral compounds on respiratory syncytial virus replication in vitro. | Antimicrobial agents and chemotherapy 19870801 |
| Tolerance and antiviral effect of ribavirin in patients with Argentine hemorrhagic fever. | Antiviral research 19870701 |
| Inhibition of murine hepatitis virus infections by the immunomodulator 2,3,5,6,7,8-hexahydro-2-phenyl-8,8-dimethoxy-imidazo[1,2a]pyridine (PR-879-317A). | Antimicrobial agents and chemotherapy 19870701 |
| Enhanced therapeutic efficacy of poly(ICLC) and ribavirin combinations against Rift Valley fever virus infection in mice. | Antimicrobial agents and chemotherapy 19870701 |
| Synthesis and antiviral evaluation of carbocyclic analogues of 2-amino-6-substituted-purine 3'-deoxyribofuranosides. | Journal of medicinal chemistry 19870601 |
| Ribavirin antagonizes the effect of azidothymidine on HIV replication. | Science (New York, N.Y.) 19870313 |
| Nucleic acid related compounds. 51. Synthesis and biological properties of sugar-modified analogues of the nucleoside antibiotics tubercidin, toyocamycin, sangivamycin, and formycin. | Journal of medicinal chemistry 19870301 |
| Selective inhibitory effect of (S)-9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine and 2'-nor-cyclic GMP on adenovirus replication in vitro. | Antimicrobial agents and chemotherapy 19870201 |
| Phase I trial of tiazofurin administered by i.v. bolus daily for 5 days, with pharmacokinetic evaluation. | Cancer treatment reports 19870201 |
| Effect of selenazofurin on influenza A and B virus infections of mice. | Antiviral research 19861001 |
| Structure-activity relationship of novel oligopeptide antiviral and antitumor agents related to netropsin and distamycin. | Journal of medicinal chemistry 19860701 |
| Comparative inhibitory effects of suramin and other selected compounds on the infectivity and replication of human T-cell lymphotropic virus (HTLV-III)/lymphadenopathy-associated virus (LAV). | International journal of cancer 19860315 |
| Influence of twenty potentially antiviral substances on in vitro multiplication of hepatitis A virus. | Antiviral research 19860301 |
| Comparative efficacy of broad-spectrum antiviral agents as inhibitors of rotavirus replication in vitro. | Antiviral research 19860101 |
| Effects of selenazofurin and ribavirin and their 5'-triphosphates on replicative functions of influenza A and B viruses. | Antimicrobial agents and chemotherapy 19860101 |
| Activity of selenazofurin against influenza A and B viruses in vitro. | Antimicrobial agents and chemotherapy 19850901 |
| Antiviral and antimetabolic activities of neplanocins. | Antimicrobial agents and chemotherapy 19850701 |
| Synthesis and antiviral evaluation of nucleosides of 5-methylimidazole-4-carboxamide. | Journal of medicinal chemistry 19850601 |
| Synthesis and antiviral/antitumor activities of certain 3-deazaguanine nucleosides and nucleotides. | Journal of medicinal chemistry 19841101 |
| Synergistic antiviral effects of ribavirin and the C-nucleoside analogs tiazofurin and selenazofurin against togaviruses, bunyaviruses, and arenaviruses. | Antimicrobial agents and chemotherapy 19841001 |
| Antiviral activity of C-5 substituted tubercidin analogues. | Journal of medicinal chemistry 19840301 |
| Combined interferon-alpha 2, rimantadine hydrochloride, and ribavirin inhibition of influenza virus replication in vitro. | Antimicrobial agents and chemotherapy 19840101 |
| Broad-spectrum antiviral activity of 2-beta-D-ribofuranosylselenazole-4-carboxamide, a new antiviral agent. | Antimicrobial agents and chemotherapy 19830901 |
| Broad-spectrum antiviral activity of the carbocyclic analog of 3-deazaadenosine. | Antiviral research 19830301 |
| Synthesis and antiviral activity of certain carbamoylpyrrolopyrimidine and pyrazolopyrimidine nucleosides. | Journal of medicinal chemistry 19821101 |
| Antiviral effects if ribavirin and 6-mercapto-9-tetrahydro-2-furylpurine against dengue viruses in vitro. | Antiviral research 19820501 |
| Inhibition of rotaviruses by selected antiviral substances: mechanisms of viral inhibition and in vivo activity. | Antimicrobial agents and chemotherapy 19820101 |
| In vivo inhibition of respiratory syncytial virus by ribavirin. | Antimicrobial agents and chemotherapy 19820101 |
| Synthesis and antiviral activity of certain 9-beta-D-ribofuranosylpurine-6-carboxamides. | Journal of medicinal chemistry 19810801 |
| Comparative inhibition of influenza and parainfluenza virus replication by ribavirin in MDCK cells. | Antimicrobial agents and chemotherapy 19810501 |
| Enhancement of activity against influenza viruses by combinations of antiviral agents. | Antimicrobial agents and chemotherapy 19801001 |
| Antiherpesviral activity and inhibitory action on cell growth of 5-alkenyl derivatives of 1-beta D-arabinofuranosyluracil. | Antimicrobial agents and chemotherapy 19800601 |
| Amantadine and ribavirin aerosol treatment of influenza A and B infection in mice. | Antimicrobial agents and chemotherapy 19800401 |
| Ribavirin: an antiviral agent. | Pharmacology & therapeutics 19790101 |
| Purines, pyrimidines, and imidazoles. Part 50. Inhibition of adenylosuccinate AMP-lyase No. 4.3.2.2. by derivatives of N-(5-amino-1-beta-D-ribofuranosylimidazole-4-carbonyl)-L-aspartic acid 5'-phosphate (SAICAR) and virazole 5'-phosphate. | Journal of the Chemical Society. Perkin transactions 1 19790101 |
| Synthesis and antiviral and enzymatic studies of certain 3-deazaguanines and their imidazolecarboxamide precursors. | Journal of medicinal chemistry 19781201 |
| Trisodium phosphonoformate, a new antiviral compound. | Science (New York, N.Y.) 19780901 |
| Synthesis and antiviral acticity of some phosphates of the broad-spectrum antiviral nucleoside, 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (ribavirin). | Journal of medicinal chemistry 19780801 |
| Thiazolinone analogues of indolmycin with antiviral and antibacterial activity. | Journal of medicinal chemistry 19780101 |
| Synthesis and antiviral and antimicrobial activity of certain 1-beta-D-ribofuranosyl-4,5-disubstituted imidazoles. | Journal of medicinal chemistry 19760801 |
| Synthesis of tetrazole ribonucleosides and their evaluation as antiviral agents. 2. 5-Amino-1-(beta-D-ribofuranosyl)-1H-tetrazole and 5-amino-2-(beta-D-ribofuranosyl)-2H-tetrazole. | Journal of medicinal chemistry 19760801 |
| Inhibition of vaccinia virus growth by the nucleoside analogue 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (virazole, ribavirin). | The Journal of general virology 19760801 |
| Effect of cytosine, arabinoside, iododeoxyuridine, ethyldeoxyuridine, thiocyanatodeoxyuridine, and ribavirin on tail lesion formation in mice infected with vaccinia virus. | Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 19760301 |
| Synthesis of tetrazole ribonucleosides and their evaluation as antiviral agents. | Journal of medicinal chemistry 19760201 |
| Efficacy of 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide against influenza virus infections in mice. | Antimicrobial agents and chemotherapy 19750501 |
| In vitro effect of virazole against influenza viruses. | Antimicrobial agents and chemotherapy 19731201 |
| Synthesis and antiviral activity of 1,2,4-triazole-3-thiocarboxamide and 1,2,4-triazole-3-carboxamidine ribonucleosides. | Journal of medicinal chemistry 19730801 |
| Suppression by 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (virazole, ICN 1229) of influenza virus-induced infections in mice. | Antimicrobial agents and chemotherapy 19730401 |
| In vitro effect of 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (virazole, ICN 1229) on deoxyribonucleic acid and ribonucleic acid viruses. | Antimicrobial agents and chemotherapy 19730201 |
| Effect of 1-beta-D-ribofuranosyl1-1,2,4-triazole-3-carboxamide (virazole, ICN 1229) on herpes and vaccinia keratitis and encephalitis in laboratory animals. | Antimicrobial agents and chemotherapy 19730201 |
| Design, synthesis, and broad spectrum antiviral activity of 1- -D-ribofuranosyl-1,2,4-triazole-3-carboxamide and related nucleosides. | Journal of medicinal chemistry 19721101 |
| Broad-spectrum antiviral activity of Virazole: 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide. | Science (New York, N.Y.) 19720825 |
Related Products
Featured Products
© 2019 Angene International Limited. All rights Reserved.